10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended JUNE 30, 2011

Commission File Number: 1-3433

THE DOW CHEMICAL COMPANY

(Exact name of registrant as specified in its charter)

Delaware	38-1285128
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

2030 DOW CENTER, MIDLAND, MICHIGAN 48674

(Address of principal executive offices) (Zip Code)

989-636-1000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

þ   Yes    ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

þ  Yes    ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	þ	Accelerated filer	¨
Non-accelerated filer	¨	Smaller reporting company	¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

¨  Yes    þ No

	Outstanding at
Class	June 30, 2011
Common Stock, par value $2.50 per share	1,181,218,850 shares

The Dow Chemical Company

QUARTERLY REPORT ON FORM 10-Q

For the quarterly period ended June 30, 2011

TABLE OF CONTENTS

		PAGE
PART I – FINANCIAL INFORMATION
Item 1.	Financial Statements.	3
	Consolidated Statements of Income	3
	Consolidated Balance Sheets	4
	Consolidated Statements of Cash Flows	5
	Consolidated Statements of Equity	6
	Consolidated Statements of Comprehensive Income	7
	Notes to the Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	40
	Disclosure Regarding Forward-Looking Information	40
	Results of Operations	41
	Changes in Financial Condition	54
	Other Matters	58
Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	62
Item 4.	Controls and Procedures.	63
PART II – OTHER INFORMATION
Item 1.	Legal Proceedings.	64
Item 1A.	Risk Factors.	64
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	64
Item 6.	Exhibits.	64
SIGNATURE		66
EXHIBIT INDEX		67

2

PART I - FINANCIAL INFORMATION

Item 1. Financial Statements.

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Income

	Three Months Ended				Six Months Ended
In millions, except per share amounts (Unaudited)	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011			Jun 30, 2010
Net Sales	$	16,046	$	13,618	$	30,779		$	27,035
Cost of sales	13,551		11,580		25,668			23,121
Research and development expenses	411		407		811			814
Selling, general and administrative expenses	695		648		1,395			1,310
Amortization of intangibles	125		125		248			253
Restructuring charges	—		13		—			29
Acquisition and integration related expenses	—		37		31			63
Equity in earnings of nonconsolidated affiliates	291		244		589			548
Sundry income (expense) - net	80		95		(369		)	178
Interest income	10		10		17			17
Interest expense and amortization of debt discount	328		367		705			743
Income Before Income Taxes	1,317		790		2,158			1,445
Provision for income taxes	240		131		360			234
Net Income	1,077		659		1,798			1,211
Net income attributable to noncontrolling interests	10		8		21			9
Net Income Attributable to The Dow Chemical Company	1,067		651		1,777			1,202
Preferred stock dividends	85		85		170			170
Net Income Available for The Dow Chemical Company Common Stockholders	$	982	$	566	$	1,607		$	1,032
Per Common Share Data:
Earnings per common share - basic	$	0.84	$	0.50	$	1.39		$	0.92
Earnings per common share - diluted	$	0.84	$	0.50	$	1.37		$	0.91
Common stock dividends declared per share of common stock	$	0.25	$	0.15	$	0.40		$	0.30
Weighted-average common shares outstanding - basic	1,149.6		1,125.4		1,144.6			1,121.4
Weighted-average common shares outstanding - diluted	1,160.9		1,141.6		1,156.2			1,138.3
Depreciation	$	526	$	571	$	1,085		$	1,162
Capital Expenditures	$	564	$	397	$	969		$	691

See Notes to the Consolidated Financial Statements.

3

The Dow Chemical Company and Subsidiaries

Consolidated Balance Sheets

In millions (Unaudited)	Jun 30, 2011			Dec 31, 2010
Assets
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2011: $107; 2010: $145)	$	2,223		$	7,039
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2011: $135; 2010: $128)	5,601			4,616
Other	5,150			4,428
Inventories	8,739			7,087
Deferred income tax assets - current	573			611
Other current assets	413			349
Total current assets	22,699			24,130
Investments
Investment in nonconsolidated affiliates	3,469			3,453
Other investments (investments carried at fair value - 2011: $2,015; 2010: $2,064)	2,480			2,542
Noncurrent receivables	341			388
Total investments	6,290			6,383
Property
Property	53,888			51,648
Less accumulated depreciation	35,839			33,980
Net property (variable interest entities restricted - 2011: $1,747; 2010: $1,388)	18,049			17,668
Other Assets
Goodwill	13,079			12,967
Other intangible assets (net of accumulated amortization - 2011: $2,127; 2010: $1,805)	5,389			5,530
Deferred income tax assets - noncurrent	2,057			2,079
Asbestos-related insurance receivables - noncurrent	217			220
Deferred charges and other assets	667			611
Total other assets	21,409			21,407
Total Assets	$	68,447		$	69,588
Liabilities and Equity
Current Liabilities
Notes payable	$	916		$	1,467
Long-term debt due within one year	661			1,755
Accounts payable:
Trade	4,893			4,356
Other	2,305			2,249
Income taxes payable	355			349
Deferred income tax liabilities - current	115			105
Dividends payable	374			257
Accrued and other current liabilities	2,810			3,358
Total current liabilities	12,429			13,896
Long-Term Debt (variable interest entities nonrecourse - 2011: $930; 2010: $167)	18,511			20,605
Other Noncurrent Liabilities
Deferred income tax liabilities - noncurrent	1,238			1,295
Pension and other postretirement benefits - noncurrent	7,552			7,492
Asbestos-related liabilities - noncurrent	643			663
Other noncurrent obligations	3,035			2,995
Total other noncurrent liabilities	12,468			12,445
Stockholders’ Equity
Preferred stock, series A	4,000			4,000
Common stock	2,953			2,931
Additional paid-in capital	2,450			2,286
Retained earnings	18,877			17,736
Accumulated other comprehensive loss	(3,647		)	(4,399		)
Unearned ESOP shares	(448		)	(476		)
Treasury stock at cost	—			(239		)
The Dow Chemical Company’s stockholders’ equity	24,185			21,839
Noncontrolling interests	854			803
Total equity	25,039			22,642
Total Liabilities and Equity	$	68,447		$	69,588

See Notes to the Consolidated Financial Statements.

4

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Cash Flows

	Six Months Ended
In millions (Unaudited)	Jun 30, 2011			Jun 30, 2010
Operating Activities
Net Income	$	1,798		$	1,211
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,428			1,491
Provision (Credit) for deferred income tax	(99		)	51
Earnings of nonconsolidated affiliates less than (in excess of) dividends received	50			(143		)
Pension contributions	(282		)	(133		)
Net gain on sales of investments	(35		)	(34		)
Net (gain) loss on sales of property, businesses and consolidated companies	(6		)	131
Other net loss	—			10
Net gain on sale of ownership interest in nonconsolidated affiliates	(61		)	—
Restructuring charges	—			29
Loss on early extinguishment of debt	482			—
Excess tax benefits from share-based payment arrangements	(14		)	(3		)
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable	(2,721		)	(1,336		)
Proceeds from interests in trade accounts receivable conduits	1,224			867
Inventories	(1,651		)	(598		)
Accounts payable	653			395
Other assets and liabilities	(146		)	(655		)
Cash provided by operating activities	620			1,283
Investing Activities
Capital expenditures	(969		)	(691		)
Construction of assets pending sale / leaseback	(113		)	—
Proceeds from sale / leaseback of assets	80			—
Proceeds from sales of property, businesses and consolidated companies	85			1,651
Acquisitions of businesses	(6		)	(5		)
Purchases of previously leased assets	—			(45		)
Investments in consolidated companies, net of cash acquired	(120		)	(120		)
Investments in nonconsolidated affiliates	(45		)	(76		)
Distributions from nonconsolidated affiliates	27			20
Proceeds from sale of ownership interests in nonconsolidated affiliates	81			—
Change in restricted cash	—			211
Purchases of investments	(427		)	(593		)
Proceeds from sales and maturities of investments	503			585
Cash provided by (used in) investing activities	(904		)	937
Financing Activities
Changes in short-term notes payable	(557		)	(298		)
Proceeds from notes payable	—			84
Payments on notes payable	—			(668		)
Proceeds from issuance of long-term debt	946			325
Payments on long-term debt	(4,738		)	(1,092		)
Purchases of treasury stock	(19		)	(13		)
Proceeds from issuance of common stock	171			79
Proceeds from sales of common stock	98			69
Excess tax benefits from share-based payment arrangements	14			3
Contribution from noncontrolling interests	20			—
Distributions to noncontrolling interests	(22		)	(5		)
Dividends paid to stockholders	(512		)	(506		)
Cash used in financing activities	(4,599		)	(2,022		)
Effect of Exchange Rate Changes on Cash	64			(22		)
Cash Assumed in Initial Consolidation of Variable Interest Entities	3			46
Summary
Increase (Decrease) in cash and cash equivalents	(4,816		)	222
Cash and cash equivalents at beginning of year	7,039			2,846
Cash and cash equivalents at end of period	$	2,223		$	3,068

See Notes to the Consolidated Financial Statements.

5

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Equity

	Six Months Ended
In millions (Unaudited)	Jun 30, 2011			Jun 30, 2010
Preferred Stock
Balance at beginning of year and end of period	$	4,000		$	4,000
Common Stock
Balance at beginning of year	2,931			2,906
Common stock issued	22			11
Balance at end of period	2,953			2,917
Additional Paid-in Capital
Balance at beginning of year	2,286			1,913
Common stock issued	149			68
Stock-based compensation and allocation of ESOP shares	15			44
Balance at end of period	2,450			2,025
Retained Earnings
Balance at beginning of year	17,736			16,704
Net income available for The Dow Chemical Company common stockholders	1,607			1,032
Dividends declared on common stock (per share: $0.40 in 2011, $0.30 in 2010)	(460		)	(337		)
Other	(6		)	(11		)
Impact of adoption of ASU 2009-17, net of tax	—			(248		)
Balance at end of period	18,877			17,140
Accumulated Other Comprehensive Loss
Unrealized Gains on Investments at beginning of year	111			79
Net change in unrealized gains	6			(19		)
Balance at end of period	117			60
Cumulative Translation Adjustments at beginning of year	367			624
Translation adjustments	600			(1,022		)
Balance at end of period	967			(398		)
Pension and Other Postretirement Benefit Plans at beginning of year	(4,871		)	(4,587		)
Adjustments to pension and other postretirement benefit plans	141			149
Balance at end of period	(4,730		)	(4,438		)
Accumulated Derivative Loss at beginning of year	(6		)	(8		)
Net hedging results	(2		)	(3		)
Reclassification to earnings	7			7
Balance at end of period	(1		)	(4		)
Total accumulated other comprehensive loss	(3,647		)	(4,780		)
Unearned ESOP Shares
Balance at beginning of year	(476		)	(519		)
Shares allocated to ESOP participants	28			26
Balance at end of period	(448		)	(493		)
Treasury Stock
Balance at beginning of year	(239		)	(557		)
Purchases	(19		)	(13		)
Issuance to employees and employee plans	258			251
Balance at end of period	—			(319		)
The Dow Chemical Company’s Stockholders’ Equity	24,185			20,490
Noncontrolling Interests
Balance at beginning of year	803			569
Net income attributable to noncontrolling interests	21			9
Distributions to noncontrolling interests	(22		)	(5		)
Capital contributions	20			—
Consolidation of a variable interest entity	31			—
Impact of adoption of ASU 2009-17	—			100
Other	1			4
Balance at end of period	854			677
Total Equity	$	25,039		$	21,167

See Notes to the Consolidated Financial Statements.

6

The Dow Chemical Company and Subsidiaries

Consolidated Statements of Comprehensive Income

	Three Months Ended						Six Months Ended
In millions (Unaudited)	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011		Jun 30, 2010
Net Income	$	1,077		$	659		$	1,798	$	1,211
Other Comprehensive Income (Loss), Net of Tax
Net change in unrealized gains (losses) on investments	(8		)	(32		)	6		(19		)
Translation adjustments	159			(592		)	600		(1,022		)
Adjustments to pension and other postretirement benefit plans	69			107			141		149
Net gains (losses) on cash flow hedging derivative instruments	14			(5		)	5		4
Total other comprehensive income (loss)	234			(522		)	752		(888		)
Comprehensive Income	1,311			137			2,550		323
Comprehensive income attributable to noncontrolling interests, net of tax	10			8			21		9
Comprehensive Income Attributable to The Dow Chemical Company	$	1,301		$	129		$	2,529	$	314

See Notes to the Consolidated Financial Statements.

7

(Unaudited) The Dow Chemical Company and Subsidiaries PART I – FINANCIAL INFORMATION, Item 1. Financial Statements. Notes to the Consolidated Financial Statements

Table of Contents

Note		Page
A	Consolidated Financial Statements	8
B	Recent Accounting Guidance	8
C	Restructuring	9
D	Acquisitions and Divestitures	10
E	Inventories	11
F	Nonconsolidated Affiliates	11
G	Goodwill and Other Intangible Assets	11
H	Financial Instruments	12
I	Fair Value Measurements	20
J	Commitments and Contingent Liabilities	22
K	Transfers of Financial Assets	28
L	Notes Payable, Long-Term Debt and Available Credit Facilities	30
M	Variable Interest Entities	32
N	Pension Plans and Other Postretirement Benefits	34
O	Stock-Based Compensation	35
P	Earnings Per Share Calculations	36
Q	Operating Segments and Geographic Areas	38

NOTE A – CONSOLIDATED FINANCIAL STATEMENTS

The unaudited interim consolidated financial statements of The Dow Chemical Company and its subsidiaries (“Dow” or the “Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.

A change to prior year balance sheet amounts has been made to properly classify the current portion of “Deferred charges and other assets” of $349 million to “Other current assets.”

NOTE B – RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

On January 1, 2011, the Company adopted Accounting Standard Update (“ASU”) 2009-13, “Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements – a consensus of the FASB Emerging Issues Task Force.” This ASU amended the criteria for when to evaluate individual delivered items in a multiple deliverable arrangement and how to allocate consideration received. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Accounting Guidance Issued But Not Adopted as of June 30, 2011

In May 2011, the FASB issued ASU 2011-04, "Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS," which provides common requirements for measuring fair value and disclosing information about fair value measurements in accordance with U.S. GAAP and International Financial Reporting Standards ("IFRS"). This ASU is effective for fiscal years beginning on or after December 15, 2011. The Company is currently evaluating the impact of adopting the guidance.

In June 2011, the FASB issued ASU 2011-05, "Comprehensive Income (Topic 220): Presentation of Comprehensive Income," which improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income. This ASU is effective for fiscal years beginning on or after December 15, 2011 and early adoption is permitted. The Company is currently evaluating the impact of adopting the guidance.

8

NOTE C – RESTRUCTURING

2009 Restructuring

On June 30, 2009, the Company’s Board of Directors approved a restructuring plan related to the Company’s acquisition of Rohm and Haas Company (“Rohm and Haas”) as well as actions to advance the Company’s strategy and to respond to continued weakness in the global economy. The restructuring plan included the elimination of approximately 2,500 positions primarily resulting from synergies to be achieved as a result of the acquisition of Rohm and Haas. In addition, the plan included the shutdown of a number of manufacturing facilities. These actions were substantially complete at March 31, 2011. As a result of the restructuring activities, the Company recorded pretax restructuring charges of $677 million in the second quarter of 2009, consisting of asset write-downs and write-offs of $454 million, costs associated with exit or disposal activities of $68 million and severance costs of $155 million.

The severance component of the 2009 restructuring charges of $155 million was for the separation of approximately 2,500 employees under the terms of the Company’s ongoing benefit arrangements, primarily over two years. At December 31, 2010, severance of $149 million had been paid and a currency adjusted liability of $6 million remained for approximately 189 employees. In the first quarter of 2011, the remaining severance of $6 million was paid, bringing the program to a close.

The following table summarizes the 2011 activities related to the Company’s restructuring reserve:

2011 Activities Related to 2009 Restructuring In millions	Costs associated with Exit or Disposal Activities		Severance Costs			Total
Reserve balance at December 31, 2010	$	68	$	6		$	74
Cash payments	—		(6		)	(6		)
Reserve balance at March 31, 2011	$	68	$	—		$	68

The shutdowns related to the 2009 restructuring plan were substantially completed in the first quarter of 2011, with remaining liabilities primarily related to environmental remediation to be paid over time.

2010 Adjustments to the 2009 Restructuring Plan

In the first quarter of 2010, the Company recorded an additional $8 million charge to adjust the impairment of long-lived assets and other assets related to the United States Federal Trade Commission (“FTC”) required divestitures completed in the first quarter of 2010, and an additional $8 million charge related to the shutdown of a small manufacturing facility under the 2009 restructuring plan. The impact of these charges is shown as “Restructuring charges” in the consolidated statements of income and was reflected in the following operating segments: Electronic and Specialty Materials ($8 million), Coatings and Infrastructure ($5 million) and Performance Products ($3 million).

In the second quarter of 2010, the Company recorded additional restructuring charges of $13 million which included the write-off of other assets of $5 million, additional costs associated with exit or disposal activities of $7 million and additional severance of $1 million related to the FTC required divestitures that were included in the 2009 restructuring plan. The impact of these charges is shown as “Restructuring charges” in the consolidated statements of income and was reflected in Performance Products ($12 million) and Corporate ($1 million).

9

Restructuring Reserve Assumed from Rohm and Haas

Included in liabilities assumed in the April 1, 2009 acquisition of Rohm and Haas was a reserve for severance and employee benefits for the separation of employees under the terms of Rohm and Haas’ ongoing benefit arrangement. The separations resulted from plant shutdowns, production schedule adjustments, productivity improvements and reductions in support services. A currency adjusted liability of $12 million remained at December 31, 2010; $5 million for employees who had left the Company and would continue to receive annuity payments in early 2011, and $7 million for approximately 44 employees. In the first quarter of 2011, the Company decreased the restructuring reserve $6 million to adjust the reserve to the expected future severance payments. The impact of this adjustment is shown as “Cost of sales” in the consolidated statements of income and was reflected in Corporate. Severance payments of $7 million were made in the six-month period ended June 30, 2011, bringing the program to a close.

Restructuring Reserve Assumed from Rohm and Haas In millions	Severance Costs
Reserve balance at December 31, 2010	$	12
Cash payments	(7		)
Adjustments to reserve	(6		)
Foreign currency impact	1
Reserve balance at June 30, 2011	$	—

NOTE D – ACQUISITIONS AND DIVESTITURES

Rohm and Haas Acquisition and Integration Related Expenses

During the first quarter of 2011, pretax charges totaling $31 million were recorded for integration costs related to the April 1, 2009 acquisition of Rohm and Haas, which was substantially completed in the first quarter of 2011. During the second quarter of 2010, pretax charges totaling $37 million ($63 million during the first six months of 2010) were recorded for integration costs related to the acquisition. These charges were recorded in “Acquisition and integration related expenses” and reflected in Corporate.

Divestitures Required as a Condition to the Acquisition of Rohm and Haas

As a condition of the FTC's approval of the April 1, 2009 acquisition of Rohm and Haas, the Company was required to divest a portion of its acrylic monomer business, a portion of its specialty latex business and its hollow sphere particle business. On July 31, 2009, the Company entered into a definitive agreement that included the sale of the portion of its acrylic monomer business and the portion of its specialty latex business. The sale was completed on January 25, 2010. Additional impairment charges of $8 million related to these assets were recognized in the first quarter of 2010. In the second quarter of 2010, additional severance costs of $1 million and the write-off of other assets of $5 million were recognized (see Note C).

The Company completed the sale of its hollow sphere particle business in the second quarter of 2010 and recognized additional costs associated with disposal activities of $7 million, related to contract termination fees (see Note C).

Divestiture of the Styron Business Unit

On March 2, 2010, the Company announced the entry into a definitive agreement to sell the Styron business unit (“Styron”) to an affiliate of Bain Capital Partners. The definitive agreement specified the assets and liabilities related to the businesses and products to be included in the sale. On June 17, 2010, the sale was completed for $1,561 million, net of working capital adjustments and costs to sell, with proceeds subject to customary post-closing adjustments. Post-closing adjustments were finalized in the fourth quarter of 2010. The proceeds included a $75 million long-term note receivable. In addition, the Company elected to acquire a 7.5 percent equity interest in the resulting privately held, global materials company.

The Company recognized a pretax gain of $51 million on the sale in the second quarter of 2010, included in “Sundry income (expense) - net” and reflected in the following operating segments: Performance Systems ($15 million), Performance Products ($26 million) and Plastics ($10 million).

On February 3, 2011, Styron repaid the $75 million long-term note receivable, plus interest. In the first quarter of 2011, the Company received dividend income of $25 million, recorded in “Sundry income (expense) - net” in the consolidated statements of income and reflected in Corporate. The Company continued to hold a 6.5 percent equity interest at June 30, 2011.

10

Subsequent Event

On July 27, 2011, the Company entered into a definitive agreement under which the Company's global Polypropylene business will be divested to Braskem SA for a total enterprise value of approximately $340 million. The transaction is expected to close by the end of the third quarter 2011, pending regulatory approval, and the Company expects to report a gain on this divestiture. The divestiture will include the Company's polypropylene manufacturing facilities at Schkopau and Wesseling, Germany, and Freeport and Seadrift, Texas. Also included are inventory, business know-how, certain product and process technology, and customer contracts and lists. Dow's Polypropylene Licensing and Catalyst business and related catalyst facilities are excluded from the scope of the transaction.

NOTE E – INVENTORIES

The following table provides a breakdown of inventories:

Inventories In millions	Jun 30, 2011		Dec 31, 2010
Finished goods	$	5,034	$	4,289
Work in process	2,021		1,498
Raw materials	924		644
Supplies	760		656
Total inventories	$	8,739	$	7,087

The reserves reducing inventories from the first-in, first-out (“FIFO”) basis to the last-in, first-out (“LIFO”) basis amounted to $1,396 million at June 30, 2011 and $1,003 million at December 31, 2010.

NOTE F – NONCONSOLIDATED AFFILIATES

The table below presents summarized financial information for Dow Corning Corporation, a significant nonconsolidated affiliate (at 100 percent):

Summarized Income Statement Information	Three Months Ended				Six Months Ended
for Dow Corning Corporation In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sales	$	1,668	$	1,545	$	3,247	$	2,898
Gross profit	$	533	$	554	$	1,072	$	1,060
Net income attributable to Dow Corning Corporation	$	191	$	221	$	370	$	439

NOTE G – GOODWILL AND OTHER INTANGIBLE ASSETS

The following table shows the carrying amount of goodwill by operating segment:

Goodwill	Electronic and Specialty Materials		Coatings and Infra- structure		Health and Ag Sciences		Perf Systems		Perf Products		Plastics		Hydro- carbons		Total
In millions
Net goodwill at Dec. 31, 2010	$	5,747	$	4,191	$	1,546	$	859	$	526	$	35	$	63	$	12,967
Foreign currency impact	45		51		—		10		6		—		—		112
Net goodwill at June 30, 2011	$	5,792	$	4,242	$	1,546	$	869	$	532	$	35	$	63	$	13,079

11

The following table provides information regarding the Company’s other intangible assets:

Other Intangible Assets	At June 30, 2011							At December 31, 2010
In millions	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Intangible assets with finite lives:
Licenses and intellectual property	$	1,715	$	(536	)	$	1,179	$	1,733	$	(466	)	$	1,267
Patents	123		(99		)	24		121		(95		)	26
Software	1,034		(557		)	477		965		(506		)	459
Trademarks	694		(199		)	495		693		(168		)	525
Customer related	3,750		(635		)	3,115		3,647		(492		)	3,155
Other	145		(101		)	44		122		(78		)	44
Total other intangible assets, finite lives	$	7,461	$	(2,127	)	$	5,334	$	7,281	$	(1,805	)	$	5,476
IPR&D (1), indefinite lives	55		—			55		54		—			54
Total other intangible assets	$	7,516	$	(2,127	)	$	5,389	$	7,335	$	(1,805	)	$	5,530

(1) Purchased in-process research and development (“IPR&D”).

The following table provides information regarding amortization expense related to intangible assets:

Amortization Expense	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Other intangible assets, excluding software	$	125	$	125	$	248	$	253
Software, included in “Cost of sales”	$	22	$	22	$	45	$	43

Total estimated amortization expense related to intangible assets for 2011 and the five succeeding fiscal years is as follows:

Estimated Amortization Expense In millions
2011	$	620
2012	$	561
2013	$	537
2014	$	514
2015	$	496
2016	$	486

NOTE H – FINANCIAL INSTRUMENTS

Investments

The Company’s investments in marketable securities are primarily classified as available-for-sale.

Investing Results	Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010
Proceeds from sales of available-for-sale securities	$	460		$	535
Gross realized gains	$	26		$	27
Gross realized losses	$	(7	)	$	(50	)

12

The following table summarizes the contractual maturities of the Company’s investments in debt securities:

Contractual Maturities of Debt Securities at June 30, 2011
In millions	Amortized Cost		Fair Value
Within one year	$	23	$	23
One to five years	534		582
Six to ten years	467		498
After ten years	213		235
Total	$	1,237	$	1,338

At June 30, 2011, the Company had $330 million of held-to-maturity securities (primarily Treasury Bills) classified as cash equivalents, as these securities had original maturities of three months or less ($3.2 billion at December 31, 2010). The Company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. At June 30, 2011, the Company had investments in money market funds of $122 million classified as cash equivalents ($35 million at December 31, 2010).

The net unrealized gain recognized during the six-month period ended June 30, 2011 on trading securities held at June 30, 2011 was $13 million ($16 million during the six-month period ended June 30, 2010).

The following table provides the fair value and gross unrealized losses of the Company’s investments that were deemed to be temporarily impaired at June 30, 2011 and December 31, 2010, aggregated by investment category:

Temporarily Impaired Securities Less than 12 Months(1)
	At June 30, 2011					At December 31, 2010
In millions	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
Debt securities:
Government debt (2,3)	$	—	$	—		$	62	$	(2	)
Corporate bonds	32		(1		)	43		(1		)
Total debt securities	$	32	$	(1	)	$	105	$	(3	)
Equity securities	96		(8		)	52		(3		)
Total temporarily impaired securities	$	128	$	(9	)	$	157	$	(6	)

(1) Unrealized losses of 12 months or more were less than $1 million.

(2) Unrealized losses of less than 12 months were less than $1 million at June 30, 2011.

(3) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

Portfolio managers regularly review the Company’s holdings to determine if any investments are other-than-temporarily impaired. The analysis includes reviewing the amount of a temporary impairment, as well as the length of time it has been impaired. In addition, specific guidelines for each instrument type are followed to determine if an other-than-temporary impairment has occurred.

For debt securities, the credit rating of the issuer, current credit rating trends, the trends of the issuer’s overall sector, the ability of the issuer to pay expected cash flows and the length of time the security has been in a loss position are considered in determining whether unrealized losses represent an other-than-temporary impairment. The Company did not have any credit-related losses on debt securities during the six-month periods ended June 30, 2011 or June 30, 2010.

For equity securities, the Company’s investments are primarily in Standard & Poor’s (“S&P”) 500 companies; however, the Company’s policies allow investments in companies outside of the S&P 500. The largest holdings are Exchange Traded Funds that represent the S&P 500 index or an S&P sector or subset. The Company considers the evidence to support the recovery of the cost basis of a security including volatility of the stock, the length of time the security has been in a loss position, value and growth expectations, and overall market and sector fundamentals, as well as technical analysis, in determining whether unrealized losses represent an other-than-temporary impairment. In the six-month period ended June 30, 2011, other-than-temporary impairment write-downs on investments still held by the Company were $3 million ($4 million in the six-month period ended June 30, 2010).

13

The aggregate cost of the Company’s cost method investments totaled $171 million at June 30, 2011 and $171 million at December 31, 2010. Due to the nature of these investments, the fair market value is not readily determinable. These investments are reviewed for impairment indicators. In the six-month period ended June 30, 2011, the Company's impairment analysis identified indicators that resulted in no reduction in the cost basis of these investments ($20 million reduction in the six-month period ended June 30, 2010).

The following table summarizes the fair value of financial instruments at June 30, 2011 and December 31, 2010:

Fair Value of Financial Instruments
	At June 30, 2011											At December 31, 2010
In millions	Cost			Gain		Loss			Fair Value			Cost			Gain		Loss			Fair Value
Marketable securities: (1)
Debt securities:
Government debt (2)	$	560		$	40	$	—		$	600		$	603		$	40	$	(2	)	$	641
Corporate bonds	677			62		(1		)	738			760			72		(1		)	831
Total debt securities	$	1,237		$	102	$	(1	)	$	1,338		$	1,363		$	112	$	(3	)	$	1,472
Equity securities	585			100		(8		)	677			501			94		(3		)	592
Total marketable securities	$	1,822		$	202	$	(9	)	$	2,015		$	1,864		$	206	$	(6	)	$	2,064
Long-term debt incl. debt due within one year (3)	$	(19,172	)	$	79	$	(2,419	)	$	(21,512	)	$	(22,360	)	$	175	$	(2,530	)	$	(24,715	)
Derivatives relating to:
Foreign currency	$	—		$	22	$	(32	)	$	(10	)	$	—		$	40	$	(38	)	$	2
Commodities	$	—		$	16	$	(4	)	$	12		$	—		$	14	$	(4	)	$	10

(1) Included in “Other investments” in the consolidated balance sheets.

(2) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

(3) Cost includes fair value adjustments of $22 million at June 30, 2011 and $23 million at December 31, 2010.

Risk Management

Dow’s business operations give rise to market risk exposure due to changes in interest rates, foreign currency exchange rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies, which enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as cash flow, fair value or net foreign investment hedges where appropriate. The guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value. A secondary objective is to add value by creating additional nonspecific exposures within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Company’s results.

The Company’s risk management program for interest rate, foreign currency and commodity risks is based on fundamental, mathematical and technical models that take into account the implicit cost of hedging. Risks created by derivative instruments and the mark-to-market valuations of positions are strictly monitored at all times, using value at risk and stress tests. Counterparty credit risk arising from these contracts is not significant because the Company minimizes counterparty concentration, deals primarily with major financial institutions of solid credit quality, and the majority of its hedging transactions mature in less than three months. In addition, the Company minimizes concentrations of credit risk through its global orientation by transacting with large, internationally diversified financial counterparties. It is the Company’s policy not to have credit-risk-related contingent features in its derivative instruments. The Company does not anticipate losses from credit risk, and the net cash requirements arising from counterparty risk associated with risk management activities are not expected to be material in 2011. No significant concentration of counterparty credit risk existed at June 30, 2011.

The Company reviews its overall financial strategies and the impacts from using derivatives in its risk management program with the Company’s Board of Directors and revises its strategies as market conditions dictate.

Interest Rate Risk Management

The Company enters into various interest rate contracts with the objective of lowering funding costs or altering interest rate exposures related to fixed and variable rate obligations. In these contracts, the Company agrees with other parties to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated on an agreed-upon notional principal amount. At June 30, 2011, the Company had no open interest rate swaps.

14

Foreign Currency Risk Management

The Company’s global operations require active participation in foreign exchange markets. The Company enters into foreign exchange forward contracts and options, and cross-currency swaps to hedge various currency exposures or create desired exposures. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. The primary business objective of the activity is to optimize the U.S. dollar value of the Company’s assets, liabilities and future cash flows with respect to exchange rate fluctuations. Assets and liabilities denominated in the same foreign currency are netted, and only the net exposure is hedged. At June 30, 2011, the Company had forward contracts, options and cross-currency swaps to buy, sell or exchange foreign currencies. These contracts had various expiration dates, primarily in the third quarter of 2011.

Commodity Risk Management

The Company has exposure to the prices of commodities in its procurement of certain raw materials. The primary purpose of commodity hedging activities is to manage the price volatility associated with these forecasted inventory purchases. At June 30, 2011, the Company had futures contracts, options and swaps to buy, sell or exchange commodities. These agreements had various expiration dates through 2012.

Accounting for Derivative Instruments and Hedging Activities

Cash Flow Hedges

For derivatives that are designated and qualify as cash flow hedging instruments, the effective portion of the gain or loss on the derivative is recorded in “Accumulated other comprehensive income (loss)” (“AOCI”); it is reclassified to “Cost of sales” in the same period or periods that the hedged transaction affects income. The unrealized amounts in AOCI fluctuate based on changes in the fair value of open contracts at the end of each reporting period. The Company anticipates volatility in AOCI and net income from its cash flow hedges. The amount of volatility varies with the level of derivative activities and market conditions during any period. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current period income.

The net loss from previously terminated interest rate cash flow hedges included in AOCI at June 30, 2011 was $1 million after tax ($2 million after tax at December 31, 2010). The Company had no open interest rate derivatives designated as cash flow hedges at June 30, 2011 or December 31, 2010.

Current open foreign currency forward contracts hedge the currency risk of forecasted feedstock purchase transactions until September 2011. The effective portion of the mark-to-market effects of the foreign currency forward contracts is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying feedstock purchase affects income. The net loss from the foreign currency hedges included in AOCI at June 30, 2011 was $5 million after tax ($4 million after tax at December 31, 2010). At June 30, 2011, the Company had open forward contracts with various expiration dates to buy, sell or exchange foreign currencies with a notional U.S. dollar equivalent of $203 million ($827 million at December 31, 2010).

Commodity swaps, futures and option contracts with maturities of not more than 36 months are utilized and designated as cash flow hedges of forecasted commodity purchases. Current open contracts hedge forecasted transactions until December 2011. The effective portion of the mark-to-market effect of the cash flow hedge instrument is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying commodity purchase affects income. The net gain from commodity hedges included in AOCI at June 30, 2011 was $6 million after tax ($3 million after tax at December 31, 2010). At June 30, 2011 and December 31, 2010, the Company had the following aggregate notionals of outstanding commodity forward contracts to hedge forecasted purchases:

Commodity	Jun 30, 2011	Dec 31, 2010	Notional Volume Unit
Crude Oil	0.5	0.1	million barrels
Ethane	0.6	1.6	million barrels
Natural Gas	1.0	2.7	million million British thermal units

15

Fair Value Hedges

For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current period income and reflected as “Interest expense and amortization of debt discount” in the consolidated statements of income. The short-cut method is used when the criteria are met. The Company had no open interest rate swaps designated as fair value hedges of underlying fixed rate debt obligations at June 30, 2011 or December 31, 2010.

Net Foreign Investment Hedges

For derivative instruments that are designated and qualify as net foreign investment hedges, the effective portion of the gain or loss on the derivative is included in “Cumulative Translation Adjustments” in AOCI. The results of hedges of the Company’s net investment in foreign operations included in “Cumulative Translation Adjustments” in AOCI was a net loss of $67 million after tax at June 30, 2011 (net gain of $70 million after tax at December 31, 2010). At June 30, 2011 and December 31, 2010, the Company had no open forward contracts or outstanding options to buy, sell or exchange foreign currencies that were designated as net foreign investment hedges. At June 30, 2011, the Company had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $614 million ($1,250 million at December 31, 2010).

Other Derivative Instruments

The Company utilizes futures, options and swap instruments that are effective as economic hedges of commodity price exposures, but do not meet the hedge accounting criteria in the accounting guidance for derivatives and hedging. At June 30, 2011 and December 31, 2010, the Company had the following aggregate notionals of outstanding commodity contracts:

Commodity	Jun 30, 2011	Dec 31, 2010	Notional Volume Unit
Crude Oil	0.3	—	million barrels
Ethane	3.0	3.8	million barrels
Naphtha	60.0	—	kilotons
Natural Gas	9.1	12.0	million million British thermal units

The Company also uses foreign exchange forward contracts, options, and cross-currency swaps that are not designated as hedging instruments primarily to manage foreign currency exposure. The Company had open foreign exchange contracts with various expiration dates to buy, sell or exchange foreign currencies with a notional U.S. dollar equivalent of $12,925 million at June 30, 2011 ($13,944 million at December 31, 2010).

16

The following table provides the fair value and gross balance sheet classification of derivative instruments at June 30, 2011 and December 31, 2010:

Fair Value of Derivative Instruments In millions	Balance Sheet Classification	Jun 30, 2011		Dec 31, 2010
Asset Derivatives
Derivatives designated as hedges:
Foreign currency	Accounts and notes receivable – Other	$	—	$	9
Commodities	Other current assets (1)	5		7
Total derivatives designated as hedges		$	5	$	16
Derivatives not designated as hedges:
Foreign currency	Accounts and notes receivable – Other	$	37	$	77
Commodities	Other current assets (1)	33		23
Total derivatives not designated as hedges		$	70	$	100
Total asset derivatives		$	75	$	116
Liability Derivatives
Derivatives designated as hedges:
Foreign currency	Accounts payable – Other	$	3	$	20
Commodities	Accounts payable – Other	1		8
Total derivatives designated as hedges		$	4	$	28
Derivatives not designated as hedges:
Foreign currency	Accounts payable – Other	$	44	$	64
Commodities	Accounts payable – Other	20		16
Total derivatives not designated as hedges		$	64	$	80
Total liability derivatives		$	68	$	108

(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheet at December 31, 2010.

17

Effect of Derivative Instruments for the three months ended June 30, 2011 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	—		Interest expense (5)	$	(1	)	$	—
Cash flow:
Commodities	5			Cost of sales	6			—
Foreign currency	(5		)	Cost of sales	(19		)	—
Total derivatives designated as hedges	$	—			$	(14	)	$	—
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	42
Commodities	—			Cost of sales	—			(14		)
Total derivatives not designated as hedges	$	—			$	—		$	28
Total derivatives	$	—			$	(14	)	$	28
Effect of Derivative Instruments for the three months ended June 30, 2010 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	(1	)	Interest expense (5)	$	—		$	(1	)
Cash flow:
Commodities	(14		)	Cost of sales	(2		)	—
Foreign currency	10			Cost of sales	3			—
Net foreign investment:
Foreign currency	(17		)	n/a	—			—
Total derivatives designated as hedges	$	(22	)		$	1		$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	14
Commodities	—			Cost of sales	—			(3		)
Total derivatives not designated as hedges	$	—			$	—		$	11
Total derivatives	$	(22	)		$	1		$	10

(1) Accumulated other comprehensive income (loss) (“AOCI”).

(2) Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain (Loss) – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity.

(3) Pretax amounts.

(4) Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness.

(5) Interest expense and amortization of debt discount.

(6) Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities.

18

Effect of Derivative Instruments for the six months ended June 30, 2011  In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	—		Interest expense (5)	$	(1	)	$	(1	)
Cash flow:
Commodities	10			Cost of sales	11			—
Foreign currency	(16		)	Cost of sales	(17		)	—
Total derivatives designated as hedges	$	(6	)		$	(7	)	$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	41
Commodities	—			Cost of sales	—			(13		)
Total derivatives not designated as hedges	$	—			$	—		$	28
Total derivatives	$	(6	)		$	(7	)	$	27
Effect of Derivative Instruments for the six months ended June 30, 2010 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	(1	)	Interest expense (5)	$	—		$	(1	)
Cash flow:
Commodities	(18		)	Cost of sales	(4		)	—
Foreign currency	20			Cost of sales	(3		)	—
Net foreign investment:
Foreign currency	(20		)	n/a	—			—
Total derivatives designated as hedges	$	(19	)		$	(7	)	$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	113
Commodities	—			Cost of sales	—			(4		)
Total derivatives not designated as hedges	$	—			$	—		$	109
Total derivatives	$	(19	)		$	(7	)	$	108

(1) Accumulated other comprehensive income (loss) (“AOCI”).

(2) Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain (Loss) – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity.

(3) Pretax amounts.

(4) Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness.

(5) Interest expense and amortization of debt discount.

(6) Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities.

The net after-tax amounts to be reclassified from AOCI to income within the next 12 months are a $1 million loss for interest rate contracts, a $6 million gain for commodity contracts and a $5 million loss for foreign currency contracts.

19

NOTE I – FAIR VALUE MEASUREMENTS

The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis in the consolidated balance sheets:

Basis of Fair Value Measurements on a Recurring Basis at June 30, 2011 In millions	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)		Counterparty and Cash Collateral Netting (1)			Total
Assets at fair value:
Interests in trade accounts receivable conduits (2)	$	—	$	—	1,343	$	1,389	$	—		$	1,389
Equity securities (3)	639		38		—	—		—			677
Debt securities: (3)
Government debt (4)	—		600		—	—		—			600
Corporate bonds	—		738		—	—		—			738
Derivatives relating to: (5)
Foreign currency	—		37		—	—		(15		)	22
Commodities	16		22		—	—		(22		)	16
Total assets at fair value	$	655	$	1,435		$	1,389	$	(37	)	$	3,442
Liabilities at fair value:
Derivatives relating to: (5)
Foreign currency	$	—	$	47		$	—	$	(15	)	$	32
Commodities	5		16			—		(17		)	4
Total liabilities at fair value	$	5	$	63		$	—	$	(32	)	$	36

Basis of Fair Value Measurements on a Recurring Basis at December 31, 2010 In millions	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Counterparty and Cash Collateral Netting (1)			Total
Assets at fair value:
Interests in trade accounts receivable conduits (2)	$	—	$	—	$	1,267	$	—		$	1,267
Equity securities (3)	556		36		—		—			592
Debt securities: (3)
Government debt (4)	—		641		—		—			641
Corporate bonds	—		831		—		—			831
Derivatives relating to: (5)
Foreign currency	—		86		—		$	(46	)	40
Commodities	12		18		—		(16		)	14
Total assets at fair value	$	568	$	1,612	$	1,267	$	(62	)	$	3,385
Liabilities at fair value:
Derivatives relating to: (5)
Foreign currency	$	—	$	84	$	—	$	(46	)	$	38
Commodities	7		17		—		(20		)	4
Total liabilities at fair value	$	7	$	101	$	—	$	(66	)	$	42

(1) Cash collateral is classified as “Accounts and notes receivable – Other” in the consolidated balance sheets. Amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

(2) Included in “Accounts and notes receivable – Other” in the consolidated balance sheets. See Note K for additional information on transfers of financial assets.

(3) The Company’s investments in equity and debt securities are primarily classified as available-for-sale and are included in “Other investments” in the consolidated balance sheets.

(4) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

(5) See Note H for the classification of derivatives in the consolidated balance sheets.

20

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets and liabilities. The Company borrowed $6 million of cash collateral against $11 million of unrealized gains at June 30, 2011 (posted $4 million of cash collateral at December 31, 2010). The net $5 million at June 30, 2011 and the $4 million at December 31, 2010 were classified as “Accounts and notes receivable – Other” in the consolidated balance sheets.

For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange in which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note H for further information on the types of instruments used by the Company for risk management.

There were no significant transfers between Levels 1 and 2 in the six-month period ended June 30, 2011 or the year ended December 31, 2010.

For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests. See Note K for further information on assets classified as Level 3 measurements.

The following table summarizes the changes in fair value measurements using Level 3 inputs for the three and six month periods ended June 30, 2011 and 2010:

Fair Value Measurements Using Level 3 Inputs	Three Months Ended						Six Months Ended
Interests Held in Trade Receivable Conduits(1) In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Balance at beginning of period	$	1,343		$	1,224		$	1,267		$	—
Gain/(Loss) included in earnings (2)	3			9			(5		)	9
Purchases – North America	161			181			1,098			1,933
Purchases – Europe	116			144			253			144
Settlements – North America	(98		)	(352		)	(1,000		)	(880		)
Settlements – Europe	(136		)	—			(224		)	—
Balance at June 30	$	1,389		$	1,206		$	1,389		$	1,206

(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheets.

(2) Included in “Selling, general and administrative expenses” in the consolidated statements of income.

21

NOTE J – COMMITMENTS AND CONTINGENT LIABILITIES

Litigation

Breast Implant Matters

On May 15, 1995, Dow Corning Corporation (“Dow Corning”), in which the Company is a 50 percent shareholder, voluntarily filed for protection under Chapter 11 of the Bankruptcy Code to resolve litigation related to Dow Corning’s breast implant and other silicone medical products. On June 1, 2004, Dow Corning’s Joint Plan of Reorganization (the “Joint Plan”) became effective and Dow Corning emerged from bankruptcy. The Joint Plan contains release and injunction provisions resolving all tort claims brought against various entities, including the Company, involving Dow Corning’s breast implant and other silicone medical products.

To the extent not previously resolved in state court actions, cases involving Dow Corning’s breast implant and other silicone medical products filed against the Company were transferred to the U.S. District Court for the Eastern District of Michigan (the “District Court”) for resolution in the context of the Joint Plan. On October 6, 2005, all such cases then pending in the District Court against the Company were dismissed. Should cases involving Dow Corning’s breast implant and other silicone medical products be filed against the Company in the future, they will be accorded similar treatment. It is the opinion of the Company’s management that the possibility is remote that a resolution of all future cases will have a material adverse impact on the Company’s consolidated financial statements.

As part of the Joint Plan, Dow and Corning Incorporated agreed to provide a credit facility to Dow Corning in an aggregate amount of $300 million, which was reduced to $150 million effective June 1, 2011. The Company’s share of the credit facility was originally $150 million, but was reduced to $75 million effective June 1, 2011, and is subject to the terms and conditions stated in the Joint Plan. At June 30, 2011, no draws had been taken against the credit facility.

DBCP Matters

Numerous lawsuits have been brought against the Company and other chemical companies, both inside and outside of the United States, alleging that the manufacture, distribution or use of pesticides containing dibromochloropropane (“DBCP”) has caused personal injury and property damage, including contamination of groundwater. It is the opinion of the Company’s management that the possibility is remote that the resolution of such lawsuits will have a material adverse impact on the Company’s consolidated financial statements.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At June 30, 2011, the Company had accrued obligations of $675 million for probable environmental remediation and restoration costs, including $66 million for the remediation of Superfund sites. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although the ultimate cost with respect to these particular matters could range up to approximately twice that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material adverse impact on the Company’s results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material adverse impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2010, the Company had accrued obligations of $607 million for probable environmental remediation and restoration costs, including $59 million for the remediation of Superfund sites.

Midland Off-Site Environmental Matters

On June 12, 2003, the Michigan Department of Environmental Quality ("MDEQ") issued a Hazardous Waste Operating License (the “License”) to the Company’s Midland, Michigan manufacturing site (the “Midland site”), which included provisions requiring the Company to conduct an investigation to determine the nature and extent of off-site contamination in the City of Midland soils; the Tittabawassee River and Saginaw River sediment and floodplain soils; and the Saginaw Bay; and, if necessary, undertake remedial action.

City of Midland

Matters related to the City of Midland remain under the primary oversight of the State of Michigan (the “State”) under the License, and the Company and the State are in ongoing discussions regarding the implementation of the requirements of the License.

22

Tittabawassee and Saginaw Rivers, Saginaw Bay

The Company, the U.S. Environmental Protection Agency (“EPA”) and the State entered into an administrative order on consent (“AOC”), effective January 21, 2010, that requires the Company to conduct a remedial investigation, a feasibility study and a remedial design for the Tittabawassee River, the Saginaw River and the Saginaw Bay, and pay the oversight costs of the EPA and the State under the authority of the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). These actions, to be conducted under the lead oversight of the EPA, will build upon the investigative work completed under the State Resource Conservation Recovery Act (“RCRA”) program from 2005 through 2009. The Tittabawassee River, beginning at the Midland Site and extending down to the first six miles of the Saginaw River, are designated as the first Operable Unit for purposes of conducting the remedial investigation, feasibility study and remedial design work. This work will be performed in a largely upriver to downriver sequence for eight geographic segments of the Tittabawassee and upper Saginaw Rivers. The remainder of the Saginaw River and the Saginaw Bay are designated as a second Operable Unit and the work associated with that unit may also be geographically segmented. The AOC does not obligate the Company to perform removal or remedial action; that action can only be required by a separate order. The Company and the EPA will be negotiating orders separate from the AOC that will obligate the Company to perform remedial actions under the scope of work of the AOC and so far have entered into two separate orders to perform limited remedial actions to implement early actions.

Alternative Dispute Resolution Process

The Company; the EPA; the U.S. Department of Justice; and the natural resource damage trustees (the Michigan Office of the Attorney General; the MDEQ; the U.S. Fish and Wildlife Service; the U.S. Bureau of Indian Affairs and the Saginaw-Chippewa tribe), have been engaged in negotiations to seek to resolve potential governmental claims against the Company related to historical off-site contamination associated with the City of Midland, the Tittabawassee and Saginaw Rivers and the Saginaw Bay. The Company and the governmental parties started meeting in the fall of 2005 and entered into a Confidentiality Agreement in December 2005. The Company continues to conduct negotiations under the Federal Alternative Dispute Resolution Act with all of the governmental parties, except the EPA which withdrew from the alternative dispute resolution process on September 12, 2007.

On September 28, 2007, the Company and the natural resource damage trustees entered into a Funding and Participation Agreement that addressed the Company’s payment of past costs incurred by the natural resource damage trustees, payment of the costs of a trustee coordinator and a process to review additional cooperative studies that the Company might agree to fund or conduct with the natural resource damage trustees. On March 18, 2008, the Company and the natural resource damage trustees entered into a Memorandum of Understanding to provide a mechanism for the Company to fund cooperative studies related to the assessment of natural resource damages. On April 7, 2008, the natural resource damage trustees released their “Natural Resource Damage Assessment Plan for the Tittabawassee River System Assessment Area.”

At June 30, 2011, the accrual for these off-site matters was $39 million (included in the total accrued obligation of $675 million at June 30, 2011). At December 31, 2010, the Company had an accrual for these off-site matters of $32 million (included in the total accrued obligation of $607 million).

Asbestos-Related Matters of Union Carbide Corporation

Union Carbide Corporation (“Union Carbide”), a wholly owned subsidiary of the Company, is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including Union Carbide and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

Based on a study completed by Analysis, Research & Planning Corporation (“ARPC”) in January 2003, Union Carbide increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. Since then, Union Carbide has compared current asbestos claim

23

and resolution activity to the results of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate. In addition, Union Carbide has requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity each November since 2004 to determine the appropriateness of updating the most recent ARPC study.

In November 2009, Union Carbide requested ARPC to review Union Carbide’s 2009 asbestos claim and resolution activity and determine the appropriateness of updating its then most recent study completed in December 2008. In response to that request, ARPC reviewed and analyzed data through October 31, 2009. In December 2009, ARPC stated that an update of its study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable. Based on Union Carbide’s own review of the asbestos claim and resolution activity and ARPC’s response, Union Carbide determined that no change to the accrual was required. At December 31, 2009, Union Carbide’s asbestos-related liability for pending and future claims was $839 million.

In November 2010, Union Carbide requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity and determine the appropriateness of updating its December 2008 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2010. The resulting study, completed by ARPC in December 2010, stated that the undiscounted cost of resolving pending and future asbestos-related claims against Union Carbide and Amchem, excluding future defense and processing costs, through 2025 was estimated to be between $744 million and $835 million. As in its earlier studies, ARPC provided estimates for a longer period of time in its December 2010 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.

In December 2010, based on ARPC’s December 2010 study and Union Carbide’s own review of the asbestos claim and resolution activity, Union Carbide decreased its asbestos-related liability for pending and future claims to $744 million, which covered the 15-year period ending 2025, excluding future defense and processing costs. The reduction was $54 million and was shown as “Asbestos-related credits” in the consolidated statements of income. At December 31, 2010, the asbestos-related liability for pending and future claims was $728 million. At December 31, 2010, approximately 21 percent of the recorded liability related to pending claims and approximately 79 percent related to future claims.

Based on Union Carbide’s review of 2011 activity, Union Carbide determined that no adjustment to the accrual was required at June 30, 2011. Union Carbide’s asbestos-related liability for pending and future claims was $703 million at June 30, 2011. Approximately 20 percent of the recorded liability related to pending claims and approximately 80 percent related to future claims.

At December 31, 2002, Union Carbide increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined by Union Carbide after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which Union Carbide and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of Union Carbide’s insurance policies and to resolve issues that the insurance carriers may raise.

In September 2003, Union Carbide filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds (the “Insurance Litigation”). The Insurance Litigation was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with Union Carbide regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. Since the filing of the case, Union Carbide has reached settlements with several of the carriers involved in the Insurance Litigation, including settlements reached with two significant carriers in the fourth quarter of 2009. The Insurance Litigation is ongoing.

Union Carbide’s receivable for insurance recoveries related to its asbestos liability was $50 million at June 30, 2011 and $50 million at December 31, 2010. At June 30, 2011 and December 31, 2010, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.

In addition to the receivable for insurance recoveries related to its asbestos liability, Union Carbide had receivables for defense and resolution costs submitted to insurance carriers that have settlement agreements in place regarding their asbestos-related insurance coverage.

24

The following table summarizes Union Carbide’s receivables related to its asbestos-related liability:

Receivables for Asbestos-Related Costs In millions	Jun 30, 2011		Dec 31, 2010
Receivables for defense costs – carriers with settlement agreements	$	23	$	12
Receivables for resolution costs – carriers with settlement agreements	190		236
Receivables for insurance recoveries – carriers without settlement agreements	50		50
Total	$	263	$	298

Union Carbide expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $15 million in the second quarter of 2011 ($22 million in the second quarter of 2010) and $28 million in the first six months of 2011 ($36 million in the first six months of 2010 ), and was reflected in “Cost of sales.”

After a review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, Union Carbide continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.

The amounts recorded by Union Carbide for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries for Union Carbide to be higher or lower than those projected or those recorded.

Because of the uncertainties described above, Union Carbide’s management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. Union Carbide’s management believes that it is reasonably possible that the cost of disposing of Union Carbide’s asbestos-related claims, including future defense costs, could have a material adverse impact on Union Carbide’s results of operations and cash flows for a particular period and on the consolidated financial position of Union Carbide.

It is the opinion of Dow’s management that it is reasonably possible that the cost of Union Carbide disposing of its asbestos-related claims, including future defense costs, could have a material adverse impact on the Company’s results of operations and cash flows for a particular period and on the consolidated financial position of the Company.

Synthetic Rubber Industry Matters

In 2003, the U.S., Canadian and European competition authorities initiated separate investigations into alleged anticompetitive behavior by certain participants in the synthetic rubber industry. Certain subsidiaries of the Company (but as to the investigation in Europe only) have responded to requests for documents and are otherwise cooperating in the investigations.

On June 10, 2005, the Company received a Statement of Objections from the European Commission (the “EC”) stating that it believed that the Company and certain subsidiaries of the Company (the “Dow Entities”), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the butadiene rubber and emulsion styrene butadiene rubber businesses. In connection therewith, on November 29, 2006, the EC issued its decision alleging infringement of Article 81 of the Treaty of Rome and imposed a fine of Euro 64.575 million (approximately $85 million at that time) on the Dow Entities; several other companies were also named and fined. As a result, the Company recognized a loss contingency of $85 million related to the fine in the fourth quarter of 2006. The Company appealed the EC’s decision and a hearing was held before the Court of First Instance on October 13, 2009. On July 13, 2011, the General Court issued a decision that partly affirmed the EC's decision with regard to the amount of the fine and the liability of the parent company, but rejected the EC's decision regarding the length of the conspiracy and determined that it was of a shorter duration. The Dow Entities are considering whether to file a further appeal. Subsequent to the imposition of the fine in 2006, the Company and/or certain subsidiaries of the Company became named parties in various related U.S., United Kingdom and Italian civil actions. The U.S. matter was settled in March 2010 through a confidential settlement agreement, with an immaterial impact on the Company’s consolidated financial statements. The United Kingdom and Italian civil actions are still pending.

25

Additionally, on March 10, 2007, the Company received a Statement of Objections from the EC stating that it believed that DuPont Dow Elastomers L.L.C. (“DDE”), a former 50:50 joint venture with E.I. du Pont de Nemours and Company (“DuPont”), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the polychloroprene business. This Statement of Objections specifically names the Company, in its capacity as a former joint venture owner of DDE. On December 5, 2007, the EC announced its decision to impose a fine on the Company, among others, in the amount of Euro 48.675 million (approximately $70 million). The Company previously transferred its joint venture ownership interest in DDE to DuPont in 2005, and DDE then changed its name to DuPont Performance Elastomers L.L.C. (“DPE”). In February 2008, DuPont, DPE and the Company each filed an appeal of the December 5, 2007 decision of the EC. Based on the Company’s allocation agreement with DuPont, the Company’s share of this fine, regardless of the outcome of the appeals, will not have a material adverse impact on the Company’s consolidated financial statements.

Rohm and Haas Pension Plan Matters

In December 2005, a federal judge in the U.S. District Court for the Southern District of Indiana (the “District Court”) issued a decision granting a class of participants in the Rohm and Haas Pension Plan (the “Rohm and Haas Plan”) who had retired from Rohm and Haas, now a wholly owned subsidiary of the Company, and who elected to receive a lump sum benefit from the Rohm and Haas Plan, the right to a cost-of-living adjustment (“COLA”) as part of their retirement benefit. In August 2007, the Seventh Circuit Court of Appeals affirmed the District Court’s decision, and in March 2008, the U.S. Supreme Court denied the Rohm and Haas Plan’s petition to review the Seventh Circuit’s decision. The case was returned to the District Court for further proceedings. In October 2008 and February 2009, the District Court issued rulings that have the effect of including in the class all Rohm and Haas retirees who received a lump sum distribution without a COLA from the Rohm and Haas Plan since January 1976. These rulings are subject to appeal, and the District Court has not yet determined the amount of the COLA benefits that may be due to the class participants. The Rohm and Haas Plan and the plaintiffs entered into a settlement agreement that, in addition to settling the litigation with respect to the Rohm and Haas retirees, provides for the amendment of the complaint and amendment of the Rohm and Haas Plan to include active employees in the settlement benefits. The District Court preliminarily approved the settlement on November 24, 2009 and, following a hearing on March 12, 2010, issued a final order approving the settlement on April 12, 2010. A group of objectors to the settlement filed an appeal from the final order. In November 2010, the District Court issued an order approving class counsel’s fee award petition in an amount consistent with the terms of the settlement. The same objectors also appealed this order. Both appeals are pending.

A pension liability associated with this matter of $185 million was recognized as part of the acquisition of Rohm and Haas on April 1, 2009. The liability, which was determined in accordance with the accounting guidance for contingencies, recognized the estimated impact of the above described judicial decisions on the long-term Rohm and Haas Plan obligations owed to the applicable Rohm and Haas retirees and active employees. The Company had a liability associated with this matter of $186 million at June 30, 2011 and $186 million at December 31, 2010.

Other Litigation Matters

In addition to breast implant, DBCP, environmental and synthetic rubber industry matters, the Company is party to a number of other claims and lawsuits arising out of the normal course of business with respect to commercial matters, including product liability, governmental regulation and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. Dow has an active risk management program consisting of numerous insurance policies secured from many carriers at various times. These policies provide coverage that will be utilized to minimize the impact, if any, of the contingencies described above.

Summary

Except for the possible effect of Union Carbide’s asbestos-related liability described above, it is the opinion of the Company’s management that the possibility is remote that the aggregate of all claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company.

26

Purchase Commitments

The Company has numerous agreements for the purchase of ethylene-related products globally. The purchase prices are determined primarily on a cost-plus basis. Total purchases under these agreements were $714 million in 2010, $784 million in 2009 and $1,502 million in 2008. The Company’s take-or-pay commitments associated with these agreements at December 31, 2010 are included in the table below. There have been no material changes to purchase commitments since December 31, 2010.

The Company also has various commitments for take-or-pay and throughput agreements. Such commitments are at prices not in excess of current market prices. The terms of all but two of these agreements extend from one to 25 years. One agreement has terms extending to 35 years and another has terms extending to 80 years. The determinable future commitments for these agreements are included for 10 years in the following table which presents the fixed and determinable portion of obligations under the Company’s purchase commitments at December 31, 2010:

Fixed and Determinable Portion of Take-or-Pay and Throughput Obligations at December 31, 2010 In millions
2011	$	3,603
2012	3,261
2013	2,647
2014	2,055
2015	1,341
2016 - 2020	8,203
Total	$	21,110

In addition to the take-or-pay obligations at December 31, 2010, the Company had outstanding commitments which ranged from one to ten years for materials, services and other items used in the normal course of business of approximately $180 million. Such commitments were at prices not in excess of current market prices.

Guarantees

The Company provides a variety of guarantees as described more fully in the following sections.

Guarantees

Guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to ten years, and trade financing transactions in Latin America, which typically expire within one year of their inception. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered unlikely.

Residual Value Guarantees

The Company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.

The following tables provide a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for each type of guarantee:

Guarantees at June 30, 2011 In millions	Final Expiration	Maximum Future Payments (1)		Recorded   Liability
Guarantees	2020	$	503	$	41
Residual value guarantees	2021	432		20
Total guarantees		$	935	$	61

(1) The Company was indemnified by a third party for $57 million if required to perform under a $113 million guarantee.

27

Guarantees at December 31, 2010 In millions	Final Expiration	Maximum Future Payments (1)		Recorded   Liability
Guarantees	2020	$	445	$	80
Residual value guarantees	2020	391		17
Total guarantees		$	836	$	97

(1) The Company was indemnified by a third party for $53 million if required to perform under a $106 million guarantee.

Asset Retirement Obligations

The Company has recognized asset retirement obligations for the following activities: demolition and remediation activities at manufacturing sites in the United States, Canada, Brazil, Chile, China and Europe; capping activities at landfill sites in the United States, Canada, Brazil and Europe; and asbestos encapsulation as a result of planned demolition and remediation activities at manufacturing and administrative sites in the United States, Canada, Brazil, Chile, China and Europe.

The aggregate carrying amount of asset retirement obligations recognized by the Company was $101 million at June 30, 2011 and $99 million at December 31, 2010. The discount rate used to calculate the Company’s asset retirement obligations was 1.78 percent at June 30, 2011 and 1.78 percent at December 31, 2010. These obligations are included in the consolidated balance sheets as “Other noncurrent obligations.”

The Company has not recognized conditional asset retirement obligations for which a fair value cannot be reasonably estimated in its consolidated financial statements. It is the opinion of the Company’s management that the possibility is remote that such conditional asset retirement obligations, when estimable, will have a material adverse impact on the Company’s consolidated financial statements based on current costs.

NOTE K – TRANSFERS OF FINANCIAL ASSETS

Sale of Trade Accounts Receivable in North America

The Company sells trade accounts receivable of select North America entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.

During the three months ended June 30, 2011, the Company recognized a loss of $2 million on the sale of these receivables ($5 million during the three months ended June 30, 2010), which is classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. During the six months ended June 30, 2011, the Company recognized a loss of $4 million on the sale of receivables ($9 million during the six months ended June 30, 2010).

The Company classifies its interests in the conduits as “Accounts and notes receivable – Other” on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was 1.38 percent at June 30, 2011 (1.42 percent at December 31, 2010), in the portfolio of receivables sold that had not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. Credit losses, net of any recoveries, on receivables sold were insignificant for the three-month period ended June 30, 2011 ($1 million for the three-month period ended June 30, 2010) and insignificant for the six-month period ended June 30, 2011 ($1 million for the six-month period ended June 30, 2010). At June 30, 2011, the carrying value of the interests held was $1,204 million ($1,110 million at December 31, 2010), which is the Company’s maximum exposure to loss related to the receivables sold.

The sensitivity of the fair value of the interests held to hypothetical adverse changes in the anticipated credit losses assumption are as follows (amounts shown are the corresponding hypothetical decreases in the carrying value of the interests):

Impact to Carrying Value In millions	Jun 30, 2011		Dec 31, 2010
10% adverse change	$	2	$	2
20% adverse change	$	5	$	5

28

Following is an analysis of certain cash flows between the Company and the North American conduits:

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of receivables	$	—	$	—	$	—	$	264
Collections reinvested in revolving receivables	$	5,152	$	4,769	$	9,718	$	7,718
Interests in conduits (1)	$	98	$	339	$	1,000	$	867

(1) Presented in "Operating Activities" in the consolidated statements of cash flows.

Delinquencies on the sold receivables that were still outstanding at June 30, 2011 were $130 million ($127 million at December 31, 2010). Trade accounts receivable outstanding and derecognized from the Company’s consolidated balance sheets at June 30, 2011 were $2,336 million ($1,930 million at December 31, 2010). In May 2010, the Company repurchased $13 million of previously sold receivables related to a divestiture.

Sale of Trade Accounts Receivable in Europe

Since June 2010, the Company sold qualifying trade accounts receivable of select European entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.

During the three months ended June 30, 2011, the Company recognized a gain of $2 million on the sale of these receivables (a loss of less than $1 million during the three months ended June 30, 2010), which is classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. During the six months ended June 30, 2011, the Company recognized a loss of $2 million on the sale of receivables (less than $1 million during the six months ended June 30, 2010).

The Company classifies its interests in the conduits as “Accounts and notes receivable – Other” on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was zero at June 30, 2011 (zero at December 31, 2010), in the portfolio of receivables sold that had not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. There were no credit losses on receivables sold during the three and six-month periods ended June 30, 2011 and June 30, 2010. At June 30, 2011, the carrying value of the interests held was $185 million ($157 million at December 31, 2010), which is the Company’s maximum exposure to loss related to the receivables sold.

Following is an analysis of certain cash flows between the Company and the European conduits:

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of receivables	$	2	$	512	$	3	$	512
Collections reinvested in revolving receivables	$	2,197	$	167	$	4,059	$	167
Interests in conduits (1)	$	136	$	—	$	224	$	—

(1) Presented in "Operating Activities" in the consolidated statements of cash flows.

Delinquencies on the sold receivables still outstanding at June 30, 2011 were $21 million ($42 million at December 31, 2010 ). Trade accounts receivable outstanding and derecognized from the Company’s consolidated balance sheets at June 30, 2011 were $479 million ($405 million at December 31, 2010).

29

Sale of Trade Accounts Receivable in Asia Pacific

The Company sells participating interests in trade accounts receivable of select Asia Pacific entities for which the Company maintains servicing responsibilities and the related costs are insignificant. The third-party holders of the participating interests do not have recourse to the Company’s assets in the event of nonpayment by the debtors.

During the six-month periods ended June 30, 2011 and 2010, the Company recognized insignificant losses on the sale of the participating interests in the receivables, which are classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. The Company receives cash upon the sale of the participating interests in the receivables.

Following is an analysis of certain cash flows between the Company and the third-party holders of the participating interests:

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of participating interests	$	41	$	53	$	87	$	102
Collections reinvested in revolving receivables	$	34	$	76	$	79	$	96

Following is additional information related to the sale of participating interests in the receivables under this facility:

Trade Accounts Receivable In millions	Jun 30, 2011		Dec 31, 2010
Derecognized from the consolidated balance sheet	$	18	$	25
Outstanding in the consolidated balance sheet	291		281
Total accounts receivable in select Asia Pacific entities	$	309	$	306

There were no credit losses on receivables relating to the participating interests sold during the three and six-month periods ended June 30, 2011 and June 30, 2010. There were no delinquencies on the outstanding receivables related to the participating interests sold at June 30, 2011 or December 31, 2010.

NOTE L – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

Notes Payable In millions	Jun 30, 2011			Dec 31, 2010
Notes payable to banks	$	692		$	1,310
Notes payable to related companies	208			157
Notes payable trade	16			—
Total notes payable	$	916		$	1,467
Period-end average interest rates	3.06		%	2.64		%

30

Long-Term Debt In millions	2011 Average Rate		Jun 30, 2011			2010 Average Rate		Dec 31, 2010
Promissory notes and debentures:
Final maturity 2011	2.52	%	$	253		5.30	%	$	1,057
Final maturity 2012	5.35	%	2,159			5.33	%	2,154
Final maturity 2013	6.11	%	395			6.05	%	389
Final maturity 2014	7.29	%	2,103			7.27	%	2,096
Final maturity 2015	5.92	%	1,257			5.90	%	1,250
Final maturity 2016	2.57	%	757			2.57	%	757
Final maturity 2017 and thereafter	7.02	%	9,020			6.78	%	10,503
Other facilities:
U.S. dollar loans, various rates and maturities	2.64	%	227			1.67	%	20
Foreign currency loans, various rates and maturities	3.36	%	1,551			2.95	%	998
Medium-term notes, varying maturities through 2022	5.53	%	972			5.96	%	2,005
Euro medium-term notes, final maturity 2011	—		—			4.63	%	665
Pollution control/industrial revenue bonds, varying maturities through 2038	5.70	%	872			5.68	%	907
Capital lease obligations	—		18			—		17
Unamortized debt discount	—		(412		)	—		(458		)
Long-term debt due within one year	—		(661		)	—		(1,755		)
Total long-term debt	—		$	18,511		—		$	20,605

Annual Installments on Long-Term Debt For Next Five Years at June 30, 2011 In millions
2011	$	614
2012	$	2,818
2013	$	675
2014	$	2,347
2015	$	1,437
2016	$	904

On March 22, 2011, the Company concluded cash tender offers for $1.5 billion aggregate principal amount of certain notes issued by the Company. As a result of the tender offers, the Company redeemed $1.5 billion of the notes and recognized a $472 million pretax loss on early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and reflected in Corporate.

In addition to the redemption of $800 million of notes that matured on February 1, 2011 and the redemption of Euro 500 million of notes that matured on May 27, 2011 ($707 million equivalent at March 31, 2011), the Company redeemed $1,208 million of InterNotes in the first six months of 2011 and recognized a $10 million pretax loss on early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and reflected in Corporate. The Company has also announced the planned redemption of $330 million of InterNotes in the third quarter of 2011, which is included in “Long-term debt due within one year.” In the second quarter of 2011, the Company issued $175 million of InterNotes.

The Company’s outstanding debt of $19.2 billion has been issued under indentures which contain, among other provisions, covenants with which the Company must comply while the underlying notes are outstanding. Such covenants include obligations to not allow liens on principal U.S. manufacturing facilities, enter into sale and lease-back transactions with respect to principal U.S. manufacturing facilities, or merge or consolidate with any other corporation, or sell or convey all or substantially all of the Company’s assets. The outstanding debt also contains customary default provisions. Failure of the Company to comply with any of these covenants could result in a default under the applicable indenture, which would allow the note holders to accelerate the due date of the outstanding principal and accrued interest on the subject notes.

31

The Company’s primary credit agreements contain covenant and default provisions in addition to the covenants set forth above with respect to the Company’s debt. Significant other covenants and default provisions related to these agreements include:

(a) the obligation to maintain the ratio of the Company’s consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Three Year Competitive Advance and Revolving Credit Facility Agreement dated June 4, 2010 exceeds $500 million,

(b) a default if the Company or an applicable subsidiary fails to make any payment on indebtedness of $50 million or more when due, or any other default under the applicable agreement permits the acceleration of $200 million or more of principal, or results in the acceleration of $100 million or more of principal, and

(c) a default if the Company or any applicable subsidiary fails to discharge or stay within 30 days after the entry of a final judgment of more than $200 million.

Failure of the Company to comply with any of the covenants or default provisions could result in a default under the applicable credit agreement which would allow the lenders to not fund future loan requests and to accelerate the due date of the outstanding principal and accrued interest on any outstanding loans.

At June 30, 2011, management believes the Company was in compliance with all of the covenants and default provisions referred to above.

NOTE M – VARIABLE INTEREST ENTITIES

Consolidated Variable Interest Entities

The Company holds variable interests in six joint ventures for which the Company is the primary beneficiary.

Three of the joint ventures are development stage enterprises, which will produce certain chemicals and provide certain services in Asia Pacific. The Company’s variable interest in these joint ventures relates to arrangements between the joint ventures and the Company, involving the majority of the output on take-or-pay terms with pricing ensuring a guaranteed return to the joint ventures.

Another joint venture will construct, own and operate a membrane chlor-alkali facility to be located at the Company’s Freeport, Texas integrated manufacturing complex. The Company’s variable interests relate to equity options between the partners and a cost-plus off-take arrangement involving proportional purchase commitments on take-or-pay terms and ensuring a guaranteed return to the joint venture. The Company will provide the joint venture with operation and maintenance services, utilities and raw materials; market the joint venture’s co-products; and toll convert the other partner’s proportional purchase commitments into ethylene dichloride. The joint venture is expected to begin operations in mid-2013.

The fifth joint venture was acquired through the acquisition of Rohm and Haas on April 1, 2009. This joint venture manufactures products in Japan for the semiconductor industry. Each joint venture partner holds several equivalent variable interests, with the exception of a royalty agreement held exclusively between the joint venture and the Company. In addition, the entire output of the joint venture is sold to the Company for resale to third-party customers.

The sixth joint venture is an existing ethylene storage joint venture located in Alberta, Canada. Previously accounted for as an equity method investment, the Company became the primary beneficiary upon execution of new storage cavern agreements in the second quarter of 2011. The Company's variable interests relate to arrangements involving a majority of the joint venture's storage capacity on take-or-pay terms with pricing ensuring a guaranteed return to the joint venture; and favorably priced leases provided to the joint venture. The Company provides the joint venture with operation and maintenance services and utilities.

The Company also holds a variable interest in an owner trust, for which the Company is the primary beneficiary. The owner trust leases an ethylene facility in The Netherlands to the Company, whereby substantially all of the rights and obligations of ownership are transferred to the Company. The Company’s variable interest in the owner trust relates to a residual value guarantee provided to the owner trust. Upon expiration of the lease, which matures in 2014, the Company may purchase the facility for an amount based on a fair market value determination. At June 30, 2011, the Company had provided to the owner trust a residual value guarantee of $363 million, which represents the Company’s maximum exposure to loss under the lease.

32

As the primary beneficiary of these variable interest enetities ("VIEs"), the entities’ assets, liabilities and results of operations are included in the Company’s consolidated financial statements. The other equity holders’ interests are reflected in “Net income attributable to noncontrolling interests” in the consolidated statements of income and “Noncontrolling interests” in the consolidated balance sheets. The following table summarizes the carrying amounts of the entities’ assets and liabilities included in the Company’s consolidated balance sheets at June 30, 2011 and December 31, 2010:

Assets and Liabilities of Consolidated VIEs In millions	Jun 30, 2011		Dec 31, 2010
Cash and cash equivalents (1)	$	107	$	145
Other current assets	135		83
Property	1,747		1,388
Other noncurrent assets	135		122
Total assets (2)	$	2,124	$	1,738
Current liabilities (nonrecourse 2011: $237; 2010: $190)	$	323	$	837
Long-term debt (nonrecourse 2011: $930; 2010: $167)	1,276		513
Other noncurrent liabilities (nonrecourse 2011: $77; 2010: $64)	77		64
Total liabilities	$	1,676	$	1,414

(1) Includes $2 million at June 30, 2011 restricted for the construction of a specific manufacturing facility.

(2) All assets were restricted at June 30, 2011 and December 31, 2010.

The Company holds a variable interest in an entity created in June 2010 to monetize accounts receivable of select European entities. The Company is the primary beneficiary of this entity as a result of holding subordinated notes while maintaining servicing responsibilities for the accounts receivable. The carrying amounts of assets and liabilities included in the Company’s consolidated balance sheets pertaining to this entity, were current assets of $186 million (zero restricted) at June 30, 2011 ($158 million, zero restricted, at December 31, 2010) and current liabilities of $1 million ($1 million nonrecourse) at June 30, 2011 ($1 million, $1 million nonrecourse, at December 31, 2010).

Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at June 30, 2011 and December 31, 2010 are adjusted for intercompany eliminations, parental guarantees and residual value guarantees.

Nonconsolidated Variable Interest Entity

The Company holds a variable interest in a joint venture accounted for under the equity method of accounting, acquired through the acquisition of Rohm and Haas on April 1, 2009. The joint venture manufactures crude acrylic acid in the United States and Germany on behalf of the Company and the other joint venture partner. The variable interest relates to a cost-plus arrangement between the joint venture and each joint venture partner. The Company is not the primary beneficiary, as a majority of the joint venture’s output is sold to the other joint venture partner, and therefore the entity is not consolidated. At June 30, 2011, the Company’s investment in the joint venture was $147 million ($144 million at December 31, 2010), classified as “Investment in nonconsolidated affiliates” in the consolidated balance sheets, representing the Company’s maximum exposure to loss.

33

NOTE N – PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

Net Periodic Benefit Cost for All Significant Plans	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Defined Benefit Pension Plans:
Service cost	$	86		$	77		$	172		$	156
Interest cost	282			273			560			549
Expected return on plan assets	(326		)	(302		)	(649		)	(606		)
Amortization of prior service cost	7			7			14			14
Amortization of net loss	94			67			186			134
Curtailment cost	—			8			—			8
Net periodic benefit cost	$	143		$	130		$	283		$	255
Other Postretirement Benefits:
Service cost	$	3		$	4		$	6		$	8
Interest cost	25			28			50			56
Expected return on plan assets	(1		)	(3		)	(2		)	(6		)
Curtailment cost	—			3			—			3
Net periodic benefit cost	$	27		$	32		$	54		$	61

As a result of the divestiture of Styron on June 17, 2010, the Company recognized a curtailment loss of $11 million and improved the funded status (plan assets less benefit obligations) by $99 million due to settlements, remeasurements and curtailments (see Note D).

34

NOTE O – STOCK-BASED COMPENSATION

The Company grants stock-based compensation to employees under the Employees' Stock Purchase Plan (“ESPP”) and the 1988 Award and Option Plan (the “1988 Plan”) and to non-employee directors under the 2003 Non-Employee Directors' Stock Incentive Plan. Most of the Company's stock-based compensation awards are granted in the first quarter of each year. Details for awards granted in the first quarter of 2011 are included in the following paragraphs. There was minimal grant activity in the second quarter of 2011.

During the first quarter of 2011, employees subscribed to the right to purchase 10.8 million shares with a weighted-average exercise price of $23.00 per share and a weighted-average fair value of $11.39 per share under the ESPP.

During the first quarter of 2011, the Company granted the following stock-based compensation awards to employees under the 1988 Plan:

• 10.5 million stock options with a weighted-average exercise price of $38.38 per share and a weighted-average fair value of $10.67 per share;

• 3.0 million shares of deferred stock with a weighted-average fair value of $38.35 per share; and

• 1.1 million shares of performance deferred stock with a weighted-average fair value of $48.94 per share.

During the first quarter of 2011, the Company granted the following stock-based compensation awards to non-employee directors under the 2003 Non-Employee Directors' Stock Incentive Plan:

• 31,350 shares of restricted stock with a weighted-average fair value of $37.26 per share.

Total unrecognized compensation cost at June 30, 2011 is provided in the following table:

Total Unrecognized Compensation Cost at June 30, 2011
In millions	Unrecognized Compensation Cost		Weighted-average Recognition Period (Years)
ESPP purchase rights	$	25	0.38
Unvested stock options	$	89	0.78
Deferred stock awards	$	138	0.83
Performance deferred stock awards	$	45	0.46

35

NOTE P – EARNINGS PER SHARE CALCULATIONS

The following tables provide the earnings per share calculations for the three-month and six-month periods ended June 30, 2011:

Net Income	Three Months Ended			Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2011
Net income	$	1,077		$	1,798
Net income attributable to noncontrolling interests	(10		)	(21		)
Net income attributable to The Dow Chemical Company	$	1,067		$	1,777
Preferred stock dividends	(85		)	(170		)
Net income attributable to participating securities (1)	(12		)	(20		)
Net income attributable to common stockholders	$	970		$	1,587

Earnings Per Share Calculations - Basic	Three Months Ended			Six Months Ended
Dollars per share	Jun 30, 2011			Jun 30, 2011
Net income	$	0.94		$	1.57
Net income attributable to noncontrolling interests	(0.01		)	(0.02		)
Net income attributable to The Dow Chemical Company	$	0.93		$	1.55
Preferred stock dividends	(0.08		)	(0.15		)
Net income attributable to participating securities (1)	(0.01		)	(0.01		)
Net income attributable to common stockholders	$	0.84		$	1.39

Earnings Per Share Calculations - Diluted	Three Months Ended			Six Months Ended
Dollars per share	Jun 30, 2011			Jun 30, 2011
Net income	$	0.93		$	1.56
Net income attributable to noncontrolling interests	(0.01		)	(0.02		)
Net income attributable to The Dow Chemical Company	$	0.92		$	1.54
Preferred stock dividends (2)	(0.07		)	(0.15		)
Net income attributable to participating securities (1)	(0.01		)	(0.02		)
Net income attributable to common stockholders	$	0.84		$	1.37

Shares in millions
Weighted-average common shares - basic	1,149.6	1,144.6
Plus dilutive effect of stock options and awards	11.3	11.6
Weighted-average common shares - diluted	1,160.9	1,156.2
Stock options and deferred stock awards excluded from EPS calculations (3)	42.8	43.0
Conversion of preferred stock excluded from EPS calculations (4)	96.8	96.8

(1) Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

(2) Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

(3) These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

(4) Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

36

The following tables provide the earnings per share calculations for the three-month and six-month periods ended June 30, 2010:

Net Income	Three Months Ended				Six Months Ended
In millions		Jun 30, 2010			Jun 30, 2010
Net income		$	659		$	1,211
Net income attributable to noncontrolling interests		(8		)	(9		)
Net income attributable to The Dow Chemical Company		$	651		$	1,202
Preferred stock dividends		(85		)	(170		)
Net income available for common stockholders		$	566		$	1,032

Earnings Per Share Calculations - Basic	Three Months Ended				Six Months Ended
Dollars per share		Jun 30, 2010			Jun 30, 2010
Net income		$	0.59		$	1.08
Net income attributable to noncontrolling interests		(0.01		)	(0.01		)
Net income attributable to The Dow Chemical Company		$	0.58		$	1.07
Preferred stock dividends		(0.08		)	(0.15		)
Net income available for common stockholders		$	0.50		$	0.92

Earnings Per Share Calculations - Diluted	Three Months Ended				Six Months Ended
Dollars per share		Jun 30, 2010			Jun 30, 2010
Net income		$	0.58		$	1.07
Net income attributable to noncontrolling interests		(0.01		)	(0.01		)
Net income attributable to The Dow Chemical Company		$	0.57		$	1.06
Preferred stock dividends (1)		(0.07		)	(0.15		)
Net income available for common stockholders		$	0.50		$	0.91

Shares in millions
Weighted-average common shares - basic	1,125.4	1,121.4
Plus dilutive effect of stock options and awards	16.2	16.9
Weighted-average common shares - diluted	1,141.6	1,138.3
Stock options and deferred stock awards excluded from EPS calculations (2)	49.1	47.3
Conversion of preferred stock excluded from EPS calculations (3)	96.8	96.8

(1) Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

(2) These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

(3) Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

37

NOTE Q – OPERATING SEGMENTS AND GEOGRAPHIC AREAS

Operating Segments	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Sales by operating segment
Electronic and Specialty Materials	$	1,450		$	1,278		$	2,796		$	2,457
Coatings and Infrastructure	1,587			1,437			2,985			2,722
Health and Agricultural Sciences	1,500			1,276			3,106			2,645
Performance Systems	1,901			1,808			3,568			3,483
Performance Products	3,157			2,754			6,060			5,543
Plastics	3,274			2,993			6,272			6,015
Chemicals and Energy	1,044			847			2,014			1,686
Hydrocarbons	2,044			1,151			3,796			2,316
Corporate	89			74			182			168
Total	$	16,046		$	13,618		$	30,779		$	27,035
EBITDA (1) by operating segment
Electronic and Specialty Materials	$	429		$	426		$	773		$	786
Coatings and Infrastructure	231			230			419			368
Health and Agricultural Sciences	287			196			693			580
Performance Systems	260			225			467			430
Performance Products	387			330			843			618
Plastics	751			696			1,560			1,414
Chemicals and Energy	282			100			573			220
Hydrocarbons	—			(1		)	—			(1		)
Corporate	(295		)	(321		)	(1,054		)	(753		)
Total	$	2,332		$	1,881		$	4,274		$	3,662
Equity in earnings (losses) of nonconsolidated affiliates by operating segment (included in EBITDA)
Electronic and Specialty Materials	$	97		$	112		$	188		$	225
Coatings and Infrastructure	—			1			—			2
Health and Agricultural Sciences	—			(1		)	3			1
Performance Systems	(6		)	2			(10		)	2
Performance Products	3			2			(3		)	9
Plastics	65			59			133			124
Chemicals and Energy	130			54			274			152
Hydrocarbons	8			20			19			44
Corporate	(6		)	(5		)	(15		)	(11		)
Total	$	291		$	244		$	589		$	548

(1) The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. A reconciliation of EBITDA to “Income Before Income Taxes” is provided below.

Reconciliation of EBITDA to “Income Before Income Taxes”	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
EBITDA	$	2,332	$	1,881	$	4,274	$	3,662
- Depreciation and amortization	697		734		1,428		1,491
+ Interest income	10		10		17		17
- Interest expense and amortization of debt discount	328		367		705		743
Income Before Income Taxes	$	1,317	$	790	$	2,158	$	1,445

38

Transfers of products between operating segments are generally valued at cost. However, transfers of products to Health and Agricultural Sciences from other segments are generally valued at market-based prices; the revenues generated by these transfers in the first six months of 2011 and 2010 were immaterial and eliminated in consolidation.

Geographic Areas	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sales by geographic area
United States	$	5,238	$	4,484	$	10,020	$	8,845
Europe, Middle East and Africa	5,713		4,721		11,071		9,468
Rest of World	5,095		4,413		9,688		8,722
Total	$	16,046	$	13,618	$	30,779	$	27,035

39

(Unaudited) The Dow Chemical Company and Subsidiaries PART I – FINANCIAL INFORMATION, Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

DISCLOSURE REGARDING FORWARD-LOOKING INFORMATION

The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements made by or on behalf of The Dow Chemical Company and its subsidiaries (“Dow” or the “Company”). This section covers the current performance and outlook of the Company and each of its operating segments. The forward-looking statements contained in this section and in other parts of this document involve risks and uncertainties that may affect the Company’s operations, markets, products, services, prices and other factors as more fully discussed elsewhere and in filings with the U.S. Securities and Exchange Commission (“SEC”). These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Company’s expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.

OVERVIEW

• The Company reported sales in the second quarter of 2011 of $16.0 billion, up 18 percent from $13.6 billion in the second quarter of 2010. Price was up 17 percent compared with the same period last year, with increases in all operating segments and all geographic areas and volume was up 1 percent. Excluding recent divestitures⁽¹⁾, sales were up 28 percent, with volume growth of 9 percent and increases in most operating segments and all geographic areas, reflecting continued improvement in global economic conditions. Price, excluding divestitures, was up 19 percent.

• Purchased feedstock and energy costs, which account for more than one-third of Dow’s total costs, increased 30 percent or $1.5 billion compared with the second quarter of 2010.

• Research and development expenses increased slightly in the second quarter of 2011 compared with the second quarter of 2010. Selling, general and administrative expenses increased $47 million in the second quarter of 2011 compared with the second quarter of 2010, as a result of the Company’s corporate growth initiatives and continued investments in the Electronic and Specialty Materials and Health and Agricultural Sciences segments.

• Equity earnings were $291 million in the second quarter of 2011, an increase of $47 million compared with the same period in 2010.

• The Company retired $1.5 billion of debt, net of new issuances, in the second quarter of 2011, which, combined with the debt retired in the first quarter of 2011, brought the Company's total debt retirement in the first-half of the year to $4 billion. These actions will reduce annual interest expense by approximately $250 million.

(1) Excludes sales of the acrylic monomer business and a portion of the specialty latex business divested on January 25, 2010, sales of the Powder Coatings business divested on June 1, 2010, and sales of Styron divested on June 17, 2010.

40

Selected Financial Data	Three Months Ended						Six Months Ended
In millions, except per share amounts	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Net sales	$	16,046		$	13,618		$	30,779		$	27,035
Cost of sales	$	13,551		$	11,580		$	25,668		$	23,121
Percent of net sales	84.5		%	85.0		%	83.4		%	85.5		%
Research and development expenses	$	411		$	407		$	811		$	814
Percent of net sales	2.6		%	3.0		%	2.6		%	3.0		%
Selling, general and administrative expenses	$	695		$	648		$	1,395		$	1,310
Percent of net sales	4.3		%	4.8		%	4.5		%	4.8		%
Effective tax rate	18.2		%	16.6		%	16.7		%	16.2		%
Net income available for common stockholders	$	982		$	566		$	1,607		$	1,032
Earnings per common share – basic	$	0.84		$	0.50		$	1.39		$	0.92
Earnings per common share – diluted	$	0.84		$	0.50		$	1.37		$	0.91
Operating rate percentage	84		%	80		%	83		%	82		%

RESULTS OF OPERATIONS

Net sales in the second quarter of 2011 were $16.0 billion, up 18 percent from $13.6 billion in the second quarter of last year, with double-digit increases in all geographic areas and all operating segments except Plastics (up 9 percent) and Performance Systems (up 5 percent). Compared with the same quarter of 2010, price increased 17 percent and volume increased 1 percent. Excluding recent divestitures (see Note D to the Consolidated Financial Statements), sales increased 28 percent compared with the same quarter of 2010. Price increased 19 percent (with approximately one-fourth of the increase due to currency) with increases in all operating segments and double-digit increases in all geographic areas, led by Europe, Middle East and Africa ("EMEA") (up 27 percent). Price increases were most pronounced in Hydrocarbons (up 46 percent), Chemicals and Energy (up 26 percent), and Plastics and Performance Products (each up 20 percent), driven by price initiatives in response to a 30 percent increase ($1.5 billion) in purchased feedstock and energy costs. Sales volume increased 9 percent, with volume improvement in all geographic areas and all segments except Coatings and Infrastructure (unchanged from the second quarter of 2010) and Chemicals and Energy (down 3 percent).

Net sales for the first six months of 2011 were $30.8 billion, up 14 percent from $27.0 billion in the same period last year. Compared with the first six months of 2010, price increased 15 percent and volume decreased 1 percent. The price increase was broad-based and reported in all geographic areas. The decline in volume reflects the impact of recent divestitures. Excluding these divestitures, sales increased 24 percent compared with the first six months of 2010, with price up 16 percent and volume up 8 percent. Price increases were recognized in all operating segments and all geographic areas, largely in response to a $2.2 billion increase in purchased feedstock and energy costs compared with the first half of 2010. Volume improved in all geographic areas with the most pronounced increases in Latin America (14 percent) and EMEA (12 percent), and all operating segments except Chemicals and Energy (down 1 percent). For additional details regarding the change in net sales, see the Sales Volume and Price tables at the end of the section entitled “Segment Results.”

Gross margin was $2,495 million in the second quarter of 2011, up from $2,038 million in the second quarter of last year. Gross margin increased due to the impact of higher selling prices and improved operating rates, which more than offset the increase in purchased feedstock and energy costs, as well as increases in other raw material costs and the unfavorable impact of currency on costs. Year to date, gross margin was $5,111 million, compared with $3,914 million in the first six months of 2010. The improvement in the year-to-date gross margin reflected higher selling prices, additional margin on increased volume and lower freight costs, which more than offset the increase in purchased feedstock and energy costs, increases in other raw material costs and the unfavorable impact of currency on costs.

41

The Company’s global plant operating rate was 84 percent of capacity in the second quarter of 2011, up from 80 percent in the second quarter of 2010. The second quarter of 2010 operating rate was impacted by planned turnarounds. For the first six months of 2011, the Company's global plant operating rate was 83 percent, up from 82 percent for the first six months of 2010.

The Company has operations at several locations in Japan, including a manufacturing site located in Soma, Japan, that manufactures product primarily for the Dow Water and Process Solutions business, part of the Electronic and Specialty Materials operating segment. The site is located in the area of Japan that was heavily impacted by the March 11, 2011 earthquakes and tsunami, and near the Fukushima Daiichi nuclear power plant. Based on an assessment of the site, the Company wrote off an immaterial amount of property and inventory in the first quarter of 2011. The Soma manufacturing site is anticipated to return to operations on a limited basis late in the third quarter of 2011 and return to full production capacity by year-end 2011. The financial impact of the disaster, net of insurance recoveries, did not have a material adverse impact on the Company’s results of operations, financial condition and cash flows.

Personnel count was 51,028 at June 30, 2011, up from 49,505 at December 31, 2010 and up from 49,055 at June 30, 2010. Headcount increased from June 30, 2010 and from year-end 2010 primarily due to the hiring of additional employees to support the Company’s growth initiatives.

Research and development (“R&D”) expenses totaled $411 million in the second quarter of 2011, up $4 million (1 percent) from $407 million in the second quarter of last year, reflecting the Company’s increased spending on strategic growth initiatives in the Electronic and Specialty Materials segment and continued investment in POWERHOUSE™ solar shingles, partially offset by the elimination of R&D expenses related to the divestiture of Styron. For the first six months of 2011, R&D expenses totaled $811 million, down slightly from $814 million in the first six months of 2010.

Selling, general and administrative (“SG&A”) expenses totaled $695 million in the second quarter of 2011, up $47 million (7 percent) from $648 million in the second quarter of last year, primarily due to growth initiatives in the Electronic and Specialty Materials and Health and Agricultural Sciences segments. For the first six months of 2011, SG&A expenses totaled $1,395 million, up $85 million (6 percent) from $1,310 million in the first six months of 2010.

Amortization of intangibles was $125 million in the second quarter of 2011, unchanged from the second quarter of last year. In the first six months of 2011, amortization of intangibles was $248 million, down slightly from $253 million in the same period last year. See Note G to the Consolidated Financial Statements for additional information on intangible assets.

In June 2009, the Company’s Board of Directors approved a restructuring plan that incorporated actions related to the Company’s acquisition of Rohm and Haas, as well as additional actions to advance the Company’s strategy and to respond to continued weakness in the global economy. The restructuring plan included the shutdown of a number of facilities and a global workforce reduction. In the second quarter of 2010, the Company recorded pretax adjustments of $13 million to the 2009 restructuring charge for additional exit or disposal activities, which were reflected in Performance Products ($12 million) and Corporate ($1 million). In the first quarter of 2010, the Company recorded pretax adjustments of $16 million to the 2009 restructuring charge for additional asset impairment costs, which were reflected in the Company’s segments as follows: $8 million in Electronic and Specialty Materials, $5 million in Coatings and Infrastructure and $3 million in Performance Products. The impact of these adjustments is shown as “Restructuring charges” in the consolidated statements of income. See Note C to the Consolidated Financial Statements for details on the Company’s restructuring activities.

In the first quarter of 2011, pretax charges totaling $31 million were recorded for integration costs related to the April 1, 2009 acquisition of Rohm and Haas. In the second quarter of 2010, pretax charges totaling $37 million ($63 million for the first six months of 2010) were recorded for integration costs. These charges were reflected in Corporate.

Dow’s share of the earnings of nonconsolidated affiliates was $291 million in the second quarter of 2011, up $47 million (19 percent) from $244 million in the second quarter of last year, driven by improved earnings at The Kuwait Olefins Company K.S.C. and MEGlobal which more than offset decreased earnings at Dow Corning Corporation (“Dow Corning”) and the SCG-Dow Group. For the first six months of 2011, Dow's share of the earnings of nonconsolidated affiliates was $589 million, an increase of $41 million (7 percent) from $548 million for the same period last year and a first-half record for the Company, with the same joint ventures driving the increase in earnings.

Sundry income (expense) – net includes a variety of income and expense items such as the gain or loss on foreign currency exchange, dividends from investments, and gains and losses on sales of investments and assets. Sundry income (expense) – net in the second quarter of 2011 was net income of $80 million, down $15 million compared with net income of $95 million in the same quarter of 2010. The second quarter of 2011 included a $10 million loss on the early extinguishment of debt (reflected in Corporate), gains from small divestitures, working capital adjustments from prior divestitures and a gain resulting from the consolidation of a joint venture. The second quarter of 2010 included a $51 million gain on the divestiture of Styron, which was reflected in the following operating segments: Performance Systems ($15 million), Performance Products ($26 million) and

42

Plastics ($10 million) (see Note D to the Consolidated Financial Statements). Year to date, sundry income (expense) - net was net expense of $369 million, reflecting a $482 million loss on the early extinguishment of debt (reflected in Corporate) (see Note L to the Consolidated Financial Statements), $25 million of dividend income received from the Company's ownership interest in the divested Styron business unit (reflected in Corporate), gains from small divestitures, working capital adjustments from prior divestitures and a gain from the consolidation of a joint venture. This compared with net income of $178 million in the first half of 2010, which included gains on several small divestitures as well as the gain on the divestiture of Styron.

Net interest expense (interest expense less capitalized interest and interest income) was $318 million in the second quarter of 2011, compared with $357 million in the second quarter of last year. Year to date, net interest expense was $688 million, compared with $726 million in the first six months of 2010. The decrease in net interest expense in the second quarter of 2011 as well as year-to-date 2011 reflected the Company's redemption of certain notes and InterNotes during the first six months of 2011 (see Note L to the Consolidated Financial Statements). Interest income was $10 million in the second quarter of 2011 and $17 million for the first six months of 2011, unchanged from the same periods last year.

The effective tax rate for the second quarter of 2011 was 18.2 percent compared with 16.6 percent for the second quarter of 2010. For the first six months of 2011 the effective tax rate was 16.7 percent compared with 16.2 percent for the first six months of 2010. The Company’s effective tax rate fluctuates based on, among other factors, where income is earned, reinvestment assertions regarding earned income and the level of income relative to tax credits available. The Company’s tax rate is also influenced by the level of equity earnings, since most of the earnings from the Company’s equity company investments are taxed at the joint venture level. Similar to the second quarter of 2010, the tax rate for the second quarter of 2011 was favorably impacted by continued growth outside of the United States, primarily in Europe, and strong equity earnings. The tax rate for the first six months of 2011 was also favorably impacted by tax benefits from the early extinguishment of debt in the United States and the reorganization of a joint venture. The tax rate in the first six months of 2010 was also favorably impacted by audit settlements and the closure of tax years.

Net income attributable to noncontrolling interests was $10 million in the second quarter of 2011, up from $8 million in the second quarter of 2010. Net income attributable to noncontrolling interests was $21 million in the first six months of 2011, compared with $9 million in the first six months of 2010, reflecting improved results in certain affiliates, primarily in the Electronic and Specialty Materials and Health and Agricultural Sciences segments.

Preferred stock dividends of $85 million were recognized in the second quarters of 2011 and 2010 ($170 million in the first six months of 2011 and 2010), related to the Company’s Cumulative Convertible Perpetual Preferred Stock, Series A.

Net income available for common stockholders was $982 million, or $0.84 per share, in the second quarter of 2011, compared with $566 million, or $0.50 per share, in the second quarter of 2010. Net income available for common stockholders for the first six months of 2011 was of $1,607 million, or $1.37 per share, compared with $1,032 million, or $0.91 per share, for the same period of 2010.

The Company and Saudi Arabian Oil Company (“Saudi Aramco”) announced on July 25, 2011, that the Board of Directors of both companies had approved the formation of a joint venture, Sadara Chemical Company (“Sadara”), to build and operate a world-scale, fully integrated chemicals complex in Jubail Industrial City, Kingdom of Saudi Arabia. Comprised of 26 manufacturing units, building on Saudi Aramco's project management and execution expertise, and utilizing many of Dow's industry leading technologies, the complex will be one of the world's largest integrated chemical facilities, and the largest ever built in one single phase. The complex will possess flexible cracking capabilities and will produce over 3 million metric tons of high value-added chemical products and performance plastics, capitalizing on rapidly growing markets in energy, transportation, infrastructure and consumer products. Construction will begin immediately and the first production units will come on line in the second half of 2015, with all units expected to be up and running in 2016. Once operational, Sadara is expected to deliver annual revenues of approximately $10 billion within a few years of operations. Total project investment is expected to be approximately $20 billion. Sadara will become an equal joint venture between Saudi Aramco and Dow after an initial public offering. In addition to equity from the partners, Export Credit Agencies and financial institutions will provide project financing to Sadara.

On July 27, 2011, the Company entered into a definitive agreement under which the Company's global Polypropylene business will be divested to Braskem SA for a total enterprise value of approximately $340 million. The transaction is expected to close by the end of the third quarter 2011, pending regulatory approval, and the Company expects to report a gain on this divestiture. The divestiture will include the Company's polypropylene manufacturing facilities at Schkopau and Wesseling, Germany, and Freeport and Seadrift, Texas. Also included are inventory, business know-how, certain product and process technology, and customer contracts and lists. Dow's Polypropylene Licensing and Catalyst business and related catalyst facilities are excluded from the scope of the transaction.

43

The following table summarizes the impact of certain items recorded in the three-month periods ended June 30, 2011 and June 30, 2010, and the six-month periods ended June 30, 2011 and June 30, 2010, and previously described in this section:

Certain Items Impacting Results	Pretax Impact(1)						Impact on Net Income(2)						Impact on EPS (3)
	Three Months Ended						Three Months Ended						Three Months Ended
In millions, except per share amounts	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Restructuring charges	$	—		$	(13	)	$	—		$	(8	)	$	—		$	(0.01	)
Acquisition-related integration expenses	—			(37		)	—			(24		)	—			(0.02		)
Loss on early extinguishment of debt	(10		)	—			(7		)	—			(0.01		)	—
Gain (Loss) on divestiture of Styron	—			51			—			(16		)	—			(0.01		)
Total	$	(10	)	$	1		$	(7	)	$	(48	)	$	(0.01	)	$	(0.04	)

Certain Items Impacting Results	Pretax Impact(1)						Impact on Net Income(2)						Impact on EPS(3)
	Six Months Ended						Six Months Ended						Six Months Ended
In millions, except per share amounts	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Restructuring charges	$	—		$	(29	)	$	—		$	(16	)	$	—		$	(0.02	)
Acquisition-related integration expenses	(31		)	(63		)	(20		)	(41		)	(0.02		)	(0.03		)
Loss on early extinguishment of debt	(482		)	—			(314		)	—			(0.27		)	—
Gain (Loss) on divestiture of Styron	—			51			—			(16		)	—			(0.01		)
Total	$	(513	)	$	(41	)	$	(334	)	$	(73	)	$	(0.29	)	$	(0.06	)

(1) Impact on “Income Before Income Taxes”

(2) Impact on “Net Income Attributable to The Dow Chemical Company”

(3) Impact on “Earnings per common share – diluted”

SEGMENT RESULTS

The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. Additional information regarding the Company’s operating segments and a reconciliation of EBITDA to “Income Before Income Taxes” can be found in Note Q to the Consolidated Financial Statements.

Due to the completion of several divestitures (see Note D to the Consolidated Financial Statements), the change in sales volume from 2010 excluding divestitures is provided by operating segment, where applicable. Sales excluding divestitures exclude the sales of the acrylic monomer business and a portion of the specialty latex business divested on January 25, 2010, sales of the Powder Coatings business divested on June 1, 2010, and sales of Styron divested on June 17, 2010.

44

ELECTRONIC AND SPECIALTY MATERIALS

The Electronic and Specialty Materials segment consists of two businesses – Dow Electronic Materials and Specialty Materials – and includes the Company’s share of the results of Dow Corning Corporation, a joint venture of the Company. Dow Electronic Materials is a leading global supplier of materials for chemical mechanical planarization; materials used in the production of electronic displays; products and technologies that drive leading edge semiconductor design; materials used in the fabrication of printed circuit boards; and integrated metallization processes critical for interconnection, corrosion resistance, metal finishing and decorative applications. These materials are found in applications such as consumer electronics, flat panel displays and telecommunications. Specialty Materials is a portfolio of five global businesses – Dow Water and Process Solutions; Dow Home and Personal Care; Dow Microbial Control; Dow Wolff Cellulosics; and Performance Materials – characterized by a vast global footprint, a broad array of unique chemistries, multi-functional ingredients and technology capabilities, combined with key positions in the pharmaceuticals, food, home and personal care, water and energy production, and industrial specialty industries.

Electronic and Specialty Materials	Three Months Ended					Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010		Jun 30, 2011			Jun 30, 2010
Sales	$	1,450		$	1,278	$	2,796		$	2,457
Price change from comparative period	7		%	N/A		6		%	N/A
Volume change from comparative period	6		%	N/A		8		%	N/A
Equity earnings	$	97		$	112	$	188		$	225
EBITDA	$	429		$	426	$	773		$	786
Certain items impacting EBITDA	$	—		$	—	$	—		$	(8	)

Electronic and Specialty Materials sales were $1,450 million in the second quarter of 2011, up 13 percent from $1,278 million in the second quarter of 2010. Compared with last year, price increased 7 percent (with approximately half of the increase due to currency) and volume increased 6 percent. Price increased across all geographic areas and across most major business units in response to increased raw material costs. Volume increased in all geographic areas, especially in Asia Pacific, and across most businesses, driven by strong demand for consumer electronics, ion exchange resins, reverse osmosis membranes, and cellulosics used in food and pharmaceutical applications. EBITDA in the second quarter of 2011 was $429 million, a quarterly record for the segment, compared with $426 million in the second quarter of 2010. EBITDA improved slightly from last year as higher sales more than offset increased raw material costs, higher SG&A expenses, increased investment in R&D and lower equity earnings from Dow Corning.

Dow Electronic Materials sales in the second quarter of 2011 increased 13 percent from the same quarter last year, with double-digit volume growth in Asia Pacific driven by higher demand for consumer electronics. Demand for films and materials used in flat panel displays and materials used in printed circuit boards also improved compared with the same quarter last year. Factory utilization rates for semiconductors remained high.

Specialty Materials sales in the second quarter of 2011 increased 14 percent from the second quarter of 2010, as price improved 10 percent (with approximately 40 percent of the increase due to currency) and volume increased 4 percent. The increase in price, in response to higher raw material costs, was broad-based with increases across all geographic areas and businesses. Volume increased in all geographic areas, except EMEA where volume decreased due to lower demand for personal care and household cleaning products. Dow Water and Process Solutions reported double-digit volume gains as demand for ion exchange resins and reverse osmosis membranes was strong, especially in Asia Pacific, in part due to demand for ultrapure water used in the production of consumer electronics. Demand for specialty cellulosics used in food and pharmaceutical applications and for glutaraldehyde used in oil and gas drilling operations also improved compared with the same quarter of last year.

Electronic and Specialty Materials sales were $2,796 million for the first six months of 2011, up 14 percent from $2,457 million in the first six months of 2010. Compared with year-to-date sales in 2010, volume increased 8 percent and price increased 6 percent (with approximately half of the increase due to currency). Despite the increase in sales, EBITDA of $773 million for the first six months of 2011 was down from $786 million in the first six months of 2010 due to higher raw material costs, increased investment in growth initiatives, the write-off of property and inventory associated with the ion exchange resins plant in Soma, Japan that was damaged by the March 11, 2011 earthquakes and tsunami, and lower equity earnings from Dow Corning. Results in the first six months of 2010 were negatively impacted by an $8 million adjustment to the 2009 restructuring charge related to the closure of a small manufacturing facility.

45

COATINGS AND INFRASTRUCTURE

The Coatings and Infrastructure segment consists of the following businesses: Dow Adhesives and Functional Polymers; Dow Building and Construction; and Dow Coating Materials. These businesses produce a wide variety of products with a broad range of applications – sticking and bonding solutions, construction materials (insulation and vinyl applications) and raw materials for architectural paints and industrial coatings.

Coatings and Infrastructure	Three Months Ended					Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010		Jun 30, 2011			Jun 30, 2010
Sales	$	1,587		$	1,437	$	2,985		$	2,722
Price change from comparative period	14		%	N/A		14		%	N/A
Volume change from comparative period	(4		)%	N/A		(4		)%	N/A
Volume change, excluding divestitures	—		%	N/A		1		%	N/A
Equity earnings	$	—		$	1	$	—		$	2
EBITDA	$	231		$	230	$	419		$	368
Certain items impacting EBITDA	$	—		$	—	$	—		$	(5	)

Coatings and Infrastructure sales were $1,587 million in the second quarter of 2011, up from $1,437 million in the second quarter of 2010. Sales increased 10 percent with price improving 14 percent (with approximately one-third of the increase due to currency) and volume decreasing 4 percent. The increase in price was broad-based, with double-digit increases across all geographic areas. Volume was down due to the United States Federal Trade Commission (“FTC”) required divestiture of certain specialty latex assets on January 25, 2010 (related to the April 1, 2009 acquisition of Rohm and Haas) and the June 1, 2010 divestiture of the Powder Coatings business. Excluding these divestitures, volume was flat compared with the second quarter of 2010. Dow Coating Materials sales increased due to higher prices, with increases across all geographic areas, especially in emerging geographies, driven by higher raw material costs. Volume excluding divestitures decreased primarily due to lower demand for architectural coatings in North America, the result of continued softness in home construction in the United States. Industrial coatings volume declined, especially in Asia Pacific and EMEA, driven by pricing initiatives implemented in response to rising raw material costs. Dow Building and Construction sales increased as prices increased in all geographic areas, especially in EMEA and North America, offsetting reduced volume in the United States due to soft end-market conditions. Dow Adhesives and Functional Polymers sales were higher due to price increases in all geographic areas and increased demand in Asia Pacific for specialty adhesives used in packaging and thermal paper applications.

EBITDA in the second quarter of 2011 was $231 million, compared with $230 million in the second quarter of 2010. EBITDA improved slightly from the same quarter last year as price increases offset higher feedstock and energy costs, increased other raw material costs, ongoing investment in POWERHOUSE™ solar shingles and the absence of earnings from divested businesses.

Coatings and Infrastructure sales were $2,985 million for the first six months of 2011, up 10 percent from $2,722 million in 2010. Compared with the first six months of 2010, price rose 14 percent (with approximately 20 percent of the increase due to currency) and volume declined 4 percent. The increase in price was broad-based across all geographic areas, primarily driven by higher raw material costs. Excluding recent divestitures, volume increased 1 percent due to higher demand for insulation products and adhesives used in packaging applications, which offset lower sales volume of architectural coatings and industrial coatings due to raw material supply constraints.

EBITDA for the first six months of 2011 was $419 million, compared with $368 million in the first six months of 2010. EBITDA improved from last year as price increases and lower SG&A expenses from divested businesses more than offset higher raw material costs, ongoing investment in the POWERHOUSE™ solar shingles and the absence of earnings from divested businesses. Results in the first six months of 2010 were negatively impacted by a $5 million increase in the 2009 restructuring charge related to the divestiture of certain specialty latex assets.

46

HEALTH AND AGRICULTURAL SCIENCES

Dow AgroSciences is a global leader in providing agricultural and plant biotechnology products, pest management solutions and healthy oils. The business invents, develops, manufactures and markets products for use in agriculture, industrial and commercial pest management, and food service.

Health and Agricultural Sciences	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Sales	$	1,500		$	1,276		$	3,106		$	2,645
Price change from comparative period	5		%	N/A			4		%	N/A
Volume change from comparative period	13		%	N/A			13		%	N/A
Equity earnings	$	—		$	(1	)	$	3		$	1
EBITDA	$	287		$	196		$	693		$	580
Certain items impacting EBITDA	$	—		$	—		$	—		$	—

Health and Agricultural Sciences sales were $1,500 million in the second quarter of 2011, up 18 percent from $1,276 million in the second quarter of 2010 and a second quarter sales record for the segment. Compared with the second quarter of 2010, volume increased 13 percent while price increased 5 percent, largely due to currency. Double-digit sales growth was recorded across all geographic areas. Seeds, Traits and Oils reported significant growth in the second quarter compared with the same quarter last year as the corn, oilseed and U.S. cotton seed businesses continued to outperform. New agricultural chemical product sales grew 39 percent compared with the same period last year as the herbicides pyroxsulam for cereals and penoxsulam for rice continued to receive strong customer support. EBITDA for the second quarter of 2011 was $287 million, up from $196 million in the second quarter of 2011, driven by strong sales growth, which more than offset increased SG&A expenses related to growth initiatives.

Health and Agricultural Sciences sales were $3,106 million for the first six months of 2011, up 17 percent from $2,645 million for the first six months of 2010, with sales growth in all geographic areas. This represents a new sales record for the first half of the year. Compared with the same period last year, volume increased 13 percent and price increased 4 percent. For the first six months of 2011, EBITDA was $693 million, up from $580 million for the first six months of 2010. EBITDA was favorably impacted by global agricultural and food industry conditions that led to strong sales increases across all geographic areas and more than offset increased R&D and SG&A spending related to ongoing growth initiatives.

PERFORMANCE SYSTEMS

The Performance Systems segment consists of the following businesses: Dow Automotive Systems; Dow Elastomers; Dow Wire and Cable; Dow Formulated Systems; Dow Oil and Gas; and Dow Fiber Solutions. These businesses produce a wide variety of products with a broad range of applications – automotive interiors and exteriors, footwear, mattresses, specialty films, wind turbines, transportation, waterproofing membranes, and electrical and telecommunication applications.

On March 2, 2010, Dow announced the entry into a definitive agreement to sell Styron to an affiliate of Bain Capital Partners; the transaction closed on June 17, 2010. Businesses and products sold included Synthetic Rubber and certain products from Dow Automotive Systems, which were reported in the Performance Systems segment through the date of the divestiture. See Note D to the Consolidated Financial Statements for additional information on this divestiture.

Performance Systems	Three Months Ended					Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010		Jun 30, 2011			Jun 30, 2010
Sales	$	1,901		$	1,808	$	3,568		$	3,483
Price change from comparative period	15		%	N/A		12		%	N/A
Volume change from comparative period	(10		)%	N/A		(10		)%	N/A
Volume change, excluding divestitures	2		%	N/A		3		%	N/A
Equity earnings	$	(6	)	$	2	$	(10	)	$	2
EBITDA	$	260		$	225	$	467		$	430
Certain items impacting EBITDA	$	—		$	15	$	—		$	15

47

Performance Systems sales were $1,901 million in the second quarter of 2011, up 5 percent from $1,808 million in the second quarter of 2010. Compared with last year, price increased 15 percent (with approximately one-quarter of the increase due to currency) and volume declined 10 percent. Price increased in all businesses and all geographic areas in response to escalating feedstock and energy and other raw material costs. Dow Elastomers reported the most significant price increase due to tight supply/demand balances. The decline in volume for the segment was primarily the result of the divestiture of Synthetic Rubber and certain products from Dow Automotive Systems as part of the June 17, 2010 divestiture of Styron. Excluding the impact of these divestitures, volume increased 2 percent. Dow Elastomers volume improved significantly across all geographic areas as demand continued to be robust, particularly in the automotive and packaging industries. Dow Formulated Systems volume declined primarily due to decreased demand for wind energy formulations in China.

EBITDA for Performance Systems for the second quarter of 2011 was $260 million, up from $225 million in the second quarter of 2010 and a new quarterly record. Compared with last year, EBITDA improved across most businesses, as the impact of price increases and reduced freight costs were partially offset by higher feedstock and energy and other raw material costs and the absence of earnings from divested businesses. EBITDA declined in Dow Formulated Systems as increased feedstock and energy and other raw material costs as well as a decline in volume offset gains from price increases and reduced freight costs. EBITDA for the second quarter of 2010 included a $15 million gain on the sale of Styron.

For the first half of 2011, Performance Systems sales were $3,568 million, an increase of 2 percent from $3,483 million in the first half of 2010. Compared with the same period last year, price increased 12 percent while volume declined 10 percent. Double-digit price increases were reported in Dow Elastomers, Dow Formulated Systems and Dow Wire and Cable. The decline in volume for the segment reflected the divestiture of Styron. Excluding this divestiture, volume increased 3 percent.

EBITDA for Performance Systems for the first six months of 2011 was $467 million, up from $430 million in the first half of 2010. Compared with the same period last year, EBITDA improved as price increases, reduced freight costs, decreased R&D spending and volume growth offset higher feedstock and energy and other raw material costs and the absence of earnings from divested businesses. EBITDA for the first half of 2010 included a $15 million gain on the sale of Styron.

PERFORMANCE PRODUCTS

The Performance Products segment consists of the following businesses: Amines; Emulsion Polymers (through the June 17, 2010 divestiture of Styron); Epoxy; Oxygenated Solvents; Performance Monomers; Polyglycols, Surfactants and Fluids; Polyurethanes; Dow Haltermann; and SAFECHEM. These businesses produce a wide variety of products with a broad range of applications – adhesives and deicing fluids, solvents, paper and paperboard applications, carpet backing and home furnishings. The segment also includes a portion of the results of the SCG-Dow Group of joint ventures.

On March 2, 2010, Dow announced the entry into a definitive agreement to sell Styron to an affiliate of Bain Capital Partners; the transaction closed on June 17, 2010. Businesses and products sold included Emulsion Polymers (styrene-butadiene latex), which was reported in the Performance Products segment through the date of the divestiture. See Note D to the Consolidated Financial Statements for additional information on this divestiture.

Performance Products	Three Months Ended					Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010		Jun 30, 2011			Jun 30, 2010
Sales	$	3,157		$	2,754	$	6,060		$	5,543
Price change from comparative period	18		%	N/A		16		%	N/A
Volume change from comparative period	(3		)%	N/A		(7		)%	N/A
Volume change, excluding divestitures	9		%	N/A		6		%	N/A
Equity earnings	$	3		$	2	$	(3	)	$	9
EBITDA	$	387		$	330	$	843		$	618
Certain items impacting EBITDA	$	—		$	14	$	—		$	11

Performance Products sales were $3,157 million in the second quarter of 2011, up 15 percent from $2,754 million in the second quarter of 2010 driven by an 18 percent increase in price (with approximately one-quarter of the increase due to currency) and a 3 percent decrease in volume. Increased feedstock and energy costs and other raw material costs led to double-digit price increases across all geographic areas and all businesses in the segment. The decline in volume for the segment reflected the divestiture of the Emulsion Polymers business as part of the June 17, 2010 divestiture of Styron. Excluding the impact of this divestiture, volume was up 9 percent, with gains in all businesses and double-digit volume gains in North America and Asia Pacific. Epoxy volume was up more than 25 percent with particular strength in North America and EMEA, driven by new product supply agreements with Styron for phenol used in polycarbonate-based applications.

48

EBITDA in the second quarter of 2011 was $387 million, up from $330 million in the second quarter of 2010. Compared with the second quarter of last year, price gains, decreased freight costs and improved operating rates, more than offset the increase in feedstock and energy costs and other raw material costs and the absence of earnings from the divested business. Results in the second quarter of 2010 were favorably impacted by a $26 million gain on the sale of Styron, partially offset by a $12 million adjustment to the 2009 restructuring charges.

For the first half of 2011, Performance Products sales were $6,060 million, up 9 percent from $5,543 million in the first half of 2010. Compared with the first six months of 2010, price increased 16 percent while volume declined 7 percent. The price increase was broad-based with double-digit price increases in all geographic areas and all businesses, driven primarily by higher feedstock and energy costs. Volume declined 7 percent, reflecting the Emulsion Polymers divestiture. Excluding the impact of this divestiture, volume was up 6 percent with especially strong volume increases in North America and EMEA.

EBITDA for the first six months of 2011 was $843 million, compared with $618 million in the first half of 2010. Results in the first half of 2010 were favorably impacted by a $26 million gain on the sale of Styron, partially offset by a $15 million adjustment to the 2009 restructuring charges. Compared with last year, strong price and volume increases, along with decreased freight costs, more than offset the increase in feedstock and energy costs and other raw material costs, lower equity earnings and the absence of earnings from the divested business.

PLASTICS

The Plastics segment includes the following businesses: Polyethylene; Polypropylene; Styrenics (through the June 17, 2010 divestiture of Styron); Plastics Licensing and Catalyst; and Polycarbonate and Compounds and Blends (through the June 17, 2010 divestiture of Styron). These world-leading businesses provide a broad range of products and solutions by leveraging Dow’s leading manufacturing and application technology, research and product development expertise, extensive market knowledge and strong customer relationships. Product applications range from beverage bottles, disposable diaper liners and toys to plastic pipe, oil tanks and road equipment. The Plastics segment also includes the results of Equipolymers, Americas Styrenics LLC (through the June 17, 2010 divestiture of Styron) and Univation Technologies, LLC, and a portion of the results of EQUATE Petrochemical Company K.S.C., The Kuwait Olefins Company K.S.C. and the SCG-Dow Group, all joint ventures of the Company.

On March 2, 2010, Dow announced the entry into a definitive agreement to sell Styron to an affiliate of Bain Capital Partners; the transaction closed on June 17, 2010. Businesses and products sold included Styrenics (polystyrene, acrylonitrile butadiene styrene, styrene acrylonitrile and expandable polystyrene), Polycarbonate and Compounds and Blends, as well as the Company’s 50-percent ownership interest in Americas Styrenics LLC, formerly a principal nonconsolidated affiliate; all of which were reported in the Plastics segment through the date of the divestiture. See Note D to the Consolidated Financial Statements for additional information on this divestiture.

Plastics	Three Months Ended					Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010		Jun 30, 2011			Jun 30, 2010
Sales	$	3,274		$	2,993	$	6,272		$	6,015
Price change from comparative period	16		%	N/A		14		%	N/A
Volume change from comparative period	(7		)%	N/A		(10		)%	N/A
Volume change, excluding divestitures	10		%	N/A		7		%	N/A
Equity earnings	$	65		$	59	$	133		$	124
EBITDA	$	751		$	696	$	1,560		$	1,414
Certain items impacting EBITDA	$	—		$	10	$	—		$	10

Plastics sales in the second quarter of 2011 were $3,274 million, up 9 percent from $2,993 million in the second quarter of 2010. Feedstock and energy costs increased significantly during the quarter, driving a 16 percent increase in price (with approximately one-quarter of the increase due to currency). Strong price increases were reported in all geographic areas with double-digit increases in North America and EMEA. Volume was down 7 percent from the second quarter of 2010, reflecting the divestiture of the Styrenics and Polycarbonate and Compounds and Blends businesses as part of the June 17, 2010 divestiture of Styron. Excluding the impact of this divestiture, volume improved 10 percent, with double-digit growth in Latin America and Asia Pacific. Compared with the second quarter of 2010, polyethylene volume grew in all geographic areas except EMEA where Middle East producers aggressively sold excess material into the region. Polypropylene volume improved in North America and EMEA despite volatile raw material costs and higher prices that dampened demand growth. During the second quarter of 2010, volume was negatively impacted in all geographic areas as planned maintenance turnarounds in North America and Europe curtailed polyethylene and polypropylene production. Polyethylene volume in Latin America was also

49

negatively impacted by the limited availability of ethylene at the Bahia Blanca facility in Argentina. Polypropylene production at the Company's facility in Schkopau, Germany was further limited due to an unplanned site outage.

EBITDA in the second quarter of 2011 was $751 million, up from $696 million in the second quarter of 2010. EBITDA improved as the impact of higher prices, lower freight costs, improved operating rates and increased equity earnings from The Kuwait Styrene Company K.S.C. and Univation Technologies, LLC more than offset an increase in feedstock and energy and other raw material costs and the absence of earnings from divested businesses. EBITDA in the second quarter of 2010 included a $10 million gain related to the sale of Styron.

Plastics sales for the first six months of 2011 were $6,272 million, up 4 percent from $6,015 million in the first half of 2010. Compared with the first half of 2010, price increased 14 percent while volume declined 10 percent, reflecting the divestiture of Styron. Excluding this divestiture, volume improved 7 percent. EBITDA for the first half of 2011 was $1,560 million, up from $1,414 million in the first half of 2010. EBITDA improved as price increases, improved operating rates, reduced freight costs and increased equity earnings from The Kuwait Styrene Company K.S.C. more than offset the unfavorable impact of higher feedstock and energy costs, other raw material costs and the absence of earnings from the divested businesses. EBITDA in the first half of 2010 included a $10 million gain on the sale of Styron.

On July 27, 2011, the Company entered into a definitive agreement under which the Company's global Polypropylene business will be divested. See "Results of Operations" for more information.

CHEMICALS AND ENERGY

The Chemicals and Energy segment includes the following businesses: Chlor-Alkali/Chlor-Vinyl; Energy; Ethylene Oxide/Ethylene Glycol; and Chlorinated Organics. The Chlor-Alkali/Chlor-Vinyl business focuses on the production of chlorine for consumption by downstream Dow derivatives, as well as production, marketing and supply of ethylene dichloride, vinyl chloride monomer and caustic soda. These products are used for applications such as alumina production, pulp and paper manufacturing, soaps and detergents, and building and construction. The Energy business supplies power, steam and other utilities, principally for use in Dow’s global operations. The Ethylene Oxide/Ethylene Glycol business is the world’s largest producer of purified ethylene oxide, principally used in Dow’s downstream performance derivatives. Dow is also a supplier of ethylene glycol to MEGlobal, a 50:50 joint venture. Ethylene glycol is used in polyester fiber, polyethylene terephthalate (PET) for food and beverage container applications, polyester film, and aircraft and runway deicers. Also included in the Chemicals and Energy segment are the results of MEGlobal and a portion of the results of EQUATE Petrochemical Company K.S.C. ("EQUATE") and The Kuwait Olefins Company K.S.C., all joint ventures of the Company.

Chemicals and Energy	Three Months Ended					Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010		Jun 30, 2011			Jun 30, 2010
Sales	$	1,044		$	847	$	2,014		$	1,686
Price change from comparative period	26		%	N/A		20		%	N/A
Volume change from comparative period	(3		)%	N/A		(1		)%	N/A
Equity earnings	$	130		$	54	$	274		$	152
EBITDA	$	282		$	100	$	573		$	220
Certain items impacting EBITDA	$	—		$	—	$	—		$	—

Chemicals and Energy sales were $1,044 million in the second quarter of 2011, up 23 percent from $847 million in the second quarter of 2010, reflecting a 26 percent increase in price and a 3 percent decline in volume. Sales for the Chlor-Alkali/Chlor-Vinyl business increased 28 percent over the second quarter of 2010, primarily driven by price. Caustic soda volume increased in all geographic areas, with double-digit volume growth in Latin America. Caustic soda price increased with double-digit growth across all geographic areas, driven by strong demand in the alumina and pulp and paper industries and limited supply in EMEA due to several large maintenance turnarounds that reduced inventory levels. Vinyl chloride monomer ("VCM") price increased in all geographic areas, while volume decreased in North America due to the Company's planned capacity reductions. Sales for the Ethylene Oxide/Ethylene Glycol ("EO/EG") business were up 36 percent compared with the second quarter of 2010, led by a 33 percent increase in price. Price increased as a result of higher ethylene costs as well as tight supply due to planned industry maintenance turnarounds. Sales for the Chlorinated Organics business increased due to strong pricing in refrigerant, fluoropolymer and solvent applications.

50

EBITDA in the second quarter of 2011 was $282 million, up significantly from $100 million in the second quarter of 2010. Despite the decline in volume and higher feedstock and energy costs, EBITDA improved primarily due to higher caustic soda and VCM sales and higher equity earnings from The Kuwait Olefins Company K.S.C., MEGlobal and EQUATE. The Energy business supplies Dow's businesses at net cost, resulting in EBITDA that is at or near break-even for the business.

For the first half of 2011, sales for Chemicals and Energy were $2,014 million, up 19 percent from $1,686 million in the same period last year due to increases in price. EBITDA for the first six months of 2011 was $573 million compared with $220 million in the same period last year. EBITDA improved significantly as higher prices and higher equity earnings from The Kuwait Olefins Company K.S.C., EQUATE and MEGlobal, more than offset an increase in feedstock and energy costs.

HYDROCARBONS

The Hydrocarbons business encompasses the procurement of fuels, natural gas liquids and crude oil-based raw materials, as well as the supply of monomers, principally for use in Dow’s global operations. The business regularly sells its by-products and buys and sells its products to balance regional production capabilities and derivative requirements. The business also sells products to certain Dow joint ventures. The Hydrocarbons segment also includes the results of Compañía Mega S.A. and a portion of the results of The Kuwait Olefins Company K.S.C. and the SCG-Dow Group, joint ventures of the Company.

On March 2, 2010, Dow announced the entry into a definitive agreement to sell Styron to an affiliate of Bain Capital Partners; the transaction closed on June 17, 2010. Businesses and products sold included certain styrene monomer assets, which were reported in the Hydrocarbons segment through the date of the divestiture. See Note D to the Consolidated Financial Statements for additional information on this divestiture.

Hydrocarbons	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Sales	$	2,044		$	1,151		$	3,796		$	2,316
Price change from comparative period	46		%	N/A			34		%	N/A
Volume change from comparative period	32		%	N/A			30		%	N/A
Volume change, excluding divestitures	33		%	N/A			32		%	N/A
Equity earnings	$	8		$	20		$	19		$	44
EBITDA	$	—		$	(1	)	$	—		$	(1	)
Certain items impacting EBITDA	$	—		$	—		$	—		$	—

Hydrocarbons sales were $2,044 million in the second quarter of 2011, up 78 percent from $1,151 million in the second quarter of 2010, with volume increasing 32 percent and price increasing 46 percent. The significant increase in volume was principally due to the Company's product supply agreements with Styron. The double-digit increase in selling price was the result of higher feedstock and energy costs. For the first six months of 2011, sales were $3,796 million for the segment, up 64 percent from $2,316 million in the same period of 2010.

The Company uses derivatives of crude oil and natural gas as a feedstock in its ethylene facilities. The Company's cost of purchased feedstocks and energy in the second quarter of 2011 increased $1.5 billion compared with the same quarter of last year, an increase of 30 percent. Year to date, the cost of purchased feedstocks and energy was up $2.2 billion from the same period last year, an increase of 21 percent.

The Hydrocarbons business transfers materials to Dow's derivatives businesses at net cost. As a result, EBITDA for the segment was breakeven in the second quarter of 2011 compared with a loss of $1 million for second quarter of 2010. EBITDA for the first half of 2011 and 2010 was at or near breakeven.

51

CORPORATE

Included in the results for Corporate are:

• results of insurance company operations,

• gains and losses on sales of financial assets,

• stock-based compensation expense and severance costs,

• changes in the allowance for doubtful receivables,

• expenses related to Ventures,

• asbestos-related defense and resolution costs,

• foreign exchange hedging results, and

• certain overhead and other cost recovery variances not allocated to the operating segments.

Corporate	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Sales	$	89		$	74		$	182		$	168
Equity earnings	$	(6	)	$	(5	)	$	(15	)	$	(11	)
EBITDA	$	(295	)	$	(321	)	$	(1,054	)	$	(753	)
Certain items impacting EBITDA	$	(10	)	$	(38	)	$	(513	)	$	(64	)

Sales for Corporate, which primarily relate to the Company's insurance operations, were $89 million in the second quarter of 2011, up from $74 million the second quarter of 2010. For the first six months of 2011, sales were $182 million, up from $168 million in the same period of 2010.

EBITDA in the second quarter of 2011 was a loss of $295 million, compared with a loss of $321 million in the second quarter of 2010. EBITDA in the second quarter of 2011 was negatively impacted by a $10 million loss related to the early extinguishment of debt. EBITDA in the second quarter of 2010 was reduced by $37 million of integration costs related to the acquisition of Rohm and Haas and a $1 million net adjustment to the 2009 restructuring plan.

EBITDA for the first six months of 2011 was a loss of $1,054 million, compared with a loss of $753 million in the same period last year. Year-to-date EBITDA was negatively impacted by a $482 million loss related to the early extinguishment of debt, as well as $31 million of integration costs related to the April 1, 2009 acquisition of Rohm and Haas. Compared with the first six months of 2010, EBITDA was favorably impacted by lower performance-based compensation costs (including stock-based compensation), $25 million in dividend income related to the Company's ownership interest in the divested Styron businesses, gain on the sale of various businesses and lower Corporate expenses. EBITDA for the first six months of 2010 was reduced by integration costs of $63 million related to the acquisition of Rohm and Haas and a $1 million net adjustment to the 2009 restructuring plan.

52

Sales Volume and Price by Operating Segment and Geographic Area
	Three Months Ended						Six Months Ended
	June 30, 2011						June 30, 2011
Percentage change from prior year	Volume		Price		Total		Volume		Price		Total
Operating segments
Electronic and Specialty Materials	6	%	7	%	13	%	8	%	6	%	14	%
Coatings and Infrastructure	(4	)	14		10		(4	)	14		10
Health and Agricultural Sciences	13		5		18		13		4		17
Performance Systems	(10	)	15		5		(10	)	12		2
Performance Products	(3	)	18		15		(7	)	16		9
Plastics	(7	)	16		9		(10	)	14		4
Chemicals and Energy	(3	)	26		23		(1	)	20		19
Hydrocarbons	32		46		78		30		34		64
Total	1	%	17	%	18	%	(1	)%	15	%	14	%
Geographic areas
United States	1	%	16	%	17	%	—	%	13	%	13	%
Europe, Middle East and Africa	(3	)	24		21		(2	)	19		17
Rest of World	4		11		15		—		11		11
Total	1	%	17	%	18	%	(1	)%	15	%	14	%
Sales Volume and Price by Operating Segment and Geographic Area Excluding Divestitures (1)
	Three Months Ended						Six Months Ended
	June 30, 2011						June 30, 2011
Percentage change from prior year	Volume		Price		Total		Volume		Price		Total
Operating segments
Electronic and Specialty Materials	6	%	7	%	13	%	8	%	6	%	14	%
Coatings and Infrastructure	—		14		14		1		14		15
Health and Agricultural Sciences	13		5		18		13		4		17
Performance Systems	2		17		19		3		14		17
Performance Products	9		20		29		6		18		24
Plastics	10		20		30		7		17		24
Chemicals and Energy	(3	)	26		23		(1	)	20		19
Hydrocarbons	33		46		79		32		35		67
Total	9	%	19	%	28	%	8	%	16	%	24	%
Geographic areas
United States	5	%	16	%	21	%	4	%	14	%	18	%
Europe, Middle East and Africa	10		27		37		12		22		34
Rest of World	12		13		25		9		12		21
Total	9	%	19	%	28	%	8	%	16	%	24	%

(1) Excludes sales of the acrylic monomer business and a portion of the specialty latex business divested on January 25, 2010, sales of the Powder Coatings business divested on June 1, 2010, and sales of Styron divested on June 17, 2010.

53

OUTLOOK

In the second quarter of 2011, many of Dow's end-markets and geographic areas reflected continued growth, as evidenced by the Company's sales increases across all operating segments and geographic areas. Looking ahead, Dow sees global growth fundamentally remaining on solid footing despite the persistence of certain headwinds that could contribute to short-term variations.

In developed regions, economic recovery is expected to continue gaining traction even in the face of persistently high unemployment, which has restrained consumer spending and contributed to weakness in certain end-markets, such as construction. Ongoing concerns around sovereign debt, particularly in southern Europe, and government austerity measures may have further near-term impact on overall consumer sentiment. The Company expects that these are temporary uncertainties, and once resolved, more stable global economic growth will emerge. In the United States and northern Europe, export demand is expected to continue to provide momentum for domestic manufacturing, particularly in those areas where Dow has a well-established footprint.

In the emerging regions, the Company continues to see more robust growth, as the underlying factors driving demand remain strong, especially in Dow's key end-markets of food and nutrition, packaging, personal care, water, transportation and electronics. In the near-term, the Company anticipates targeted measures to address rising inflation to moderate the rate of growth to sustainable levels in sectors more heavily reliant on government spending, such as construction and infrastructure. Despite these near-term adjustments, Dow expects clear, positive fundamentals across most end-markets as a result of the rapid growth in the size and economic influence of the middle class in these regions.

Feedstock costs are expected to remain at elevated levels and volatility in these costs is expected to continue. In the United States, the Company expects to continue to benefit from its flexible feedstock position, taking advantage of the relatively low cost of natural gas and the growing supply of natural gas liquids.

As global economic growth continues, Dow will remain focused on executing its strategy by building on the Company's enhanced financial flexibility, innovative technologies, broad geographic reach and strong presence in many rapidly growing end-markets. The Company will also continue its focused implementation of price and volume actions to manage margins. Taken together, Dow's transformed and diversified business portfolio will continue to benefit from ongoing growth trends while mitigating areas of uncertainty, contributing to the Company's goal of higher and more sustainable earnings.

CHANGES IN FINANCIAL CONDITION

The Company’s cash flows from operating, investing and financing activities, as reflected in the Consolidated Statements of Cash Flows, are summarized in the following table:

Cash Flow Summary	Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010
Cash provided by (used in):
Operating activities	$	620		$	1,283
Investing activities	(904		)	937
Financing activities	(4,599		)	(2,022		)
Effect of exchange rate changes on cash	64			(22		)
Cash assumed in initial consolidation of variable interest entities	3			46
Net change in cash and cash equivalents	$	(4,816	)	$	222

In the first six months of 2011, cash provided by operating activities decreased compared with the same period last year primarily due to increased pension contributions and an increase in working capital requirements that more than offset increased earnings and higher dividends from nonconsolidated affiliates.

Cash used in investing activities in the first six months of 2011 reflects increased capital expenditures in 2011, compared with cash provided by investing activities in the first six months of 2010 primarily due to proceeds from the divestiture of Styron in the second quarter of 2010.

54

In the first six months of 2011, cash was used in financing activities primarily for payments on long- and short-term debt including the retirement of $4 billion of debt as further discussed below, as well as dividends paid to stockholders. In the first six months of 2010, cash was used in financing activities primarily for payments on long-term debt and commercial paper, and payments on notes payable related to the monetization of accounts receivable in Europe, as well as dividends paid to stockholders.

The Company had cash and cash equivalents of $2,223 million at June 30, 2011 and $7,039 million at December 31, 2010, of which $1,500 million at June 30, 2011 and $1,139 million at December 31, 2010 was held by foreign subsidiaries. For each of its foreign subsidiaries, the Company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States. The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. A deferred tax liability has been accrued for the funds that are available to be repatriated to the United States. At June 30, 2011, management believed that sufficient liquidity was available in the United States. However, in the unusual event that additional foreign funds are needed in the United States, the Company has the ability to repatriate additional funds. The repatriation could result in an adjustment to the tax liability after considering available foreign tax credits and other tax attributes.

The Company has undertaken restructuring plans during the past two years as follows (additional details are provided in Note C to the Consolidated Financial Statements):

• On June 30, 2009, the Board of Directors approved a restructuring plan related to the Company’s acquisition of Rohm and Haas (the “2009 Plan”). The restructuring activities under this plan were substantially completed in the first quarter of 2011, with remaining liabilities primarily related to environmental remediation to be paid over time.

• Included in the liabilities assumed with the April 1, 2009 acquisition of Rohm and Haas was a reserve of $122 million for severance and employee benefits for the separation of employees associated with Rohm and Haas’ 2008 restructuring initiatives. The restructuring activities under this plan were completed in the second quarter of 2011.

The restructuring activities related to the 2009 Plan are expected to result in additional cash expenditures of approximately $68 million related to environmental remediation to be paid over time. The Company expects to incur future costs related to its restructuring activities, as the Company continually looks for ways to enhance the efficiency and cost effectiveness of its operations to ensure competitiveness across its businesses and across geographic areas. Future costs are expected to include demolition costs related to the closed facilities, which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits and pension plan settlement costs, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

Management expects that the Company will continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.

The following table presents working capital and certain balance sheet ratios:

Working Capital In millions	Jun 30, 2011		Dec 31, 2010
Current assets	$	22,699	$	24,130
Current liabilities	12,429		13,896
Working capital	$	10,270	$	10,234
Current ratio	1.83:1		1.74:1
Days-sales-outstanding-in-receivables	44		43
Days-sales-in-inventory	68		62

55

As shown in the following table, net debt is equal to total debt minus “Cash and cash equivalents.” As Dow continues to strengthen its balance sheet and increase financial flexibility, management is principally focused on net debt, as Dow believes this is the best measure of the Company’s financial leverage.

Total Debt In millions	Jun 30, 2011			Dec 31, 2010
Notes payable	$	916		$	1,467
Long-term debt due within one year	661			1,755
Long-term debt	18,511			20,605
Gross debt	$	20,088		$	23,827
Cash and cash equivalents	2,223			7,039
Net debt	$	17,865		$	16,788
Gross debt as a percent of total capitalization	44.5		%	51.3		%
Net debt as a percent of total capitalization	41.6		%	42.6		%

As part of its ongoing financing activities, Dow has the ability to issue promissory notes under its U.S. and Euromarket commercial paper programs. The Company had no commercial paper outstanding at June 30, 2011 or December 31, 2010.

In the event Dow has short-term liquidity needs and is unable to issue commercial paper under these programs for any reason, Dow has the ability to access liquidity through its committed and available $3 billion Three Year Competitive Advance and Revolving Credit Facility Agreement dated June 4, 2010 (the “Revolving Credit Facility”) with various U.S. and foreign banks. The Revolving Credit Facility has a maturity date in June 2013 and provides for interest at a LIBOR-plus rate or Base Rate as defined in the Agreement. At June 30, 2011, the full $3 billion Revolving Credit Facility was available to the Company.

As a well-known seasoned issuer, the Company filed an automatic shelf registration for an unspecified amount of mixed securities with the SEC on February 19, 2010. Under this shelf registration, the Company may offer common stock, preferred stock, depositary shares, debt securities, warrants, stock purchase contracts and stock purchase units with pricing and availability dependent on market conditions; and, on February 19, 2010, registered an unlimited amount of securities for issuance under the Company’s U.S. retail medium-term note program (InterNotes). At June 30, 2011, the Company had Euro 5 billion (approximately $7.2 billion) available for issuance under the Company’s Euro Medium Term Note Program, as well as Japanese yen 50 billion (approximately $600 million) of securities available for issuance under a shelf registration renewed with the Tokyo Stock Exchange effective September 8, 2010, which will expire on September 7, 2012.

On March 22, 2011, the Company concluded cash tender offers for $1.5 billion aggregate principal amount of certain notes issued by the Company. As a result of the tender offers, the Company redeemed $1.5 billion of the notes and recognized a $472 million pretax loss on early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and reflected in Corporate.

In addition to the redemption of $800 million of notes that matured on February 1, 2011 and the redemption of Euro 500 million of notes that matured on May 27, 2011 ($707 million equivalent at March 31, 2011), the Company redeemed $1,208 million of InterNotes in the first six months of 2011 and recognized a $10 million pretax loss on early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and reflected in Corporate. In the second quarter of 2011, the Company issued $175 million of InterNotes.

Taken together, these actions will reduce the Company's interest expense by approximately $250 million on an annual basis going forward. The Company has also announced the planned redemption of $330 million of InterNotes in the third quarter of 2011, which is included in "Long-term debt due within one year."

Dow’s public debt instruments and documents for its private funding transactions contain, among other provisions, certain covenants and default provisions. The Company’s most significant debt covenant with regard to its financial position is the obligation to maintain the ratio of the Company’s consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Revolving Credit Facility exceeds $500 million. The ratio of the Company’s consolidated indebtedness to consolidated capitalization as defined in the credit agreements was 0.43 to 1.00 at June 30, 2011. At June 30, 2011, management believes the Company was in compliance with all of its covenants and default provisions.

56

The Company’s credit rating is investment grade. The Company’s long-term credit ratings are BBB with a stable outlook (Standard & Poor’s), Baa3 with a positive outlook (Moody’s) and BBB with a stable outlook (Fitch). In the second quarter of 2011, Standard & Poor’s upgraded the Company’s long-term credit rating from BBB- to BBB, the Company's short-term credit rating from A-3 to A-2, and changed the outlook from positive to stable. Also in the second quarter of 2011, Moody’s upgraded the Company’s outlook from stable to positive. The Company’s short-term credit ratings are A-2 (Standard & Poor’s), P-3 (Moody’s) and F2 (Fitch). If the Company’s credit ratings are downgraded, borrowing costs will increase on certain indentures, and it could have a negative impact on the Company’s ability to access credit markets.

Capital Expenditures

Capital spending was $564 million in the second quarter of 2011, compared with capital spending of $397 million in the second quarter of 2010. Year to date, capital spending was $969 million compared with $691 million in 2010. The Company expects capital spending in 2011 to be approximately $2.4 billion.

Contractual Obligations

Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest at December 31, 2010 can be found in Notes N, P, Q, R and Y to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010. With the exception of the items noted below, there have been no material changes in the Company’s contractual obligations since December 31, 2010.

The following table represents long-term debt obligations and expected cash requirements for interest at June 30, 2011, reflecting the early redemptions of debt in the first and second quarters of 2011 (see Note L to the Consolidated Financial Statements).

Contractual Obligations at June 30, 2011	Payments Due by Year
In millions	2011		2012		2013		2014		2015		2016 and beyond		Total
Long-term debt – current and noncurrent (1,2)	$	614	$	2,818	$	675	$	2,347	$	1,437	$	11,693	$	19,584
Expected cash requirements for interest	$	588	$	1,146	$	999	$	903	$	776	$	7,145	$	11,557

(1) Excludes unamortized debt discount of $412 million.

(2) 2011 includes $330 million of InterNotes planned for redemption in the third quarter of 2011.

Contractual Obligations at December 31, 2010	Payments Due by Year
In millions	2011		2012		2013		2014		2015		2016 and beyond		Total
Long-term debt – current and noncurrent (1)	$	1,755	$	2,886	$	943	$	2,548	$	1,574	$	13,112	$	22,818
Expected cash requirements for interest	$	1,382	$	1,332	$	1,187	$	1,061	$	926	$	7,659	$	13,547

(1) Excludes unamortized debt discount of $458 million.

Off-Balance Sheet Arrangements

The Company holds a variable interest in a joint venture accounted for under the equity method of accounting. The Company is not the primary beneficiary of the joint venture and therefore is not required to consolidate the entity (see Note M to the Consolidated Financial Statements). In addition, see Note K to the Consolidated Financial Statements for information regarding the transfer of financial assets.

Guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others if specific triggering events occur. The Company had outstanding guarantees at June 30, 2011 of $935 million, up from $836 million at December 31, 2010. Additional information related to these guarantees can be found in the “Guarantees” section of Note J to the Consolidated Financial Statements.

Fair Value Measurements

The Company’s assets and liabilities measured at fair value are classified in the fair value hierarchy (Level 1, 2 or 3) based on the inputs used for valuation. Assets and liabilities that are traded on an exchange with a quoted price are classified as Level 1. Assets and liabilities that are valued based on a bid or bid evaluation are classified as Level 2. The custodian of the Company’s debt and equity securities uses multiple industry-recognized vendors for pricing information and established processes for validation and verification to assist the Company in its process for determining and validating fair values for these assets. For the Company's interests held in trade receivable conduits, classified as Level 3, the fair value is determined by calculating the

57

expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. For pension or other post retirement benefit plan assets classified as Level 3, the total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment. The sensitivity of fair value estimates is immaterial relative to the assets and liabilities measured at fair value, as well as to the total equity of the Company. See Note I to the Consolidated Financial Statements for the Company’s disclosures about fair value measurements.

Portfolio managers and external investment managers regularly review all of the Company’s holdings to determine if any investments are other-than-temporarily impaired. The analysis includes reviewing the amount of the temporary impairment, as well as the length of time it has been impaired. In addition, specific guidelines for each instrument type are followed to determine if an other-than-temporary impairment has occurred. For debt securities, the credit rating of the issuer, current credit rating trends and the trends of the issuer’s overall sector are considered in determining whether unrealized losses represent an other-than-temporary impairment. For equity securities, the Company’s investments are primarily in Standard & Poor’s (“S&P”) 500 companies; however, the Company also allows investments in companies outside of the S&P 500. The Company considers the evidence to support the recovery of the cost basis of a security including volatility of the stock, the length of time the security has been in a loss position, value and growth expectations, and overall market and sector fundamentals, as well as technical analysis, in determining impairment. Other-than-temporary impairment write-downs on investments still held by the Company were $3 million in the first six months of 2011 ($4 million in the first six months of 2010).

Dividends

On April 14, 2011, the Board of Directors declared a quarterly dividend for the second quarter of 2011 of $0.25 per common share, payable July 29, 2011, to stockholders of record on June 30, 2011. The 67 percent increase in the second quarter of 2011 dividend (from $0.15 per common share in the first quarter of 2011) demonstrates the Board’s commitment to increasingly reward shareholders as the Company continues to grow earnings. Since 1912, the Company has paid a cash dividend every quarter and, in each instance prior to and since February 12, 2009, had maintained or increased the amount of the dividend, adjusted for stock splits. The dividend was reduced in February 2009, for the first time in the 97-year period, due to uncertainty in the credit markets, unprecedented lower demand for chemical products and the global recession. Since 1912, Dow has increased the amount of the quarterly dividend 48 times (approximately 12 percent of the time), reduced the dividend once, and maintained the amount of the quarterly dividend approximately 88 percent of the time.

On May 11, 2011, the Board of Directors declared a quarterly dividend of $85 million to Cumulative Convertible Perpetual Preferred Stock, Series A shareholders of record on June 15, 2011, which was paid on July 1, 2011. Ongoing dividends related to Cumulative Convertible Perpetual Preferred Stock, Series A will accrue at the rate of $85 million per quarter, and are payable quarterly subject to Board of Directors’ approval.

OTHER MATTERS

Recent Accounting Guidance

See Note B to the Consolidated Financial Statements for a summary of recent accounting guidance.

Critical Accounting Policies

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note A to the Consolidated Financial Statements in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010 (“2010 10-K”) describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. Dow’s critical accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s 2010 10-K. Since December 31, 2010, there have been no material changes in the Company’s critical accounting policies.

58

Asbestos-Related Matters of Union Carbide Corporation

Introduction

Union Carbide Corporation (“Union Carbide”), a wholly owned subsidiary of the Company, is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including Union Carbide and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

The table below provides information regarding asbestos-related claims filed against Union Carbide and Amchem:

	2011		2010
Claims unresolved at January 1	62,582		75,030
Claims filed	4,253		3,675
Claims settled, dismissed or otherwise resolved	(8,878	)	(12,606	)
Claims unresolved at June 30	57,957		66,099
Claimants with claims against both UCC and Amchem	18,098		21,226
Individual claimants at June 30	39,859		44,873

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

Estimating the Liability

Based on a study completed by Analysis, Research & Planning Corporation (“ARPC”) in January 2003, Union Carbide increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. Since then, Union Carbide has compared current asbestos claim and resolution activity to the results of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate. In addition, Union Carbide has requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity each November since 2004 to determine the appropriateness of updating the most recent ARPC study.

In November 2009, Union Carbide requested ARPC to review Union Carbide’s 2009 asbestos claim and resolution activity and determine the appropriateness of updating its then most recent study completed in December 2008. In response to that request, ARPC reviewed and analyzed data through October 31, 2009. In December 2009, ARPC stated that an update of its study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable. Based on Union Carbide’s own review of the asbestos claim and resolution activity and ARPC’s response, Union Carbide determined that no change to the accrual was required. At December 31, 2009, Union Carbide’s asbestos-related liability for pending and future claims was $839 million.

59

In November 2010, Union Carbide requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity and determine the appropriateness of updating its December 2008 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2010. The resulting study, completed by ARPC in December 2010, stated that the undiscounted cost of resolving pending and future asbestos-related claims against Union Carbide and Amchem, excluding future defense and processing costs, through 2025 was estimated to be between $744 million and $835 million. As in its earlier studies, ARPC provided estimates for a longer period of time in its December 2010 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.

In December 2010, based on ARPC’s December 2010 study and Union Carbide’s own review of the asbestos claim and resolution activity, Union Carbide decreased its asbestos-related liability for pending and future claims to $744 million, which covered the 15-year period ending 2025, excluding future defense and processing costs. The reduction was $54 million and was shown as “Asbestos-related credits” in the consolidated statements of income. At December 31, 2010, the asbestos-related liability for pending and future claims was $728 million. At December 31, 2010, approximately 21 percent of the recorded liability related to pending claims and approximately 79 percent related to future claims.

Based on Union Carbide’s review of 2011 activity, Union Carbide determined that no adjustment to the accrual was required at June 30, 2011. Union Carbide’s asbestos-related liability for pending and future claims was $703 million at June 30, 2011. Approximately 20 percent of the recorded liability related to pending claims and approximately 80 percent related to future claims.

Defense and Resolution Costs

The following table provides information regarding defense and resolution costs related to asbestos-related claims filed against Union Carbide and Amchem:

Defense and Resolution Costs	Six Months Ended				Aggregate Costs   to Date as of
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011
Defense costs	$	28	$	36	$	802
Resolution costs	$	26	$	26	$	1,549

The average resolution payment per asbestos claimant and the rate of new claim filings has fluctuated both up and down since the beginning of 2001. Union Carbide’s management expects such fluctuations to continue in the future based upon a number of factors, including the number and type of claims settled in a particular period, the jurisdictions in which such claims arose and the extent to which any proposed legislative reform related to asbestos litigation is being considered.

Union Carbide expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $15 million in the second quarter of 2011 ($22 million in the second quarter of 2010) and $28 million in the first six months of 2011 ($36 million in the first six months of 2010), and was reflected in “Cost of sales” in the consolidated statements of income.

Insurance Receivables

At December 31, 2002, Union Carbide increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined by Union Carbide after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which Union Carbide and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of Union Carbide’s insurance policies and to resolve issues that the insurance carriers may raise.

60

In September 2003, Union Carbide filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds (the “Insurance Litigation”). The Insurance Litigation was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with Union Carbide regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. Since the filing of the case, Union Carbide has reached settlements with several of the carriers involved in the Insurance Litigation, including settlements reached with two significant carriers in the fourth quarter of 2009. The Insurance Litigation is ongoing.

Union Carbide’s receivable for insurance recoveries related to its asbestos liability was $50 million at June 30, 2011 and $50 million at December 31, 2010. At June 30, 2011 and December 31, 2010, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.

In addition to the receivable for insurance recoveries related to its asbestos liability, Union Carbide had receivables for defense and resolution costs submitted to insurance carriers that have settlement agreements in place regarding their asbestos-related insurance coverage.

The following table summarizes Union Carbide’s receivables related to its asbestos-related liability:

Receivables for Asbestos-Related Costs In millions	Jun 30, 2011		Dec 31, 2010
Receivables for defense costs – carriers with settlement agreements	$	23	$	12
Receivables for resolution costs – carriers with settlement agreements	190		236
Receivables for insurance recoveries – carriers without settlement agreements	50		50
Total	$	263	$	298

After a review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, and after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, Union Carbide continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.

Summary

The amounts recorded by Union Carbide for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries for Union Carbide to be higher or lower than those projected or those recorded.

Because of the uncertainties described above, Union Carbide’s management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. Union Carbide’s management believes that it is reasonably possible that the cost of disposing of Union Carbide’s asbestos-related claims, including future defense costs, could have a material adverse impact on Union Carbide’s results of operations and cash flows for a particular period and on the consolidated financial position of Union Carbide.

It is the opinion of Dow’s management that it is reasonably possible that the cost of Union Carbide disposing of its asbestos-related claims, including future defense costs, could have a material adverse impact on the Company’s results of operations and cash flows for a particular period and on the consolidated financial position of the Company.

61

The Dow Chemical Company and Subsidiaries

PART I – FINANCIAL INFORMATION

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

Dow’s business operations give rise to market risk exposure due to changes in foreign exchange rates, interest rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies, which enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as hedges per the accounting guidance related to derivatives and hedging activities, where appropriate. A secondary objective is to add value by creating additional non-specific exposure within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Company’s results.

The global nature of Dow’s business requires active participation in the foreign exchange markets. As a result of investments, production facilities and other operations on a global basis, the Company has assets, liabilities and cash flows in currencies other than the U.S. dollar. The primary objective of the Company’s foreign exchange risk management is to optimize the U.S. dollar value of net assets and cash flows, keeping the adverse impact of currency movements to a minimum. To achieve this objective, the Company hedges on a net exposure basis using foreign currency forward contracts, over-the-counter option contracts, cross-currency swaps, and nonderivative instruments in foreign currencies. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. The largest exposures are denominated in European currencies, the Japanese yen and the Canadian dollar, although exposures also exist in other currencies of Asia Pacific, Latin America, and India, Middle East and Africa.

The main objective of interest rate risk management is to reduce the total funding cost to the Company and to alter the interest rate exposure to the desired risk profile. Dow uses interest rate swaps, “swaptions,” and exchange-traded instruments to accomplish this objective. The Company’s primary exposure is to the U.S. dollar yield curve.

Dow has a portfolio of equity securities derived primarily from the investment activities of its insurance subsidiaries. This exposure is managed in a manner consistent with the Company’s market risk policies and procedures.

Inherent in Dow’s business is exposure to price changes for several commodities. Some exposures can be hedged effectively through liquid tradable financial instruments. Feedstocks for ethylene production and natural gas constitute the main commodity exposures. Over-the-counter and exchange traded instruments are used to hedge these risks when feasible.

Dow uses value at risk (“VAR”), stress testing and scenario analysis for risk measurement and control purposes. VAR estimates the maximum potential loss in fair market values, given a certain move in prices over a certain period of time, using specified confidence levels. The VAR methodology used by the Company is a historical simulation model which captures co-movements in market rates across different instruments and market risk exposure categories. The historical simulation model uses a 97.5 percent confidence level and the historical scenario period includes at least six months of historical data. The June 30, 2011, 2010 year-end and 2010 average daily VAR for the aggregate of all positions are shown below. These amounts are immaterial relative to the total equity of the Company:

Total Daily VAR			2010
In millions	At June 30, 2011		Year-end		Average
Foreign exchange	$	2	$	1	$	3
Interest rate	$	135	$	251	$	211
Equities	$	15	$	15	$	12
Commodities	$	4	$	1	$	2
Composite	$	152	$	252	$	218

The Company’s daily VAR for the aggregate of all positions decreased from a composite VAR of $252 million at December 31, 2010 to a composite VAR of $152 million at June 30, 2011. The decrease related primarily to a decrease in the interest rate VAR from $251 million to $135 million, principally due to a decrease in the amount of debt outstanding.

See Note H to the Consolidated Financial Statements for further disclosure regarding market risk.

62

The Dow Chemical Company and Subsidiaries

PART I – FINANCIAL INFORMATION

ITEM 4.  CONTROLS AND PROCEDURES.

Evaluation of Disclosure Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, the Company carried out an evaluation, under the supervision and with the participation of the Company’s Disclosure Committee and the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 or 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting

There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 or 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

63

The Dow Chemical Company and Subsidiaries

PART II – OTHER INFORMATION

ITEM 1.  LEGAL PROCEEDINGS.

Asbestos-Related Matters of Union Carbide Corporation

No material developments regarding this matter occurred during the second quarter of 2011. For a summary of the history and current status of this matter, see Note J to the Consolidated Financial Statements; and Management’s Discussion and Analysis of Financial Condition and Results of Operations, Asbestos-Related Matters of Union Carbide Corporation.

Environmental Matters

In a meeting on April 28, 2010, the Company received verbal and written communications from the U.S. Environmental Protection Agency (“EPA”) notifying the Company of the EPA's intent to seek injunctive relief and assess a civil penalty against the Company for alleged violations of various environmental rules and regulations at the Company's Midland, Michigan site. The Company and the EPA have entered into a proposed settlement that would include a civil penalty of $2.5 million plus certain enhancements of fugitive emission detection and repair practices, beyond existing legal requirements, at two manufacturing units at the Midland site. The settlement will not be final until after an opportunity for public comment, the EPA's response to any comments, and entry of the settlement by a federal court.

Rohm and Haas Texas Incorporated, a wholly owned subsidiary of the Company, received an Administrative Complaint dated May 17, 2011 from the Texas Council of Environmental Quality seeking a civil penalty in an amount of $124,405 for alleged violations of various environmental requirements regulating air emissions from operations at its Deer Park, Texas manufacturing facility.

ITEM 1A.  RISK FACTORS.

There were no material changes in the Company’s risk factors in the second quarter of 2011.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Issuer Purchases of Equity Securities

The Company does not currently have a share repurchase program, and there were no purchases of the Company's common stock by the Company during the three months ended June 30, 2011.

ITEM 6.  EXHIBITS.

See the Exhibit Index on page 67 of this Quarterly Report on Form 10-Q for exhibits filed with this report.

64

The Dow Chemical Company and Subsidiaries

Trademark Listing

The following trademark of The Dow Chemical Company appears in this report: POWERHOUSE

65

The Dow Chemical Company and Subsidiaries

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

THE DOW CHEMICAL COMPANY

Registrant

Date: August 3, 2011

/s/ RONALD C. EDMONDS

Ronald C. Edmonds

Vice President and Controller

66

The Dow Chemical Company and Subsidiaries

Exhibit Index

EXHIBIT NO.	DESCRIPTION
12.1	Computation of Ratio of Earnings to Fixed charges.
23	Analysis, Research & Planning Corporation’s Consent.
31(a)	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31(b)	Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32(a)	Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32(b)	Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL Instance Document (1)
101.SCH	XBRL Taxonomy Extension Schema Document (1)
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document (1)
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document (1)
101.LAB	XBRL Taxonomy Extension Label Linkbase Document (1)
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document (1)

(1) Pursuant to Rule 406T of Regulation S-T, this interactive data file is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.

67

EX-12.1

The Dow Chemical Company and Subsidiaries EXHIBIT 12.1

Computation of Ratio of Earnings to Fixed Charges and Combined

Fixed Charges and Preferred Stock Dividend Requirements

	Six Months Ended						For the Years Ended December 31
In millions, except ratio (Unaudited)	Jun 30, 2011			Jun 30, 2010			2010			2009			2008			2007			2006
Income from Continuing Operations Before     Income Taxes	$	2,158		$	1,445		$	2,802		$	469		$	1,277		$	4,192		$	4,938
Add (deduct):
Equity in earnings of nonconsolidated affiliates	(589		)	(548		)	(1,112		)	(630		)	(787		)	(1,122		)	(959		)
Distributed income of earnings of     nonconsolidated affiliates	639			405			668			690			836			774			616
Capitalized interest	(45		)	(32		)	(72		)	(61		)	(97		)	(85		)	(73		)
Amortization of capitalized interest	50			48			95			91			84			79			70
Preferred security dividends	—			—			—			(20		)	(63		)	(81		)	(77		)
Adjusted earnings	$	2,213		$	1,318		$	2,381		$	539		$	1,250		$	3,757		$	4,515
Fixed charges:
Interest expense and amortization of debt     discount	705			743			1,473			1,571			648			584			616
Capitalized interest	45			32			72			61			97			85			73
Preferred security dividends	—			—			—			20			63			81			77
Rental expense – interest component	51			47			95			107			120			124			131
Total fixed charges	$	801		$	822		$	1,640		$	1,759		$	928		$	874		$	897
Earnings available for the payment of     fixed charges	$	3,014		$	2,140		$	4,021		$	2,298		$	2,178		$	4,631		$	5,412
Ratio of earnings to fixed charges	3.8			2.6			2.5			1.3			2.3			5.3			6.0
Earnings required for combined fixed     charges and preferred stock dividends:
Preferred stock dividends	$	170		$	170		$	340		$	312		$	—		$	—		$	—
Adjustment to pretax basis (at 35 percent)	92			92			183			168			—			—			—
	$	262		$	262		$	523		$	480		$	—		$	—		$	—
Combined fixed charges and preferred stock     dividend requirements	$	1,063		$	1,084		$	2,163		$	2,239		$	928		$	874		$	897
Ratio of earnings to combined fixed charges     and preferred stock dividend requirements	2.8			2.0			1.9			1.0			2.3			5.3			6.0

EX-23

Analysis, Research & Planning Corporation's Consent EXHIBIT 23

The Dow Chemical Company:

Analysis, Research & Planning Corporation (“ARPC”) hereby consents to the use of ARPC's name and the reference to ARPC's reports in this Quarterly Report on Form 10-Q of The Dow Chemical Company for the period ended June 30, 2011, and the incorporation by reference thereof in the following Registration Statements of The Dow Chemical Company:

Form S-3:
No.	333-164985
Form S-4:
No.	333-88443
Form S-8:
Nos.	2-64560
	33-21748
	33-51453
	33-52841
	33-58205
	33-61795
	333-27381
	333-40271
	333-43730
	333-49183
	333-67414
	333-88443
	333-91027
	333-103518
	333-103519
	333-105080
	333-115185
	333-122932
	333-145015
	333-162910
	333-170384

/s/ B. THOMAS FLORENCE

B. Thomas Florence

President

Analysis, Research & Planning Corporation

August 1, 2011

EX-31.(A)

The Dow Chemical Company and Subsidiaries EXHIBIT 31(a)

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Andrew N. Liveris, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Dow Chemical Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 3, 2011

/s/ ANDREW N. LIVERIS

Andrew N. Liveris

President, Chief Executive Officer and

Chairman of the Board

EX-31.(B)

The Dow Chemical Company and Subsidiaries EXHIBIT 31(b)

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, William H. Weideman, certify that:

1. I have reviewed this quarterly report on Form 10-Q of The Dow Chemical Company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 3, 2011

/s/ WILLIAM H. WEIDEMAN

William H. Weideman

Executive Vice President and Chief Financial Officer

EX-32.(A)

The Dow Chemical Company and Subsidiaries EXHIBIT 32(a)

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Andrew N. Liveris, President, Chief Executive Officer and Chairman of the Board of The Dow Chemical Company (the “Company”), certify that:

1. the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2011 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ ANDREW N. LIVERIS

Andrew N. Liveris

President, Chief Executive Officer and

Chairman of the Board

August 3, 2011

EX-32.(B)

The Dow Chemical Company and Subsidiaries EXHIBIT 32(b)

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, William H. Weideman, President, Chief Executive Officer and Chairman of the Board of The Dow Chemical Company (the “Company”), certify that:

1. the Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2011 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ WILLIAM H. WEIDEMAN

William H. Weideman

Executive Vice President and Chief Financial Officer

August 3, 2011

XML



OPERATING SEGMENTS AND GEOGRAPHIC AREAS (Reconciliation of EBITDA to Income Before Income Taxes) (Details) (USD $) In Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010
Reconciliation of EBITDA to Income Before Income Taxes [Abstract]
Earnings before interest, taxes, depreciation and amortization	$ 2,332	[1]	$ 1,881	[1]	$ 4,274	[1]	$ 3,662	[1]
Minus depreciation and amortization	697		734		1,428		1,491
Plus interest income	10		10		17		17
Minus interest expense and amortization of debt discount	328		367		705		743
Income Before Income Taxes	$ 1,317		$ 790		$ 2,158		$ 1,445

[1] The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. A reconciliation of EBITDA to “Income Before Income Taxes” is provided below.

XML



FINANCIAL INSTRUMENTS (Investments) (Details) (USD $) In Millions	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Financial Instruments [Abstact]
Investing Results, Proceeds from sales of available-for-sale securities	$ 460	$ 535
Investing Results, Gross realized gains	26	27
Investing Results, Gross realized losses	(7)	(50)
Contractual Maturities of Debt Securities, Within one year, Amortized Cost	23
Contractual Maturities of Debt Securities, One to five years, Amortized Cost	534
Contractual Maturities of Debt Securities, Six to ten years, Amortized Cost	467
Contractual Maturities of Debt Securities, After ten years, Amortized Cost	213
Contractual Maturities of Debt Securities, Total, Amortized Cost	1,237
Contractual Maturities of Debt Securities, Within one year, Fair Value	23
Contractual Maturities of Debt Securities, One to five years, Fair Value	582
Contractual Maturities of Debt Securities, Six to ten years, Fair Value	498
Contractual Maturities of Debt Securities, After ten years, Fair Value	235
Contractual Maturities of Debt Securities, Total, Fair Value	1,338
Held-to-maturity securities	330		3,200
Investments in money market funds	122		35
Net unrealized gain recognized on trading securities	$ 13	$ 16

XML



Consolidated Balance Sheets (USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents (variable interest entities restricted - 2011: $107; 2010: $145)	$ 2,223	$ 7,039
Accounts and notes receivable:
Trade (net of allowance for doubtful receivables - 2011: $135; 2010: $128)	5,601	4,616
Other	5,150	4,428
Inventories	8,739	7,087
Deferred income tax assets current	573	611
Other current assets	413	349
Total current assets	22,699	24,130
Investments
Investment in nonconsolidated affiliates	3,469	3,453
Other investments (investments carried at fair value - 2011: $2,015; 2010: $2,064)	2,480	2,542
Noncurrent receivables	341	388
Total investments	6,290	6,383
Property
Property	53,888	51,648
Less accumulated depreciation	35,839	33,980
Net property (variable interest entities restricted - 2011: $1,747; 2010: $1,388)	18,049	17,668
Other Assets
Goodwill	13,079	12,967
Other intangible assets (net of accumulated amortization - 2011: $2,127; 2010: $1,805)	5,389	5,530
Deferred income tax assets - noncurrent	2,057	2,079
Asbestos-related insurance receivables - noncurrent	217	220
Deferred charges and other assets	667	611
Total other assets	21,409	21,407
Total Assets	68,447	69,588
Current Liabilities
Notes payable	916	1,467
Long-term debt due within one year	661	1,755
Accounts payable:
Trade	4,893	4,356
Other	2,305	2,249
Income taxes payable	355	349
Deferred income tax liabilities current	115	105
Dividends payable	374	257
Accrued and other current liabilities	2,810	3,358
Total current liabilities	12,429	13,896
Long-Term Debt (variable interest entities nonrecourse - 2011: $930; 2010: $167)	18,511	20,605
Other Noncurrent Liabilities
Deferred income tax liabilities - noncurrent	1,238	1,295
Pension and other postretirement benefits - noncurrent	7,552	7,492
Asbestos-related liabilities - noncurrent	643	663
Other noncurrent obligations	3,035	2,995
Total other noncurrent liabilities	12,468	12,445
Stockholders' Equity
Preferred stock, series A	4,000	4,000
Common stock	2,953	2,931
Additional paid in capital	2,450	2,286
Retained earnings	18,877	17,736
Accumulated other comprehensive loss	(3,647)	(4,399)
Unearned ESOP shares	(448)	(476)
Treasury stock at cost	0	(239)
The Dow Chemical Company's stockholders' equity	24,185	21,839
Noncontrolling interests	854	803
Total equity	25,039	22,642
Total Liabilities and Equity	$ 68,447	$ 69,588

XML



Consolidated Balance Sheets (Parenthetical) (USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010
Current Assets
Cash and cash equivalents (variable interest entities restricted)	$ 107	$ 145
Accounts and notes receivable:
Trade (allowance for doubtful receivables)	135	128
Investments
Other investments (investments carried at fair value)	2,015	2,064
Property
Net property (variable interest entities restricted)	1,747	1,388
Other Assets
Other intangible assets (accumulated amortization)	2,127	1,805
Long-Term Debt
Long Term Debt (Variable interest entities nonrecourse)	$ 930	$ 167

XML



NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Narrative) (Details) In Millions, unless otherwise specified	6 Months Ended		1 Months Ended		3 Months Ended	6 Months Ended
	Jun. 30, 2011 USD ($)	Jun. 30, 2010 USD ($)	May 31, 2011 Long-term Debt [Member] EUR (€)	Feb. 28, 2011 Long-term Debt [Member] USD ($)	Mar. 31, 2011 Long-term Debt [Member] USD ($)	Jun. 30, 2011 InterNotes Redemption in Third Quarter 2011 [Member] USD ($)	Jun. 30, 2011 InterNotes Issued in Second Quarter 2011 [Member] USD ($)	Jun. 30, 2011 Revolving Credit Facility Agreement [Member] USD ($)
Notes Payable Long Term Debt and Available Credit Facilities [Line Items]
Repayments of Notes Payable	$ 0	$ 668	€ 500	$ 800	$ 707	$ 330
Notes Payable							175
Outstanding debt	19,172
Debt instrument covenant, ratio of indebtedness to net capital, maximum	0.65
Amount of debt, if exceeded, causes company to comply with capitalization ratios								500
Amount at which a failure to pay results in default	50
Permitted amount of acceleration of principal which causes default	200
Amount of acceleration of principal which causes default	100
Amount of judgment which causes default	$ 200

XML



FINANCIAL INSTRUMENTS (Accounting for Derivative Instruments and Hedging Activities) (Details) (USD $) In Millions, unless otherwise specified	Jun. 30, 2011	Dec. 31, 2010
Financial Instruments [Line Items]
Notional amount of foreign currency derivatives	$ 203	$ 827
AOCI, Net gain (loss) in net investment in foreign operations	(67)	70
Notional amount of outstanding foreign-currency denominated debt designated as net foreign investment hedges	614	1,250
Notional U.S. dollar equivalent of nondesignated foreign exchange contracts	12,925	13,944
Commodity Contract [Member]
Financial Instruments [Line Items]
AOCI, Net gain (loss) in cash flow hedging instruments	6	3
Commodity Forward Contract Crude Oil [Member]
Financial Instruments [Line Items]
Nonmonetary notional amount of price risk cash flow hedge derivatives	0.5	0.1
Commodity Forward Contract Ethane [Member]
Financial Instruments [Line Items]
Nonmonetary notional amount of price risk cash flow hedge derivatives	0.6	1.6
Commodity Forward Contract Natural Gas [Member]
Financial Instruments [Line Items]
Nonmonetary notional amount of price risk cash flow hedge derivatives	1.0	2.7
Commodity Contract Crude Oil [Member]
Financial Instruments [Line Items]
Derivative, nonmonetary notional amount	0.3	0.0
Commodity Contract Ethane [Member]
Financial Instruments [Line Items]
Derivative, nonmonetary notional amount	3.0	3.8
Commodity Contract Naphtha [Member]
Financial Instruments [Line Items]
Derivative, nonmonetary notional amount	60.0	0.0
Commodity Contract Natural Gas [Member]
Financial Instruments [Line Items]
Derivative, nonmonetary notional amount	9.1	12.0
Foreign Currency Contract [Member]
Financial Instruments [Line Items]
AOCI, Net gain (loss) in cash flow hedging instruments	(5)	(4)
Interest Rate Contract [Member]
Financial Instruments [Line Items]
AOCI, Net gain (loss) in cash flow hedging instruments	$ (1)	$ (2)

XML



STOCK-BASED COMPENSATION

6 Months Ended

Jun. 30, 2011

Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]

STOCK-BASED COMPENSATION

STOCK-BASED COMPENSATION

The Company grants stock-based compensation to employees under the Employees' Stock Purchase Plan (“ESPP”) and the 1988 Award and Option Plan (the “1988 Plan”) and to non-employee directors under the 2003 Non-Employee Directors' Stock Incentive Plan. Most of the Company's stock-based compensation awards are granted in the first quarter of each year. Details for awards granted in the first quarter of 2011 are included in the following paragraphs. There was minimal grant activity in the second quarter of 2011.

During the first quarter of 2011, employees subscribed to the right to purchase 10.8 million shares with a weighted-average exercise price of $23.00 per share and a weighted-average fair value of $11.39 per share under the ESPP.

During the first quarter of 2011, the Company granted the following stock-based compensation awards to employees under the 1988 Plan:

• 10.5 million stock options with a weighted-average exercise price of $38.38 per share and a weighted-average fair value of $10.67 per share;

• 3.0 million shares of deferred stock with a weighted-average fair value of $38.35 per share; and

• 1.1 million shares of performance deferred stock with a weighted-average fair value of $48.94 per share.

During the first quarter of 2011, the Company granted the following stock-based compensation awards to non-employee directors under the 2003 Non-Employee Directors' Stock Incentive Plan:

• 31,350 shares of restricted stock with a weighted-average fair value of $37.26 per share.

Total unrecognized compensation cost at June 30, 2011 is provided in the following table:

Total Unrecognized Compensation Cost at June 30, 2011
In millions	Unrecognized Compensation Cost		Weighted-average Recognition Period (Years)
ESPP purchase rights	$	25	0.38
Unvested stock options	$	89	0.78
Deferred stock awards	$	138	0.83
Performance deferred stock awards	$	45	0.46

XML



EARNINGS PER SHARE CALCULATIONS (Reconciliation of Shares) (Details) In Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010
Earnings Per Share Disclosure [Line Items]
Weighted-average common shares - basic	1,149.6		1,125.4		1,144.6		1,121.4
Plus dilutive effect of stock options and awards	11.3		16.2		11.6		16.9
Weighted-average common shares outstanding - diluted	1,160.9		1,141.6		1,156.2		1,138.3
Stock Options [Member]
Earnings Per Share Disclosure [Line Items]
Stock options and deferred stock awards excluded from EPS calculations	42.8	[1]	49.1	[1]	43.0	[1]	47.3	[1]
Convertible Preferred Stock [Member]
Earnings Per Share Disclosure [Line Items]
Stock options and deferred stock awards excluded from EPS calculations	96.8	[2]	96.8	[2]	96.8	[2]	96.8	[2]

[1] These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

[2] Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

XML



Document and Entity Information	6 Months Ended
	Jun. 30, 2011
Document and Entity Information [Abstract]
Document Type	10-Q
Document Period End Date	Jun. 30, 2011
Amendment Flag	false
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q2
Entity Registrant Name	DOW CHEMICAL CO /DE/
Entity Central Index Key	0000029915
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding	1,181,218,850

XML



GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Amortization Expense of Intangible Assets) (Details) (USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense, other intangible assets, excluding software	$ 125	$ 125	$ 248	$ 253
Amortization expense, software, included in 'Cost of sales'	$ 22	$ 22	$ 45	$ 43

XML



RESTRUCTURING (Tables)

6 Months Ended

Jun. 30, 2011

Restructuring and Related Activities [Abstract]

Schedule of Restructuring and Related Costs [Table Text Block]

2011 Activities Related to 2009 Restructuring In millions	Costs associated with Exit or Disposal Activities		Severance Costs			Total
Reserve balance at December 31, 2010	$	68	$	6		$	74
Cash payments	—		(6		)	(6		)
Reserve balance at March 31, 2011	$	68	$	—		$	68

Schedule Of Restructuring Reserve Assumed From Acquired Company [Table Text Block]

Restructuring Reserve Assumed from Rohm and Haas In millions	Severance Costs
Reserve balance at December 31, 2010	$	12
Cash payments	(7		)
Adjustments to reserve	(6		)
Foreign currency impact	1
Reserve balance at June 30, 2011	$	—

XML



GOODWILL AND OTHER INTANGIBLE ASSETS (Other Intangible Assets) (Details) (USD $) In Millions	Jun. 30, 2011		Dec. 31, 2010
Goodwill and Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 7,461		$ 7,281
Intangible assets gross carrying amount	7,516		7,335
Other Intangible Assets, Accumulated Amortization	(2,127)		(1,805)
Finite-Lived Intangible Assets, Net	5,334		5,476
Other Intangible Assets, Net	5,389		5,530
IPRD Indefinite Lives [Member]
Goodwill and Other Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets (Excluding Goodwill)	55	[1]	54	[1]
Licenses and Intellectual Property [Member]
Goodwill and Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,715		1,733
Other Intangible Assets, Accumulated Amortization	(536)		(466)
Finite-Lived Intangible Assets, Net	1,179		1,267
Patents [Member]
Goodwill and Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	123		121
Other Intangible Assets, Accumulated Amortization	(99)		(95)
Finite-Lived Intangible Assets, Net	24		26
Software [Member]
Goodwill and Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,034		965
Other Intangible Assets, Accumulated Amortization	(557)		(506)
Finite-Lived Intangible Assets, Net	477		459
Trademarks [Member]
Goodwill and Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	694		693
Other Intangible Assets, Accumulated Amortization	(199)		(168)
Finite-Lived Intangible Assets, Net	495		525
Customer Related [Member]
Goodwill and Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	3,750		3,647
Other Intangible Assets, Accumulated Amortization	(635)		(492)
Finite-Lived Intangible Assets, Net	3,115		3,155
Other Intangible Assets [Member]
Goodwill and Other Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	145		122
Other Intangible Assets, Accumulated Amortization	(101)		(78)
Finite-Lived Intangible Assets, Net	$ 44		$ 44

[1] Purchased in-process research and development (“IPR&D”).

XML



EARNINGS PER SHARE CALCULATIONS (Net Income) (Details) (USD $) In Millions	3 Months Ended			6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010	Jun. 30, 2011		Jun. 30, 2010
Earnings Per Share [Abstract]
Net Income	$ 1,077		$ 659	$ 1,798		$ 1,211
Net income attributable to noncontrolling interests	(10)		(8)	(21)		(9)
Net Income attributable to The Dow Chemical Company	1,067		651	1,777		1,202
Preferred stock dividends	(85)		(85)	(170)		(170)
Net Income Available for The Dow Chemical Company Common Stockholders	982		566	1,607		1,032
Net income attributable to participating securities	(12)	[1]		(20)	[1]
Net income attributable to common stockholders	$ 970			$ 1,587

[1] Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

XML



ACQUISITIONS AND DIVESTITURES

6 Months Ended

Jun. 30, 2011

Acquisitions And Divestures

ACQUISITIONS AND DIVESTITURES

ACQUISITIONS AND DIVESTITURES

Rohm and Haas Acquisition and Integration Related Expenses

During the first quarter of 2011, pretax charges totaling $31 million were recorded for integration costs related to the April 1, 2009 acquisition of Rohm and Haas, which was substantially completed in the first quarter of 2011. During the second quarter of 2010, pretax charges totaling $37 million ($63 million during the first six months of 2010) were recorded for integration costs related to the acquisition. These charges were recorded in “Acquisition and integration related expenses” and reflected in Corporate.

Divestitures Required as a Condition to the Acquisition of Rohm and Haas

As a condition of the FTC's approval of the April 1, 2009 acquisition of Rohm and Haas, the Company was required to divest a portion of its acrylic monomer business, a portion of its specialty latex business and its hollow sphere particle business. On July 31, 2009, the Company entered into a definitive agreement that included the sale of the portion of its acrylic monomer business and the portion of its specialty latex business. The sale was completed on January 25, 2010. Additional impairment charges of $8 million related to these assets were recognized in the first quarter of 2010. In the second quarter of 2010, additional severance costs of $1 million and the write-off of other assets of $5 million were recognized (see Note C).

The Company completed the sale of its hollow sphere particle business in the second quarter of 2010 and recognized additional costs associated with disposal activities of $7 million, related to contract termination fees (see Note C).

Divestiture of the Styron Business Unit

On March 2, 2010, the Company announced the entry into a definitive agreement to sell the Styron business unit (“Styron”) to an affiliate of Bain Capital Partners. The definitive agreement specified the assets and liabilities related to the businesses and products to be included in the sale. On June 17, 2010, the sale was completed for $1,561 million, net of working capital adjustments and costs to sell, with proceeds subject to customary post-closing adjustments. Post-closing adjustments were finalized in the fourth quarter of 2010. The proceeds included a $75 million long-term note receivable. In addition, the Company elected to acquire a 7.5 percent equity interest in the resulting privately held, global materials company.

The Company recognized a pretax gain of $51 million on the sale in the second quarter of 2010, included in “Sundry income (expense) - net” and reflected in the following operating segments: Performance Systems ($15 million), Performance Products ($26 million) and Plastics ($10 million).

On February 3, 2011, Styron repaid the $75 million long-term note receivable, plus interest. In the first quarter of 2011, the Company received dividend income of $25 million, recorded in “Sundry income (expense) - net” in the consolidated statements of income and reflected in Corporate. The Company continued to hold a 6.5 percent equity interest at June 30, 2011.

Subsequent Event

On July 27, 2011, the Company entered into a definitive agreement under which the Company's global Polypropylene business will be divested to Braskem SA for a total enterprise value of approximately $340 million. The transaction is expected to close by the end of the third quarter 2011, pending regulatory approval, and the Company expects to report a gain on this divestiture. The divestiture will include the Company's polypropylene manufacturing facilities at Schkopau and Wesseling, Germany, and Freeport and Seadrift, Texas. Also included are inventory, business know-how, certain product and process technology, and customer contracts and lists. Dow's Polypropylene Licensing and Catalyst business and related catalyst facilities are excluded from the scope of the transaction.

XML



INVENTORIES (Tables)

6 Months Ended

Jun. 30, 2011

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

Inventories In millions	Jun 30, 2011		Dec 31, 2010
Finished goods	$	5,034	$	4,289
Work in process	2,021		1,498
Raw materials	924		644
Supplies	760		656
Total inventories	$	8,739	$	7,087

XML



ACQUISITIONS AND DIVESTITURES (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended				3 Months Ended		6 Months Ended	3 Months Ended							0 Months Ended	1 Months Ended	3 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Mar. 31, 2011	Jul. 27, 2011 Definitive agreement for divestiture of Polypropylene Business [Member]	Mar. 31, 2011 Corporate [Member] Rohm And Haas [Member]	Jun. 30, 2010 Corporate [Member] Rohm And Haas [Member]	Jun. 30, 2010 Corporate [Member] Rohm And Haas [Member]	Jun. 30, 2010 Performance Systems [Member] Styron [Member]	Jun. 30, 2010 Performance Products [Member] Styron [Member]	Jun. 30, 2010 Plastics [Member] Styron [Member]	Mar. 31, 2011 Corporate [Member] Styron [Member]	Jun. 30, 2010 Certain Acrylic Monomer And Specialty Latex Assets Divestiture As Condition To The Acquisition Of Rohm And Haas [Member]	Mar. 31, 2010 Certain Acrylic Monomer And Specialty Latex Assets Divestiture As Condition To The Acquisition Of Rohm And Haas [Member]	Jun. 30, 2010 Hollow Sphere Particle Business Divesture as Condition to The Acquisition of Rohm and Haas [Member]	Feb. 03, 2011 Styron [Member]	Jun. 30, 2010 Styron [Member]	Jun. 30, 2010 Styron [Member]	Jun. 17, 2010 Styron [Member]
Acquisition and integration related costs	$ 0	$ 37	$ 31	$ 63			$ 31	$ 37	$ 63
Asset impairment charges														5	8
Exit or disposal activities																7
Proceeds from sales of property, businesses and consolidated companies			85	1,651														1,561
Severance costs														1
Long-term note receivable																				75
Equity option consideration in connection with divestiture					6.50%															7.50%
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal										15	26	10							51
Proceeds from repayments of notes receivable																	75
Dividend income													25
Enterprise value of business to be sold per definitive sale agreement						$ 340

XML



EARNINGS PER SHARE CALCULATIONS (Tables)

6 Months Ended

Jun. 30, 2011

Earnings Per Share [Abstract]

Net Income [Table Text Block]

Net Income	Three Months Ended				Six Months Ended
In millions		Jun 30, 2010			Jun 30, 2010
Net income		$	659		$	1,211
Net income attributable to noncontrolling interests		(8		)	(9		)
Net income attributable to The Dow Chemical Company		$	651		$	1,202
Preferred stock dividends		(85		)	(170		)
Net income available for common stockholders		$	566		$	1,032

Net Income	Three Months Ended			Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2011
Net income	$	1,077		$	1,798
Net income attributable to noncontrolling interests	(10		)	(21		)
Net income attributable to The Dow Chemical Company	$	1,067		$	1,777
Preferred stock dividends	(85		)	(170		)
Net income attributable to participating securities (1)	(12		)	(20		)
Net income attributable to common stockholders	$	970		$	1,587

(1) Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

Earnings Per Share Calculation - Basic

Earnings Per Share Calculations - Basic	Three Months Ended			Six Months Ended
Dollars per share	Jun 30, 2011			Jun 30, 2011
Net income	$	0.94		$	1.57
Net income attributable to noncontrolling interests	(0.01		)	(0.02		)
Net income attributable to The Dow Chemical Company	$	0.93		$	1.55
Preferred stock dividends	(0.08		)	(0.15		)
Net income attributable to participating securities (1)	(0.01		)	(0.01		)
Net income attributable to common stockholders	$	0.84		$	1.39

Earnings Per Share Calculations - Basic	Three Months Ended				Six Months Ended
Dollars per share		Jun 30, 2010			Jun 30, 2010
Net income		$	0.59		$	1.08
Net income attributable to noncontrolling interests		(0.01		)	(0.01		)
Net income attributable to The Dow Chemical Company		$	0.58		$	1.07
Preferred stock dividends		(0.08		)	(0.15		)
Net income available for common stockholders		$	0.50		$	0.92

(1) Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

Earnings Per Share Calculation - Diluted

(1) Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

(1) Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

(2) Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

(1) Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

Earnings Per Share Calculations - Diluted	Three Months Ended				Six Months Ended
Dollars per share		Jun 30, 2010			Jun 30, 2010
Net income		$	0.58		$	1.07
Net income attributable to noncontrolling interests		(0.01		)	(0.01		)
Net income attributable to The Dow Chemical Company		$	0.57		$	1.06
Preferred stock dividends (1)		(0.07		)	(0.15		)
Net income available for common stockholders		$	0.50		$	0.91

Earnings Per Share Calculations - Diluted	Three Months Ended			Six Months Ended
Dollars per share	Jun 30, 2011			Jun 30, 2011
Net income	$	0.93		$	1.56
Net income attributable to noncontrolling interests	(0.01		)	(0.02		)
Net income attributable to The Dow Chemical Company	$	0.92		$	1.54
Preferred stock dividends (2)	(0.07		)	(0.15		)
Net income attributable to participating securities (1)	(0.01		)	(0.02		)
Net income attributable to common stockholders	$	0.84		$	1.37

Schedule of Weighted Average Number of Shares [Table Text Block]

(3) These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

(4) Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

Shares in millions
Weighted-average common shares - basic	1,149.6	1,144.6
Plus dilutive effect of stock options and awards	11.3	11.6
Weighted-average common shares - diluted	1,160.9	1,156.2
Stock options and deferred stock awards excluded from EPS calculations (3)	42.8	43.0
Conversion of preferred stock excluded from EPS calculations (4)	96.8	96.8

(2) These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

(3) Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

Shares in millions
Weighted-average common shares - basic	1,125.4	1,121.4
Plus dilutive effect of stock options and awards	16.2	16.9
Weighted-average common shares - diluted	1,141.6	1,138.3
Stock options and deferred stock awards excluded from EPS calculations (2)	49.1	47.3
Conversion of preferred stock excluded from EPS calculations (3)	96.8	96.8

XML



OPERATING SEGMENTS AND GEOGRAPHIC AREAS

6 Months Ended

Jun. 30, 2011

Segment Reporting [Abstract]

OPERATING SEGMENTS AND GEOGRAPHIC AREAS

OPERATING SEGMENTS AND GEOGRAPHIC AREAS

Operating Segments	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Sales by operating segment
Electronic and Specialty Materials	$	1,450		$	1,278		$	2,796		$	2,457
Coatings and Infrastructure	1,587			1,437			2,985			2,722
Health and Agricultural Sciences	1,500			1,276			3,106			2,645
Performance Systems	1,901			1,808			3,568			3,483
Performance Products	3,157			2,754			6,060			5,543
Plastics	3,274			2,993			6,272			6,015
Chemicals and Energy	1,044			847			2,014			1,686
Hydrocarbons	2,044			1,151			3,796			2,316
Corporate	89			74			182			168
Total	$	16,046		$	13,618		$	30,779		$	27,035
EBITDA (1) by operating segment
Electronic and Specialty Materials	$	429		$	426		$	773		$	786
Coatings and Infrastructure	231			230			419			368
Health and Agricultural Sciences	287			196			693			580
Performance Systems	260			225			467			430
Performance Products	387			330			843			618
Plastics	751			696			1,560			1,414
Chemicals and Energy	282			100			573			220
Hydrocarbons	—			(1		)	—			(1		)
Corporate	(295		)	(321		)	(1,054		)	(753		)
Total	$	2,332		$	1,881		$	4,274		$	3,662
Equity in earnings (losses) of nonconsolidated affiliates by operating segment (included in EBITDA)
Electronic and Specialty Materials	$	97		$	112		$	188		$	225
Coatings and Infrastructure	—			1			—			2
Health and Agricultural Sciences	—			(1		)	3			1
Performance Systems	(6		)	2			(10		)	2
Performance Products	3			2			(3		)	9
Plastics	65			59			133			124
Chemicals and Energy	130			54			274			152
Hydrocarbons	8			20			19			44
Corporate	(6		)	(5		)	(15		)	(11		)
Total	$	291		$	244		$	589		$	548

(1) The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. A reconciliation of EBITDA to “Income Before Income Taxes” is provided below.

Reconciliation of EBITDA to “Income Before Income Taxes”	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
EBITDA	$	2,332	$	1,881	$	4,274	$	3,662
- Depreciation and amortization	697		734		1,428		1,491
+ Interest income	10		10		17		17
- Interest expense and amortization of debt discount	328		367		705		743
Income Before Income Taxes	$	1,317	$	790	$	2,158	$	1,445

Transfers of products between operating segments are generally valued at cost. However, transfers of products to Health and Agricultural Sciences from other segments are generally valued at market-based prices; the revenues generated by these transfers in the first six months of 2011 and 2010 were immaterial and eliminated in consolidation.

Geographic Areas	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sales by geographic area
United States	$	5,238	$	4,484	$	10,020	$	8,845
Europe, Middle East and Africa	5,713		4,721		11,071		9,468
Rest of World	5,095		4,413		9,688		8,722
Total	$	16,046	$	13,618	$	30,779	$	27,035

XML



FAIR VALUE MEASUREMENTS

6 Months Ended

Jun. 30, 2011

Fair Value Disclosures [Abstract]

Fair Value Disclosures [Text Block]

FAIR VALUE MEASUREMENTS

The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis in the consolidated balance sheets:

Basis of Fair Value Measurements on a Recurring Basis at June 30, 2011 In millions	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)		Counterparty and Cash Collateral Netting (1)			Total
Assets at fair value:
Interests in trade accounts receivable conduits (2)	$	—	$	—	1,343	$	1,389	$	—		$	1,389
Equity securities (3)	639		38		—	—		—			677
Debt securities: (3)
Government debt (4)	—		600		—	—		—			600
Corporate bonds	—		738		—	—		—			738
Derivatives relating to: (5)
Foreign currency	—		37		—	—		(15		)	22
Commodities	16		22		—	—		(22		)	16
Total assets at fair value	$	655	$	1,435		$	1,389	$	(37	)	$	3,442
Liabilities at fair value:
Derivatives relating to: (5)
Foreign currency	$	—	$	47		$	—	$	(15	)	$	32
Commodities	5		16			—		(17		)	4
Total liabilities at fair value	$	5	$	63		$	—	$	(32	)	$	36

Basis of Fair Value Measurements on a Recurring Basis at December 31, 2010 In millions	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Counterparty and Cash Collateral Netting (1)			Total
Assets at fair value:
Interests in trade accounts receivable conduits (2)	$	—	$	—	$	1,267	$	—		$	1,267
Equity securities (3)	556		36		—		—			592
Debt securities: (3)
Government debt (4)	—		641		—		—			641
Corporate bonds	—		831		—		—			831
Derivatives relating to: (5)
Foreign currency	—		86		—		$	(46	)	40
Commodities	12		18		—		(16		)	14
Total assets at fair value	$	568	$	1,612	$	1,267	$	(62	)	$	3,385
Liabilities at fair value:
Derivatives relating to: (5)
Foreign currency	$	—	$	84	$	—	$	(46	)	$	38
Commodities	7		17		—		(20		)	4
Total liabilities at fair value	$	7	$	101	$	—	$	(66	)	$	42

(1) Cash collateral is classified as “Accounts and notes receivable – Other” in the consolidated balance sheets. Amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

(2) Included in “Accounts and notes receivable – Other” in the consolidated balance sheets. See Note K for additional information on transfers of financial assets.

(3) The Company’s investments in equity and debt securities are primarily classified as available-for-sale and are included in “Other investments” in the consolidated balance sheets.

(4) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

(5) See Note H for the classification of derivatives in the consolidated balance sheets.

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets and liabilities. The Company borrowed $6 million of cash collateral against $11 million of unrealized gains at June 30, 2011 (posted $4 million of cash collateral at December 31, 2010). The net $5 million at June 30, 2011 and the $4 million at December 31, 2010 were classified as “Accounts and notes receivable – Other” in the consolidated balance sheets.

For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange in which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources.

For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note H for further information on the types of instruments used by the Company for risk management.

There were no significant transfers between Levels 1 and 2 in the six-month period ended June 30, 2011 or the year ended December 31, 2010.

For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s interests held in trade receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests. See Note K for further information on assets classified as Level 3 measurements.

The following table summarizes the changes in fair value measurements using Level 3 inputs for the three and six month periods ended June 30, 2011 and 2010:

Fair Value Measurements Using Level 3 Inputs	Three Months Ended						Six Months Ended
Interests Held in Trade Receivable Conduits(1) In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Balance at beginning of period	$	1,343		$	1,224		$	1,267		$	—
Gain/(Loss) included in earnings (2)	3			9			(5		)	9
Purchases – North America	161			181			1,098			1,933
Purchases – Europe	116			144			253			144
Settlements – North America	(98		)	(352		)	(1,000		)	(880		)
Settlements – Europe	(136		)	—			(224		)	—
Balance at June 30	$	1,389		$	1,206		$	1,389		$	1,206

(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheets.

(2) Included in “Selling, general and administrative expenses” in the consolidated statements of income.

XML



Consolidated Statements of Comprehensive Income (USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Net Income	$ 1,077	$ 659	$ 1,798	$ 1,211
Other Comprehensive Income (Loss), Net of Tax
Net change in unrealized gains (losses) on investments	(8)	(32)	6	(19)
Translation adjustments	159	(592)	600	(1,022)
Adjustments to pension and other postretirement benefit plans	69	107	141	149
Net gains (losses) on cash flow hedging derivative instruments	14	(5)	5	4
Total other comprehensive income (loss)	234	(522)	752	(888)
Comprehensive Income	1,311	137	2,550	323
Comprehensive income attributable to noncontrolling interests, net of tax	10	8	21	9
Comprehensive Income Attributable to The Dow Chemical Company	$ 1,301	$ 129	$ 2,529	$ 314

XML



VARIABLE INTEREST ENTITIES (Tables)

6 Months Ended

Jun. 30, 2011

VARIABLE INTEREST ENTITIES [Abstract]

Schedule of Variable Interest Entities [Table Text Block]

Assets and Liabilities of Consolidated VIEs In millions	Jun 30, 2011		Dec 31, 2010
Cash and cash equivalents (1)	$	107	$	145
Other current assets	135		83
Property	1,747		1,388
Other noncurrent assets	135		122
Total assets (2)	$	2,124	$	1,738
Current liabilities (nonrecourse 2011: $237; 2010: $190)	$	323	$	837
Long-term debt (nonrecourse 2011: $930; 2010: $167)	1,276		513
Other noncurrent liabilities (nonrecourse 2011: $77; 2010: $64)	77		64
Total liabilities	$	1,676	$	1,414

(1) Includes $2 million at June 30, 2011 restricted for the construction of a specific manufacturing facility.

(2) All assets were restricted at June 30, 2011 and December 31, 2010.

XML



NONCONSOLIDATED AFFILIATES

6 Months Ended

Jun. 30, 2011

Equity Method Investments and Joint Ventures [Abstract]

NONCONSOLIDATED AFFILIATES

NONCONSOLIDATED AFFILIATES

The table below presents summarized financial information for Dow Corning Corporation, a significant nonconsolidated affiliate (at 100 percent):

Summarized Income Statement Information	Three Months Ended				Six Months Ended
for Dow Corning Corporation In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sales	$	1,668	$	1,545	$	3,247	$	2,898
Gross profit	$	533	$	554	$	1,072	$	1,060
Net income attributable to Dow Corning Corporation	$	191	$	221	$	370	$	439

XML



TRANSFERS OF FINANCIAL ASSETS

6 Months Ended

Jun. 30, 2011

Transfers and Servicing [Abstract]

TRANSFERS OF FINANCIAL ASSETS

TRANSFERS OF FINANCIAL ASSETS

Sale of Trade Accounts Receivable in North America

The Company sells trade accounts receivable of select North America entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.

During the three months ended June 30, 2011, the Company recognized a loss of $2 million on the sale of these receivables ($5 million during the three months ended June 30, 2010), which is classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. During the six months ended June 30, 2011, the Company recognized a loss of $4 million on the sale of receivables ($9 million during the six months ended June 30, 2010).

The Company classifies its interests in the conduits as “Accounts and notes receivable – Other” on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was 1.38 percent at June 30, 2011 (1.42 percent at December 31, 2010), in the portfolio of receivables sold that had not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. Credit losses, net of any recoveries, on receivables sold were insignificant for the three-month period ended June 30, 2011 ($1 million for the three-month period ended June 30, 2010) and insignificant for the six-month period ended June 30, 2011 ($1 million for the six-month period ended June 30, 2010). At June 30, 2011, the carrying value of the interests held was $1,204 million ($1,110 million at December 31, 2010), which is the Company’s maximum exposure to loss related to the receivables sold.

The sensitivity of the fair value of the interests held to hypothetical adverse changes in the anticipated credit losses assumption are as follows (amounts shown are the corresponding hypothetical decreases in the carrying value of the interests):

Impact to Carrying Value In millions	Jun 30, 2011		Dec 31, 2010
10% adverse change	$	2	$	2
20% adverse change	$	5	$	5

Following is an analysis of certain cash flows between the Company and the North American conduits:

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of receivables	$	—	$	—	$	—	$	264
Collections reinvested in revolving receivables	$	5,152	$	4,769	$	9,718	$	7,718
Interests in conduits (1)	$	98	$	339	$	1,000	$	867

(1) Presented in "Operating Activities" in the consolidated statements of cash flows.

Delinquencies on the sold receivables that were still outstanding at June 30, 2011 were $130 million ($127 million at December 31, 2010). Trade accounts receivable outstanding and derecognized from the Company’s consolidated balance sheets at June 30, 2011 were $2,336 million ($1,930 million at December 31, 2010). In May 2010, the Company repurchased $13 million of previously sold receivables related to a divestiture.

Sale of Trade Accounts Receivable in Europe

Since June 2010, the Company sold qualifying trade accounts receivable of select European entities on a revolving basis to certain multi-seller commercial paper conduit entities. The Company maintains servicing responsibilities and the related costs are insignificant. The proceeds received are comprised of cash and interests in specified assets (the receivables sold by the Company) of the conduits that entitle the Company to the residual cash flows of such specified assets in the conduits after the commercial paper has been repaid. Neither the conduits nor the investors in those entities have recourse to other assets of the Company in the event of nonpayment by the debtors.

During the three months ended June 30, 2011, the Company recognized a gain of $2 million on the sale of these receivables (a loss of less than $1 million during the three months ended June 30, 2010), which is classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. During the six months ended June 30, 2011, the Company recognized a loss of $2 million on the sale of receivables (less than $1 million during the six months ended June 30, 2010).

The Company classifies its interests in the conduits as “Accounts and notes receivable – Other” on the consolidated balance sheets and those interests are carried at fair value. Fair value of the interests is determined by calculating the expected amount of cash to be received and is based on unobservable inputs (a Level 3 measurement). The key input in the valuation is percentage of anticipated credit losses, which was zero at June 30, 2011 (zero at December 31, 2010), in the portfolio of receivables sold that had not yet been collected. Given the short-term nature of the underlying receivables, discount rates and prepayments are not factors in determining the fair value of the interests. There were no credit losses on receivables sold during the three and six-month periods ended June 30, 2011 and June 30, 2010. At June 30, 2011, the carrying value of the interests held was $185 million ($157 million at December 31, 2010), which is the Company’s maximum exposure to loss related to the receivables sold.

Following is an analysis of certain cash flows between the Company and the European conduits:

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of receivables	$	2	$	512	$	3	$	512
Collections reinvested in revolving receivables	$	2,197	$	167	$	4,059	$	167
Interests in conduits (1)	$	136	$	—	$	224	$	—

(1) Presented in "Operating Activities" in the consolidated statements of cash flows.

Delinquencies on the sold receivables still outstanding at June 30, 2011 were $21 million ($42 million at December 31, 2010 ). Trade accounts receivable outstanding and derecognized from the Company’s consolidated balance sheets at June 30, 2011 were $479 million ($405 million at December 31, 2010).

Sale of Trade Accounts Receivable in Asia Pacific

The Company sells participating interests in trade accounts receivable of select Asia Pacific entities for which the Company maintains servicing responsibilities and the related costs are insignificant. The third-party holders of the participating interests do not have recourse to the Company’s assets in the event of nonpayment by the debtors.

During the six-month periods ended June 30, 2011 and 2010, the Company recognized insignificant losses on the sale of the participating interests in the receivables, which are classified as “Interest expense and amortization of debt discount” in the consolidated statements of income. The Company receives cash upon the sale of the participating interests in the receivables.

Following is an analysis of certain cash flows between the Company and the third-party holders of the participating interests:

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of participating interests	$	41	$	53	$	87	$	102
Collections reinvested in revolving receivables	$	34	$	76	$	79	$	96

Following is additional information related to the sale of participating interests in the receivables under this facility:

Trade Accounts Receivable In millions	Jun 30, 2011		Dec 31, 2010
Derecognized from the consolidated balance sheet	$	18	$	25
Outstanding in the consolidated balance sheet	291		281
Total accounts receivable in select Asia Pacific entities	$	309	$	306

There were no credit losses on receivables relating to the participating interests sold during the three and six-month periods ended June 30, 2011 and June 30, 2010. There were no delinquencies on the outstanding receivables related to the participating interests sold at June 30, 2011 or December 31, 2010.

XML



VARIABLE INTEREST ENTITIES (Schedule of Consolidated Variable Interest Entities, Carrying Amounts of Assets and Liabilities) (Details) (USD $)	Jun. 30, 2011		Dec. 31, 2010		Jun. 30, 2010	Dec. 31, 2009
Cash and cash equivalents	$ 2,223,000,000		$ 7,039,000,000		$ 3,068,000,000	$ 2,846,000,000
Other current assets	413,000,000		349,000,000
Current assets	22,699,000,000		24,130,000,000
Property	18,049,000,000		17,668,000,000
Other noncurrent assets	667,000,000		611,000,000
Total Assets	68,447,000,000		69,588,000,000
Current liabilities (nonrecourse 2011: $237; 2010: $190)	12,429,000,000		13,896,000,000
Long-Term Debt (variable interest entities nonrecourse - 2011: $930; 2010: $167)	18,511,000,000		20,605,000,000
Other noncurrent liabilities (nonrecourse 2011: $77; 2010: $64)	3,035,000,000		2,995,000,000
Cash and cash equivalents, restricted	107,000,000		145,000,000
Long Term Debt (Variable interest entities nonrecourse)	930,000,000		167,000,000
Restricted For Construction Of Manufacturing Facility [Member] | Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents	2
Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents	107,000,000	[1]	145,000,000	[1]
Other current assets	135,000,000		83,000,000
Property	1,747,000,000		1,388,000,000
Other noncurrent assets	135,000,000		122,000,000
Total Assets	2,124,000,000	[2]	1,738,000,000	[2]
Current liabilities (nonrecourse 2011: $237; 2010: $190)	323,000,000		837,000,000
Long-Term Debt (variable interest entities nonrecourse - 2011: $930; 2010: $167)	1,276,000,000		513,000,000
Other noncurrent liabilities (nonrecourse 2011: $77; 2010: $64)	77,000,000		64,000,000
Total liabilities	1,676,000,000		1,414,000,000
Cash and cash equivalents, restricted	2,000,000
Current liabilities, nonrecourse	237,000,000		190,000,000
Long Term Debt (Variable interest entities nonrecourse)	930,000,000		167,000,000
Other noncurrent liabilities, nonrecourse	77,000,000		64,000,000
Variable Interest Entities Used to Monetize Accounts Receivable [Member]
Current assets	186,000,000		158,000,000
Current liabilities (nonrecourse 2011: $237; 2010: $190)	1,000,000		1,000,000
Current liabilities, nonrecourse	1,000,000		1,000,000
Netherlands Owner Trust [Member]
Variable Interest Entities, maximum exposure to loss	$ 363,000,000

[1] Includes $2 million at June 30, 2011 restricted for the construction of a specific manufacturing facility.

[2] All assets were restricted at June 30, 2011 and December 31, 2010

XML



GOODWILL AND OTHER INTANGIBLE ASSETS

6 Months Ended

Jun. 30, 2011

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

GOODWILL AND OTHER INTANGIBLE ASSETS

The following table shows the carrying amount of goodwill by operating segment:

Goodwill	Electronic and Specialty Materials		Coatings and Infra- structure		Health and Ag Sciences		Perf Systems		Perf Products		Plastics		Hydro- carbons		Total
In millions
Net goodwill at Dec. 31, 2010	$	5,747	$	4,191	$	1,546	$	859	$	526	$	35	$	63	$	12,967
Foreign currency impact	45		51		—		10		6		—		—		112
Net goodwill at June 30, 2011	$	5,792	$	4,242	$	1,546	$	869	$	532	$	35	$	63	$	13,079

The following table provides information regarding the Company’s other intangible assets:

Other Intangible Assets	At June 30, 2011							At December 31, 2010
In millions	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Intangible assets with finite lives:
Licenses and intellectual property	$	1,715	$	(536	)	$	1,179	$	1,733	$	(466	)	$	1,267
Patents	123		(99		)	24		121		(95		)	26
Software	1,034		(557		)	477		965		(506		)	459
Trademarks	694		(199		)	495		693		(168		)	525
Customer related	3,750		(635		)	3,115		3,647		(492		)	3,155
Other	145		(101		)	44		122		(78		)	44
Total other intangible assets, finite lives	$	7,461	$	(2,127	)	$	5,334	$	7,281	$	(1,805	)	$	5,476
IPR&D (1), indefinite lives	55		—			55		54		—			54
Total other intangible assets	$	7,516	$	(2,127	)	$	5,389	$	7,335	$	(1,805	)	$	5,530

(1) Purchased in-process research and development (“IPR&D”).

The following table provides information regarding amortization expense related to intangible assets:

Amortization Expense	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Other intangible assets, excluding software	$	125	$	125	$	248	$	253
Software, included in “Cost of sales”	$	22	$	22	$	45	$	43

Total estimated amortization expense related to intangible assets for 2011 and the five succeeding fiscal years is as follows:

Estimated Amortization Expense In millions
2011	$	620
2012	$	561
2013	$	537
2014	$	514
2015	$	496
2016	$	486

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Tables)

6 Months Ended

Jun. 30, 2011

Commitments and Contingencies Disclosure [Abstract]

Receivables for Asbestos-Related Costs

Receivables for Asbestos-Related Costs In millions	Jun 30, 2011		Dec 31, 2010
Receivables for defense costs – carriers with settlement agreements	$	23	$	12
Receivables for resolution costs – carriers with settlement agreements	190		236
Receivables for insurance recoveries – carriers without settlement agreements	50		50
Total	$	263	$	298

Table of Fixed and Determinable Portion of Take-or-Pay and Throughput Obligations

Fixed and Determinable Portion of Take-or-Pay and Throughput Obligations at December 31, 2010 In millions
2011	$	3,603
2012	3,261
2013	2,647
2014	2,055
2015	1,341
2016 - 2020	8,203
Total	$	21,110

Table of Guarantees by Type

Guarantees at December 31, 2010 In millions	Final Expiration	Maximum Future Payments (1)		Recorded   Liability
Guarantees	2020	$	445	$	80
Residual value guarantees	2020	391		17
Total guarantees		$	836	$	97

(1) The Company was indemnified by a third party for $53 million if required to perform under a $106 million

Guarantees at June 30, 2011 In millions	Final Expiration	Maximum Future Payments (1)		Recorded   Liability
Guarantees	2020	$	503	$	41
Residual value guarantees	2021	432		20
Total guarantees		$	935	$	61

(1) The Company was indemnified by a third party for $57 million if required to perform under a $113 million guarantee.

XML



INVENTORIES

6 Months Ended

Jun. 30, 2011

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

The following table provides a breakdown of inventories:

Inventories In millions	Jun 30, 2011		Dec 31, 2010
Finished goods	$	5,034	$	4,289
Work in process	2,021		1,498
Raw materials	924		644
Supplies	760		656
Total inventories	$	8,739	$	7,087

The reserves reducing inventories from the first-in, first-out (“FIFO”) basis to the last-in, first-out (“LIFO”) basis amounted to $1,396 million at June 30, 2011 and $1,003 million at December 31, 2010.

XML



FINANCIAL INSTRUMENTS (Fair Value of Financial Instruments) (Details) (USD $) In Millions	Jun. 30, 2011		Dec. 31, 2010
Financial Instruments [Line Items]
Fair Value Adjustments	$ 22		$ 23
Equity Securities [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	585	[1]	501	[1]
Financial Instruments, Gross Unrealized Gain	100	[1]	94	[1]
Financial Instruments, Gross Unrealized Loss	(8)	[1]	(3)	[1]
Financial Instruments, Fair Value	677	[1]	592	[1]
Marketable Securities [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	1,822	[1]	1,864	[1]
Financial Instruments, Gross Unrealized Gain	202	[1]	206	[1]
Financial Instruments, Gross Unrealized Loss	(9)	[1]	(6)	[1]
Financial Instruments, Fair Value	2,015	[1]	2,064	[1]
Fixed Income Securities [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	1,237	[1]	1,363	[1]
Financial Instruments, Gross Unrealized Gain	102	[1]	112	[1]
Financial Instruments, Gross Unrealized Loss	(1)	[1]	(3)	[1]
Financial Instruments, Fair Value	1,338	[1]	1,472	[1]
Fixed Income Securities [Member] | Government Bonds [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	560	[1],[2]	603	[1],[2]
Financial Instruments, Gross Unrealized Gain	40	[1],[2]	40	[1],[2]
Financial Instruments, Gross Unrealized Loss	0	[1],[2]	(2)	[1],[2]
Financial Instruments, Fair Value	600	[1],[2]	641	[1],[2]
Fixed Income Securities [Member] | Corporate Bond Securities [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	677	[1]	760	[1]
Financial Instruments, Gross Unrealized Gain	62	[1]	72	[1]
Financial Instruments, Gross Unrealized Loss	(1)	[1]	(1)	[1]
Financial Instruments, Fair Value	738	[1]	831	[1]
Foreign Currency Contract [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	0		0
Financial Instruments, Gross Unrealized Gain	22		40
Financial Instruments, Gross Unrealized Loss	(32)		(38)
Financial Instruments, Fair Value	(10)		2
Commodity Contract [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	0		0
Financial Instruments, Gross Unrealized Gain	16		14
Financial Instruments, Gross Unrealized Loss	(4)		(4)
Financial Instruments, Fair Value	12		10
Long-term Debt [Member]
Financial Instruments [Line Items]
Financial Instruments, Cost	(19,172)	[3]	(22,360)	[3]
Financial Instruments, Gross Unrealized Gain	79	[3]	175	[3]
Financial Instruments, Gross Unrealized Loss	(2,419)	[3]	(2,530)	[3]
Financial Instruments, Fair Value	$ (21,512)	[3]	$ (24,715)	[3]

[1] Included in “Other investments” in the consolidated balance sheets

[2] U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

[3] Cost includes fair value adjustments of $22 million at June 30, 2011 and $23 million at December 31, 2010

XML



Consolidated Statements of Equity (USD $) In Millions	Total	The Dow Chemical Company's Stockholder's Equity [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Income [Member]	Unrealized Gains on Investments [Member]	Cumulative Translation Adjustments [Member]	Pension and other Postretirement Benefit Plans [Member]	Accumulated Derivative Loss [Member]	Unearned ESOP Shares [Member]	Treasury Stock [Member]	Noncontrolling Interests [Member]
Stockholders' Equity Attributable to Parent, Beginning at Dec. 31, 2009			$ 4,000	$ 2,906	$ 1,913	$ 16,704		$ 79	$ 624	$ (4,587)	$ (8)	$ (519)	$ (557)
Stockholders' Equity Attributable to Noncontrolling Interest, Beginning at Dec. 31, 2009														569
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued				11
Net income attributable to noncontrolling interests	9													9
Net Income available for The Dow Chemical Company common stockholders	1,032					1,032
Dividends declared on common stock (Per share: $0.40 in 2011, $0.30 in 2010)						(337)
Other						(11)								4
Net change in unrealized gains (losses) on investments	(19)							(19)
Adjustments to pension and other postretirement benefit plans	149									149
Net hedging results	4										(3)
Reclassification to earnings											7
Purchases													(13)
Issuance to employees and employee plans													251
Distributions to noncontrolling interests	(5)													(5)
Translation adjustments	(1,022)								(1,022)
Capital contributions	0													0
Consolidation of variable interest entity														0
Impact of adoption of ASU 2009-17, net of tax						(248)								100
Common stock issued					68
Stock-based compensation and allocation of ESOP shares					44
Shares Allocated to ESOP participants												26
Stockholders' Equity Attributable to Parent, Ending at Jun. 30, 2010		20,490	4,000	2,917	2,025	17,140	(4,780)	60	(398)	(4,438)	(4)	(493)	(319)
Stockholders' Equity Attributable to Noncontrolling Interest, Ending at Jun. 30, 2010														677
Total Equity at Jun. 30, 2010	21,167
Stockholders' Equity Attributable to Parent, Beginning at Dec. 31, 2010	21,839		4,000	2,931	2,286	17,736		111	367	(4,871)	(6)	(476)	(239)
Stockholders' Equity Attributable to Noncontrolling Interest, Beginning at Dec. 31, 2010	803													803
Balance at Beginning of Year at Dec. 31, 2010	22,642
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued				22
Net income attributable to noncontrolling interests	21													21
Net Income available for The Dow Chemical Company common stockholders	1,607					1,607
Dividends declared on common stock (Per share: $0.40 in 2011, $0.30 in 2010)						(460)
Other						(6)								1
Net change in unrealized gains (losses) on investments	6							6
Adjustments to pension and other postretirement benefit plans	141									141
Net hedging results	5										(2)
Reclassification to earnings											7
Purchases													(19)
Issuance to employees and employee plans													258
Distributions to noncontrolling interests	(22)													(22)
Translation adjustments	600								600
Capital contributions	20													20
Consolidation of variable interest entity														31
Impact of adoption of ASU 2009-17, net of tax						0								0
Common stock issued					149
Stock-based compensation and allocation of ESOP shares					15
Shares Allocated to ESOP participants												28
Stockholders' Equity Attributable to Parent, Ending at Jun. 30, 2011	24,185	24,185	4,000	2,953	2,450	18,877	(3,647)	117	967	(4,730)	(1)	(448)	0
Stockholders' Equity Attributable to Noncontrolling Interest, Ending at Jun. 30, 2011	854													854
Total Equity at Jun. 30, 2011	$ 25,039

XML



OPERATING SEGMENTS AND GEOGRAPHIC AREAS (Schedule of Revenue by Geographic Area) (Details) (USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Sales by operating segment [Line Items]
Net Sales	$ 16,046	$ 13,618	$ 30,779	$ 27,035
United States [Member]
Sales by operating segment [Line Items]
Net Sales	5,238	4,484	10,020	8,845
Europe Middle East And Africa [Member]
Sales by operating segment [Line Items]
Net Sales	5,713	4,721	11,071	9,468
Rest of World [Member]
Sales by operating segment [Line Items]
Net Sales	$ 5,095	$ 4,413	$ 9,688	$ 8,722

XML



CONSOLIDATED FINANCIAL STATEMENTS

6 Months Ended

Jun. 30, 2011

Consolidated Financial Statements [Abstract]

CONSOLIDATED FINANCIAL STATEMENTS

CONSOLIDATED FINANCIAL STATEMENTS

The unaudited interim consolidated financial statements of The Dow Chemical Company and its subsidiaries (“Dow” or the “Company”) were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and reflect all adjustments (including normal recurring accruals) which, in the opinion of management, are considered necessary for the fair presentation of the results for the periods presented. These statements should be read in conjunction with the audited consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010.

A change to prior year balance sheet amounts has been made to properly classify the current portion of “Deferred charges and other assets” of $349 million to “Other current assets.”

XML



CONSOLIDATED FINANCIAL STATEMENTS (Details) (From Deferred Charges and Other Assets to Other Current Assets [Member], USD $) In Millions	12 Months Ended
	Dec. 31, 2010
From Deferred Charges and Other Assets to Other Current Assets [Member]
Prior period reclassification	$ 349

XML



FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Jun. 30, 2011

Fair Value Disclosures [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

Basis of Fair Value Measurements on a Recurring Basis at June 30, 2011 In millions	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)		Counterparty and Cash Collateral Netting (1)			Total
Assets at fair value:
Interests in trade accounts receivable conduits (2)	$	—	$	—	1,343	$	1,389	$	—		$	1,389
Equity securities (3)	639		38		—	—		—			677
Debt securities: (3)
Government debt (4)	—		600		—	—		—			600
Corporate bonds	—		738		—	—		—			738
Derivatives relating to: (5)
Foreign currency	—		37		—	—		(15		)	22
Commodities	16		22		—	—		(22		)	16
Total assets at fair value	$	655	$	1,435		$	1,389	$	(37	)	$	3,442
Liabilities at fair value:
Derivatives relating to: (5)
Foreign currency	$	—	$	47		$	—	$	(15	)	$	32
Commodities	5		16			—		(17		)	4
Total liabilities at fair value	$	5	$	63		$	—	$	(32	)	$	36

Basis of Fair Value Measurements on a Recurring Basis at December 31, 2010 In millions	Quoted Prices in Active Markets for Identical Items (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Counterparty and Cash Collateral Netting (1)			Total
Assets at fair value:
Interests in trade accounts receivable conduits (2)	$	—	$	—	$	1,267	$	—		$	1,267
Equity securities (3)	556		36		—		—			592
Debt securities: (3)
Government debt (4)	—		641		—		—			641
Corporate bonds	—		831		—		—			831
Derivatives relating to: (5)
Foreign currency	—		86		—		$	(46	)	40
Commodities	12		18		—		(16		)	14
Total assets at fair value	$	568	$	1,612	$	1,267	$	(62	)	$	3,385
Liabilities at fair value:
Derivatives relating to: (5)
Foreign currency	$	—	$	84	$	—	$	(46	)	$	38
Commodities	7		17		—		(20		)	4
Total liabilities at fair value	$	7	$	101	$	—	$	(66	)	$	42

(1) Cash collateral is classified as “Accounts and notes receivable – Other” in the consolidated balance sheets. Amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

(2) Included in “Accounts and notes receivable – Other” in the consolidated balance sheets. See Note K for additional information on transfers of financial assets.

(3) The Company’s investments in equity and debt securities are primarily classified as available-for-sale and are included in “Other investments” in the consolidated balance sheets.

(4) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

(5) See Note H for the classification of derivatives in the consolidated balance sheets.

Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]

Fair Value Measurements Using Level 3 Inputs	Three Months Ended						Six Months Ended
Interests Held in Trade Receivable Conduits(1) In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Balance at beginning of period	$	1,343		$	1,224		$	1,267		$	—
Gain/(Loss) included in earnings (2)	3			9			(5		)	9
Purchases – North America	161			181			1,098			1,933
Purchases – Europe	116			144			253			144
Settlements – North America	(98		)	(352		)	(1,000		)	(880		)
Settlements – Europe	(136		)	—			(224		)	—
Balance at June 30	$	1,389		$	1,206		$	1,389		$	1,206

(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheets.

(2) Included in “Selling, general and administrative expenses” in the consolidated statements of income.

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Breast Implant Matters) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	Jun. 30, 2011	Jun. 02, 2011 Credit Facility Provided To Joint Venture Reporting Entity Share [Member] Corporate Joint Venture [Member]	Jun. 02, 2004 Credit Facility Provided To Joint Venture Reporting Entity Share [Member] Corporate Joint Venture [Member]	Jun. 02, 2011 Corporate Joint Venture [Member]	Jun. 02, 2004 Corporate Joint Venture [Member]
Loss Contingencies [Line Items]
Dow Chemical Company ownership percentage in Dow Corning Corporation	50.00%
Joint Plan credit facility		$ 75	$ 150	$ 150	$ 300

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Asbestos-Related Matters of Union Carbide Corporation) (Table and Narrative) (Details) (Union Carbide [Member], USD $) In Millions, unless otherwise specified	1 Months Ended	3 Months Ended		6 Months Ended
	Dec. 31, 2010	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 02, 2010	Dec. 31, 2009	Dec. 31, 2002
Loss Contingencies [Line Items]
Liability for asbestos claims, gross	$ 728	$ 703		$ 703		$ 744	$ 839	$ 2,200
Asbestos related charges credit	(54)
Percentage of recorded asbestos liability related to pending claims	21.00%	20.00%		20.00%
Percentage of recorded asbestos liability related to future claims	79.00%	80.00%		80.00%
Estimated insurance recoveries	298	263		263				1,350
Defense and resolution costs for asbestos related claims		15	22	28	36
Estimated Insurance Recoveries Carriers Without Settlement Agreements [Member]
Loss Contingencies [Line Items]
Estimated insurance recoveries	50	50		50
Estimated Insurance Recoveries Defense Costs [Member]
Loss Contingencies [Line Items]
Estimated insurance recoveries	12	23		23
Estimated Insurance Recoveries Resolution Costs [Member]
Loss Contingencies [Line Items]
Estimated insurance recoveries	236	190		190
Asbestos Related Matters [Member]
Loss Contingencies [Line Items]
Liability for asbestos claims, estimated minimum	744
Liability for asbestos claims, estimated maximum	$ 835

XML



FINANCIAL INSTRUMENTS (Fair Value and Gross Unrealized Losses of the Company's Investments) (Details) (USD $) In Millions	6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010	Dec. 31, 2010
Schedule of Available-for-sale Securities [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	$ 128	[1]		$ 157	[1]
Temporarily Impaired Securities, Less than 12 Months, Unrealized Losses	(9)	[1]		(6)	[1]
Other than temporary impairment write-downs on investments still held	3		4
Cost method investments, aggregate cost	171			171
Cost method investments, reduction in cost basis due to impairment			20
Fixed Income Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	32	[1]		105	[1]
Temporarily Impaired Securities, Less than 12 Months, Unrealized Losses	(1)	[1]		(3)	[1]
Government Bonds [Member]
Schedule of Available-for-sale Securities [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	0	[1],[2],[3]		62	[1],[2],[3]
Temporarily Impaired Securities, Less than 12 Months, Unrealized Losses	0	[1],[2],[3]		(2)	[1],[2],[3]
Corporate Bonds - Investment Grade [Member]
Schedule of Available-for-sale Securities [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	32	[1]		43	[1]
Temporarily Impaired Securities, Less than 12 Months, Unrealized Losses	(1)	[1]		(1)	[1]
Equity Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Temporarily Impaired Securities, Less than 12 Months, Fair Value	96	[1]		52	[1]
Temporarily Impaired Securities, Less than 12 Months, Unrealized Losses	$ (8)	[1]		$ (3)	[1]

[1] Unrealized losses of 12 months or more were less than $1 million.

[2] U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

[3] Unrealized losses of less than 12 months were less than $1 million at June 30, 2011.

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Guarantees) (Table and Narrative) (Details) (USD $) In Millions	6 Months Ended		12 Months Ended
	Jun. 30, 2011		Dec. 31, 2010
Guarantees subject to indemnification from third parties [Member]
Guarantor Obligations [Line Items]
indemnified amount if required to perform under a guarantee	$ 57		$ 53
Guarantor obligations, maximum exposure, undiscounted	113		106
Guarantees [Member]
Guarantor Obligations [Line Items]
Final expiration	2020		2020
Guarantor obligations, maximum exposure, undiscounted	503	[1]	445	[2]
Guarantor obligations, current carrying value	41		80
Residual Value Guarantees [Member]
Guarantor Obligations [Line Items]
Final expiration	2021		2020
Guarantor obligations, maximum exposure, undiscounted	432	[1]	391	[2]
Guarantor obligations, current carrying value	20		17
Total Guarantees [Member]
Guarantor Obligations [Line Items]
Guarantor obligations, maximum exposure, undiscounted	935	[1]	836	[2]
Guarantor obligations, current carrying value	$ 61		$ 97

[1] The Company was indemnified by a third party for $57 million if required to perform under a $113 million guarantee.

[2] The Company was indemnified by a third party for $53 million if required to perform under a

XML



RECENT ACCOUNTING GUIDANCE

6 Months Ended

Jun. 30, 2011

Recent Accounting Guidance [Abstract]

Recent Accounting Guidance [Text Block]

RECENT ACCOUNTING GUIDANCE

Recently Adopted Accounting Guidance

On January 1, 2011, the Company adopted Accounting Standard Update (“ASU”) 2009-13, “Revenue Recognition (Topic 605): Multiple-Deliverable Revenue Arrangements – a consensus of the FASB Emerging Issues Task Force.” This ASU amended the criteria for when to evaluate individual delivered items in a multiple deliverable arrangement and how to allocate consideration received. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

Accounting Guidance Issued But Not Adopted as of June 30, 2011

In May 2011, the FASB issued ASU 2011-04, "Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS," which provides common requirements for measuring fair value and disclosing information about fair value measurements in accordance with U.S. GAAP and International Financial Reporting Standards ("IFRS"). This ASU is effective for fiscal years beginning on or after December 15, 2011. The Company is currently evaluating the impact of adopting the guidance.

In June 2011, the FASB issued ASU 2011-05, "Comprehensive Income (Topic 220): Presentation of Comprehensive Income," which improves the comparability, consistency and transparency of financial reporting and increases the prominence of items reported in other comprehensive income. This ASU is effective for fiscal years beginning on or after December 15, 2011 and early adoption is permitted. The Company is currently evaluating the impact of adopting the guidance.

XML



STOCK-BASED COMPENSATION (Details) (USD $) In Millions, except Share data, unless otherwise specified	3 Months Ended					6 Months Ended
	Mar. 31, 2011 Employee [Member] Employees' Stock Purchase Plan [Member]	Mar. 31, 2011 Employee [Member] Unvested Stock Options [Member]	Mar. 31, 2011 Employee [Member] Deferred Stock Awards [Member]	Mar. 31, 2011 Employee [Member] Performance Deferred Stock Awards [Member]	Mar. 31, 2011 Director [Member] Restricted Stock Awards [Member]	Jun. 30, 2011 Employees' Stock Purchase Plan [Member] years	Jun. 30, 2011 Unvested Stock Options [Member] years	Jun. 30, 2011 Deferred Stock Awards [Member] years	Jun. 30, 2011 Performance Deferred Stock Awards [Member] years
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Right to purchase shares subscribed by employees	10,800,000
Weighted-average exercise price right to purchase shares by employees	$ 23.00
Weighted-average fair value of shares under the Employee Stock Purchase Plan	$ 11.39
Stock options granted to employees under the 1988 plan		10,500,000
Weighted-average exercise price options granted under the 1988 plan		$ 38.38
Weighted-average fair value per share of purchase rights granted		$ 10.67
Deferred stock granted to employees under the 1988 plan			3,000,000	1,100,000
Restricted stock granted to non-employee directors					31,350
Weighted-average fair value of deferred stock granted under the 1988 plan			$ 38.35	$ 48.94	$ 37.26
Weighted-average Recognition Period, in years						0.38	0.78	0.83	0.46
Unrecognized Compensation Cost						$ 25	$ 89	$ 138	$ 45

XML



RESTRUCTURING (Restructuring Reserve Assumed from Rohm and Haas) (Details) (Restructuring Reserve Assumed From Rohm and Haas [Member], USD $) In Millions, unless otherwise specified	3 Months Ended	6 Months Ended
	Mar. 31, 2011 Employee Severance [Member] Corporate [Member]	Jun. 30, 2011 Employee Severance [Member]	Dec. 31, 2010 Severance For Remaining Employees [Member] employees	Dec. 31, 2010 Termination Benefits for Former Employees [Member]
Restructuring Cost and Reserve [Line Items]
Entity Number of Employees			44
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance		$ 12	$ 7	$ 5
Cash payments		(7)
Adjustments to reserve	6	6
Foreign currency impact		1
Restructuring reserve, ending balance		$ 0	$ 7	$ 5

XML



NONCONSOLIDATED AFFILIATES (Tables)

6 Months Ended

Jun. 30, 2011

Equity Method Investments and Joint Ventures [Abstract]

Equity Method Investment Summarized income statement information

Summarized Income Statement Information	Three Months Ended				Six Months Ended
for Dow Corning Corporation In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sales	$	1,668	$	1,545	$	3,247	$	2,898
Gross profit	$	533	$	554	$	1,072	$	1,060
Net income attributable to Dow Corning Corporation	$	191	$	221	$	370	$	439

XML



TRANSFERS OF FINANCIAL ASSETS (Certain Cash Flows Between the Company and the North American Conduits) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				6 Months Ended				12 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010		Dec. 31, 2010
Tranfers of Financial Assets [Line Items]
Anticipated credit losses in the portfolio of receivables sold that have not yet been collected							0.00%
Interests in conduits					$ 1,224		$ 867
North America [Member]
Tranfers of Financial Assets [Line Items]
Anticipated credit losses in the portfolio of receivables sold that have not yet been collected					1.38%				1.42%
Sensitivity analysis of fair value of interests held in conduits, impact of 10 percent adverse change in valuation assumption	2				2				2
Sensitivity analysis of fair value of interests held in conduits, impact of 20 percent adverse change in valuation assumption	5				5				5
Carrying value of interests held	1,204				1,204				1,110
North America [Member] | Trade Accounts Receivable [Member]
Tranfers of Financial Assets [Line Items]
Derecognized Assets, Securitized or Asset-backed Financing Arrangement Assets and any Other Financial Assets Managed Together, Net Credit Losses During Period			1				1
Loss from sale of transferred financial assets	2		5		4		9
Sale of receivables	0		0		0		264
Collections reinvested in revolving receivables	5,152		4,769		9,718		7,718
Interests in conduits	98	[1]	339	[1]	1,000	[1]	867	[1]
Trade accounts receivable outstanding and derecognized from the consolidated balance sheet	2,336				2,336				1,930
Repurchase of previously sold receivables, related to a divestiture									13
Delinquencies on sold receivables that were outstanding at the end of the period	$ 130				$ 130				$ 127

[1] Presented in "Operating Activities" in the consolidated statements of cash flows.

XML



EARNINGS PER SHARE CALCULATIONS (Earnings Per Share Calculation - Basic) (Details) (USD $)	3 Months Ended			6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010	Jun. 30, 2011		Jun. 30, 2010
Earnings Per Share [Abstract]
Net income, basic	$ 0.94		$ 0.59	$ 1.57		$ 1.08
Net income attributable to noncontrolling interests, basic	$ (0.01)		$ (0.01)	$ (0.02)		$ (0.01)
Net income (loss) attributable to The Dow Chemical Company	$ 0.93		$ 0.58	$ 1.55		$ 1.07
Preferred stock dividends, basic	$ (0.08)		$ (0.08)	$ (0.15)		$ (0.15)
Net income attributable to participating securities	$ (0.01)	[1]		$ (0.01)	[1]
Net income attributable to common stockholders	$ 0.84		$ 0.50	$ 1.39		$ 0.92

[1] Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Rohm and Haas Pension Plan Matters) (Narrative) (Details) (Rohm And Haas [Member], USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010	Apr. 02, 2009
Rohm And Haas [Member]
Loss Contingencies [Line Items]
Pension liability from Rohm and Haas acquisition	$ 186	$ 186	$ 185

XML



TRANSFERS OF FINANCIAL ASSETS (Tables)

6 Months Ended

Jun. 30, 2011

North America [Member]

Tranfers of Financial Assets [Line Items]

Schedule of Sensitivity Analysis of Fair Value, Transferor's Interests in Transferred Financial Assets [Table Text Block]

Impact to Carrying Value In millions	Jun 30, 2011		Dec 31, 2010
10% adverse change	$	2	$	2
20% adverse change	$	5	$	5

Schedule of Certain Cash Flows Between the Company and the Conduits

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of receivables	$	—	$	—	$	—	$	264
Collections reinvested in revolving receivables	$	5,152	$	4,769	$	9,718	$	7,718
Interests in conduits (1)	$	98	$	339	$	1,000	$	867

(1) Presented in "Operating Activities" in the consolidated statements of cash flows.

Europe [Member]

Tranfers of Financial Assets [Line Items]

Schedule of Certain Cash Flows Between the Company and the Conduits

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of receivables	$	2	$	512	$	3	$	512
Collections reinvested in revolving receivables	$	2,197	$	167	$	4,059	$	167
Interests in conduits (1)	$	136	$	—	$	224	$	—

(1) Presented in "Operating Activities" in the consolidated statements of cash flows.

Asia Pacific [Member]

Tranfers of Financial Assets [Line Items]

Schedule of Certain Cash Flows Between the Company and the Third-Party Holders of the Participating Interests

Cash Proceeds	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sale of participating interests	$	41	$	53	$	87	$	102
Collections reinvested in revolving receivables	$	34	$	76	$	79	$	96

Qualitative and Quantitative Information, Transferor's Continuing Involvement [Table Text Block]

Trade Accounts Receivable In millions	Jun 30, 2011		Dec 31, 2010
Derecognized from the consolidated balance sheet	$	18	$	25
Outstanding in the consolidated balance sheet	291		281
Total accounts receivable in select Asia Pacific entities	$	309	$	306

XML



RESTRUCTURING (2009 Restructuring) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended		3 Months Ended						18 Months Ended	3 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Mar. 31, 2011 2009 Restructuring Plan [Member]	Jun. 30, 2010 2009 Restructuring Plan [Member]	Mar. 31, 2010 2009 Restructuring Plan [Member]	Jun. 30, 2009 2009 Restructuring Plan [Member] employees	Mar. 31, 2011 2009 Restructuring Plan [Member] Exit Or Disposal Activities [Member]	Mar. 31, 2011 2009 Restructuring Plan [Member] Employee Severance [Member]	Dec. 31, 2010 2009 Restructuring Plan [Member] Employee Severance [Member] employees	Mar. 31, 2010 2009 Restructuring Plan [Member] Electronic And Specialty Materials [Member]	Mar. 31, 2010 2009 Restructuring Plan [Member] Coatings And Infrastructure [Member]	Jun. 30, 2010 2009 Restructuring Plan [Member] Performance Products [Member]	Mar. 31, 2010 2009 Restructuring Plan [Member] Performance Products [Member]	Jun. 30, 2010 2009 Restructuring Plan [Member] Corporate [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date								2,500
Restructuring charges	$ 0	$ 13	$ 0	$ 29		$ 13		$ 677				$ 8	$ 5	$ 12	$ 3	$ 1
Asset write-downs and write-offs						5	8	454
Exit or disposal activities						7	8	68
Severance costs						1		155
Entity Number of Employees											189
Restructuring Reserve [Roll Forward]
Restructuring reserve, beginning balance					74				68	6
Cash payments					(6)				0	(6)	(149)
Restructuring reserve, ending balance					$ 68				$ 68	$ 0	$ 6

XML



FINANCIAL INSTRUMENTS (Tables)

6 Months Ended

Jun. 30, 2011

Financial Instruments [Abstact]

Investing Results

Investing Results	Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010
Proceeds from sales of available-for-sale securities	$	460		$	535
Gross realized gains	$	26		$	27
Gross realized losses	$	(7	)	$	(50	)

Contractual Maturities of Debt Securities

Contractual Maturities of Debt Securities at June 30, 2011
In millions	Amortized Cost		Fair Value
Within one year	$	23	$	23
One to five years	534		582
Six to ten years	467		498
After ten years	213		235
Total	$	1,237	$	1,338

Fair Value and Gross Unrealized Losses of Investments Temporarily Impaired

Temporarily Impaired Securities Less than 12 Months(1)
	At June 30, 2011					At December 31, 2010
In millions	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
Debt securities:
Government debt (2,3)	$	—	$	—		$	62	$	(2	)
Corporate bonds	32		(1		)	43		(1		)
Total debt securities	$	32	$	(1	)	$	105	$	(3	)
Equity securities	96		(8		)	52		(3		)
Total temporarily impaired securities	$	128	$	(9	)	$	157	$	(6	)

(1) Unrealized losses of 12 months or more were less than $1 million.

(2) Unrealized losses of less than 12 months were less than $1 million at June 30, 2011.

(3) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

Fair Value of Financial Instruments

Fair Value of Financial Instruments
	At June 30, 2011											At December 31, 2010
In millions	Cost			Gain		Loss			Fair Value			Cost			Gain		Loss			Fair Value
Marketable securities: (1)
Debt securities:
Government debt (2)	$	560		$	40	$	—		$	600		$	603		$	40	$	(2	)	$	641
Corporate bonds	677			62		(1		)	738			760			72		(1		)	831
Total debt securities	$	1,237		$	102	$	(1	)	$	1,338		$	1,363		$	112	$	(3	)	$	1,472
Equity securities	585			100		(8		)	677			501			94		(3		)	592
Total marketable securities	$	1,822		$	202	$	(9	)	$	2,015		$	1,864		$	206	$	(6	)	$	2,064
Long-term debt incl. debt due within one year (3)	$	(19,172	)	$	79	$	(2,419	)	$	(21,512	)	$	(22,360	)	$	175	$	(2,530	)	$	(24,715	)
Derivatives relating to:
Foreign currency	$	—		$	22	$	(32	)	$	(10	)	$	—		$	40	$	(38	)	$	2
Commodities	$	—		$	16	$	(4	)	$	12		$	—		$	14	$	(4	)	$	10

(1) Included in “Other investments” in the consolidated balance sheets.

(2) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

(3) Cost includes fair value adjustments of $22 million at June 30, 2011 and $23 million at December 31, 2010.

Notional Amount of Commodity Forward Contracts

Commodity	Jun 30, 2011	Dec 31, 2010	Notional Volume Unit
Crude Oil	0.5	0.1	million barrels
Ethane	0.6	1.6	million barrels
Natural Gas	1.0	2.7	million million British thermal units

Notional Amount of Other Commodity Contracts

Commodity	Jun 30, 2011	Dec 31, 2010	Notional Volume Unit
Crude Oil	0.3	—	million barrels
Ethane	3.0	3.8	million barrels
Naphtha	60.0	—	kilotons
Natural Gas	9.1	12.0	million million British thermal units

Schedule Fair Values of Derivative Instruments

Fair Value of Derivative Instruments In millions	Balance Sheet Classification	Jun 30, 2011		Dec 31, 2010
Asset Derivatives
Derivatives designated as hedges:
Foreign currency	Accounts and notes receivable – Other	$	—	$	9
Commodities	Other current assets (1)	5		7
Total derivatives designated as hedges		$	5	$	16
Derivatives not designated as hedges:
Foreign currency	Accounts and notes receivable – Other	$	37	$	77
Commodities	Other current assets (1)	33		23
Total derivatives not designated as hedges		$	70	$	100
Total asset derivatives		$	75	$	116
Liability Derivatives
Derivatives designated as hedges:
Foreign currency	Accounts payable – Other	$	3	$	20
Commodities	Accounts payable – Other	1		8
Total derivatives designated as hedges		$	4	$	28
Derivatives not designated as hedges:
Foreign currency	Accounts payable – Other	$	44	$	64
Commodities	Accounts payable – Other	20		16
Total derivatives not designated as hedges		$	64	$	80
Total liability derivatives		$	68	$	108

(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheet at December 31, 2010.

Schedule of Gain Loss Effect of Derivative Instruments

Effect of Derivative Instruments for the three months ended June 30, 2011 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	—		Interest expense (5)	$	(1	)	$	—
Cash flow:
Commodities	5			Cost of sales	6			—
Foreign currency	(5		)	Cost of sales	(19		)	—
Total derivatives designated as hedges	$	—			$	(14	)	$	—
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	42
Commodities	—			Cost of sales	—			(14		)
Total derivatives not designated as hedges	$	—			$	—		$	28
Total derivatives	$	—			$	(14	)	$	28
Effect of Derivative Instruments for the three months ended June 30, 2010 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	(1	)	Interest expense (5)	$	—		$	(1	)
Cash flow:
Commodities	(14		)	Cost of sales	(2		)	—
Foreign currency	10			Cost of sales	3			—
Net foreign investment:
Foreign currency	(17		)	n/a	—			—
Total derivatives designated as hedges	$	(22	)		$	1		$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	14
Commodities	—			Cost of sales	—			(3		)
Total derivatives not designated as hedges	$	—			$	—		$	11
Total derivatives	$	(22	)		$	1		$	10

(1) Accumulated other comprehensive income (loss) (“AOCI”).

(2) Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain (Loss) – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity.

(3) Pretax amounts.

(4) Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness.

(5) Interest expense and amortization of debt discount.

(6) Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities.

Effect of Derivative Instruments for the six months ended June 30, 2011  In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	—		Interest expense (5)	$	(1	)	$	(1	)
Cash flow:
Commodities	10			Cost of sales	11			—
Foreign currency	(16		)	Cost of sales	(17		)	—
Total derivatives designated as hedges	$	(6	)		$	(7	)	$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	41
Commodities	—			Cost of sales	—			(13		)
Total derivatives not designated as hedges	$	—			$	—		$	28
Total derivatives	$	(6	)		$	(7	)	$	27
Effect of Derivative Instruments for the six months ended June 30, 2010 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	(1	)	Interest expense (5)	$	—		$	(1	)
Cash flow:
Commodities	(18		)	Cost of sales	(4		)	—
Foreign currency	20			Cost of sales	(3		)	—
Net foreign investment:
Foreign currency	(20		)	n/a	—			—
Total derivatives designated as hedges	$	(19	)		$	(7	)	$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	113
Commodities	—			Cost of sales	—			(4		)
Total derivatives not designated as hedges	$	—			$	—		$	109
Total derivatives	$	(19	)		$	(7	)	$	108

(1) Accumulated other comprehensive income (loss) (“AOCI”).

(2) Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain (Loss) – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity.

(3) Pretax amounts.

(4) Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness.

(5) Interest expense and amortization of debt discount.

(6) Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlyin

XML



COMMITMENTS AND CONTINGENT LIABILITIES

6 Months Ended

Jun. 30, 2011

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

COMMITMENTS AND CONTINGENT LIABILITIES

Litigation

Breast Implant Matters

On May 15, 1995, Dow Corning Corporation (“Dow Corning”), in which the Company is a 50 percent shareholder, voluntarily filed for protection under Chapter 11 of the Bankruptcy Code to resolve litigation related to Dow Corning’s breast implant and other silicone medical products. On June 1, 2004, Dow Corning’s Joint Plan of Reorganization (the “Joint Plan”) became effective and Dow Corning emerged from bankruptcy. The Joint Plan contains release and injunction provisions resolving all tort claims brought against various entities, including the Company, involving Dow Corning’s breast implant and other silicone medical products.

To the extent not previously resolved in state court actions, cases involving Dow Corning’s breast implant and other silicone medical products filed against the Company were transferred to the U.S. District Court for the Eastern District of Michigan (the “District Court”) for resolution in the context of the Joint Plan. On October 6, 2005, all such cases then pending in the District Court against the Company were dismissed. Should cases involving Dow Corning’s breast implant and other silicone medical products be filed against the Company in the future, they will be accorded similar treatment. It is the opinion of the Company’s management that the possibility is remote that a resolution of all future cases will have a material adverse impact on the Company’s consolidated financial statements.

As part of the Joint Plan, Dow and Corning Incorporated agreed to provide a credit facility to Dow Corning in an aggregate amount of $300 million, which was reduced to $150 million effective June 1, 2011. The Company’s share of the credit facility was originally $150 million, but was reduced to $75 million effective June 1, 2011, and is subject to the terms and conditions stated in the Joint Plan. At June 30, 2011, no draws had been taken against the credit facility.

DBCP Matters

Numerous lawsuits have been brought against the Company and other chemical companies, both inside and outside of the United States, alleging that the manufacture, distribution or use of pesticides containing dibromochloropropane (“DBCP”) has caused personal injury and property damage, including contamination of groundwater. It is the opinion of the Company’s management that the possibility is remote that the resolution of such lawsuits will have a material adverse impact on the Company’s consolidated financial statements.

Environmental Matters

Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated, based on current law and existing technologies. At June 30, 2011, the Company had accrued obligations of $675 million for probable environmental remediation and restoration costs, including $66 million for the remediation of Superfund sites. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although the ultimate cost with respect to these particular matters could range up to approximately twice that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material adverse impact on the Company’s results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material adverse impact on the Company’s results of operations, financial condition and cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. At December 31, 2010, the Company had accrued obligations of $607 million for probable environmental remediation and restoration costs, including $59 million for the remediation of Superfund sites.

Midland Off-Site Environmental Matters

On June 12, 2003, the Michigan Department of Environmental Quality ("MDEQ") issued a Hazardous Waste Operating License (the “License”) to the Company’s Midland, Michigan manufacturing site (the “Midland site”), which included provisions requiring the Company to conduct an investigation to determine the nature and extent of off-site contamination in the City of Midland soils; the Tittabawassee River and Saginaw River sediment and floodplain soils; and the Saginaw Bay; and, if necessary, undertake remedial action.

City of Midland

Matters related to the City of Midland remain under the primary oversight of the State of Michigan (the “State”) under the License, and the Company and the State are in ongoing discussions regarding the implementation of the requirements of the License.

Tittabawassee and Saginaw Rivers, Saginaw Bay

The Company, the U.S. Environmental Protection Agency (“EPA”) and the State entered into an administrative order on consent (“AOC”), effective January 21, 2010, that requires the Company to conduct a remedial investigation, a feasibility study and a remedial design for the Tittabawassee River, the Saginaw River and the Saginaw Bay, and pay the oversight costs of the EPA and the State under the authority of the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA”). These actions, to be conducted under the lead oversight of the EPA, will build upon the investigative work completed under the State Resource Conservation Recovery Act (“RCRA”) program from 2005 through 2009. The Tittabawassee River, beginning at the Midland Site and extending down to the first six miles of the Saginaw River, are designated as the first Operable Unit for purposes of conducting the remedial investigation, feasibility study and remedial design work. This work will be performed in a largely upriver to downriver sequence for eight geographic segments of the Tittabawassee and upper Saginaw Rivers. The remainder of the Saginaw River and the Saginaw Bay are designated as a second Operable Unit and the work associated with that unit may also be geographically segmented. The AOC does not obligate the Company to perform removal or remedial action; that action can only be required by a separate order. The Company and the EPA will be negotiating orders separate from the AOC that will obligate the Company to perform remedial actions under the scope of work of the AOC and so far have entered into two separate orders to perform limited remedial actions to implement early actions.

Alternative Dispute Resolution Process

The Company; the EPA; the U.S. Department of Justice; and the natural resource damage trustees (the Michigan Office of the Attorney General; the MDEQ; the U.S. Fish and Wildlife Service; the U.S. Bureau of Indian Affairs and the Saginaw-Chippewa tribe), have been engaged in negotiations to seek to resolve potential governmental claims against the Company related to historical off-site contamination associated with the City of Midland, the Tittabawassee and Saginaw Rivers and the Saginaw Bay. The Company and the governmental parties started meeting in the fall of 2005 and entered into a Confidentiality Agreement in December 2005. The Company continues to conduct negotiations under the Federal Alternative Dispute Resolution Act with all of the governmental parties, except the EPA which withdrew from the alternative dispute resolution process on September 12, 2007.

On September 28, 2007, the Company and the natural resource damage trustees entered into a Funding and Participation Agreement that addressed the Company’s payment of past costs incurred by the natural resource damage trustees, payment of the costs of a trustee coordinator and a process to review additional cooperative studies that the Company might agree to fund or conduct with the natural resource damage trustees. On March 18, 2008, the Company and the natural resource damage trustees entered into a Memorandum of Understanding to provide a mechanism for the Company to fund cooperative studies related to the assessment of natural resource damages. On April 7, 2008, the natural resource damage trustees released their “Natural Resource Damage Assessment Plan for the Tittabawassee River System Assessment Area.”

At June 30, 2011, the accrual for these off-site matters was $39 million (included in the total accrued obligation of $675 million at June 30, 2011). At December 31, 2010, the Company had an accrual for these off-site matters of $32 million (included in the total accrued obligation of $607 million).

Asbestos-Related Matters of Union Carbide Corporation

Union Carbide Corporation (“Union Carbide”), a wholly owned subsidiary of the Company, is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past three decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

Influenced by the bankruptcy filings of numerous defendants in asbestos-related litigation and the prospects of various forms of state and national legislative reform, the rate at which plaintiffs filed asbestos-related suits against various companies, including Union Carbide and Amchem, increased in 2001, 2002 and the first half of 2003. Since then, the rate of filing has significantly abated. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

Based on a study completed by Analysis, Research & Planning Corporation (“ARPC”) in January 2003, Union Carbide increased its December 31, 2002 asbestos-related liability for pending and future claims for the 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. Since then, Union Carbide has compared current asbestos claim and resolution activity to the results of the most recent ARPC study at each balance sheet date to determine whether the accrual continues to be appropriate. In addition, Union Carbide has requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity each November since 2004 to determine the appropriateness of updating the most recent ARPC study.

In November 2009, Union Carbide requested ARPC to review Union Carbide’s 2009 asbestos claim and resolution activity and determine the appropriateness of updating its then most recent study completed in December 2008. In response to that request, ARPC reviewed and analyzed data through October 31, 2009. In December 2009, ARPC stated that an update of its study would not provide a more likely estimate of future events than the estimate reflected in its study of the previous year and, therefore, the estimate in that study remained applicable. Based on Union Carbide’s own review of the asbestos claim and resolution activity and ARPC’s response, Union Carbide determined that no change to the accrual was required. At December 31, 2009, Union Carbide’s asbestos-related liability for pending and future claims was $839 million.

In November 2010, Union Carbide requested ARPC to review Union Carbide’s historical asbestos claim and resolution activity and determine the appropriateness of updating its December 2008 study. In response to that request, ARPC reviewed and analyzed data through October 31, 2010. The resulting study, completed by ARPC in December 2010, stated that the undiscounted cost of resolving pending and future asbestos-related claims against Union Carbide and Amchem, excluding future defense and processing costs, through 2025 was estimated to be between $744 million and $835 million. As in its earlier studies, ARPC provided estimates for a longer period of time in its December 2010 study, but also reaffirmed its prior advice that forecasts for shorter periods of time are more accurate than those for longer periods of time.

In December 2010, based on ARPC’s December 2010 study and Union Carbide’s own review of the asbestos claim and resolution activity, Union Carbide decreased its asbestos-related liability for pending and future claims to $744 million, which covered the 15-year period ending 2025, excluding future defense and processing costs. The reduction was $54 million and was shown as “Asbestos-related credits” in the consolidated statements of income. At December 31, 2010, the asbestos-related liability for pending and future claims was $728 million. At December 31, 2010, approximately 21 percent of the recorded liability related to pending claims and approximately 79 percent related to future claims.

Based on Union Carbide’s review of 2011 activity, Union Carbide determined that no adjustment to the accrual was required at June 30, 2011. Union Carbide’s asbestos-related liability for pending and future claims was $703 million at June 30, 2011. Approximately 20 percent of the recorded liability related to pending claims and approximately 80 percent related to future claims.

At December 31, 2002, Union Carbide increased the receivable for insurance recoveries related to its asbestos liability to $1.35 billion, substantially exhausting its asbestos product liability coverage. The insurance receivable related to the asbestos liability was determined by Union Carbide after a thorough review of applicable insurance policies and the 1985 Wellington Agreement, to which Union Carbide and many of its liability insurers are signatory parties, as well as other insurance settlements, with due consideration given to applicable deductibles, retentions and policy limits, and taking into account the solvency and historical payment experience of various insurance carriers. The Wellington Agreement and other agreements with insurers are designed to facilitate an orderly resolution and collection of Union Carbide’s insurance policies and to resolve issues that the insurance carriers may raise.

In September 2003, Union Carbide filed a comprehensive insurance coverage case, now proceeding in the Supreme Court of the State of New York, County of New York, seeking to confirm its rights to insurance for various asbestos claims and to facilitate an orderly and timely collection of insurance proceeds (the “Insurance Litigation”). The Insurance Litigation was filed against insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place with Union Carbide regarding their asbestos-related insurance coverage, in order to facilitate an orderly resolution and collection of such insurance policies and to resolve issues that the insurance carriers may raise. Since the filing of the case, Union Carbide has reached settlements with several of the carriers involved in the Insurance Litigation, including settlements reached with two significant carriers in the fourth quarter of 2009. The Insurance Litigation is ongoing.

Union Carbide’s receivable for insurance recoveries related to its asbestos liability was $50 million at June 30, 2011 and $50 million at December 31, 2010. At June 30, 2011 and December 31, 2010, all of the receivable for insurance recoveries was related to insurers that are not signatories to the Wellington Agreement and/or do not otherwise have agreements in place regarding their asbestos-related insurance coverage.

In addition to the receivable for insurance recoveries related to its asbestos liability, Union Carbide had receivables for defense and resolution costs submitted to insurance carriers that have settlement agreements in place regarding their asbestos-related insurance coverage.

The following table summarizes Union Carbide’s receivables related to its asbestos-related liability:

Receivables for Asbestos-Related Costs In millions	Jun 30, 2011		Dec 31, 2010
Receivables for defense costs – carriers with settlement agreements	$	23	$	12
Receivables for resolution costs – carriers with settlement agreements	190		236
Receivables for insurance recoveries – carriers without settlement agreements	50		50
Total	$	263	$	298

Union Carbide expenses defense costs as incurred. The pretax impact for defense and resolution costs, net of insurance, was $15 million in the second quarter of 2011 ($22 million in the second quarter of 2010) and $28 million in the first six months of 2011 ($36 million in the first six months of 2010 ), and was reflected in “Cost of sales.”

After a review of its insurance policies, with due consideration given to applicable deductibles, retentions and policy limits, after taking into account the solvency and historical payment experience of various insurance carriers; existing insurance settlements; and the advice of outside counsel with respect to the applicable insurance coverage law relating to the terms and conditions of its insurance policies, Union Carbide continues to believe that its recorded receivable for insurance recoveries from all insurance carriers is probable of collection.

The amounts recorded by Union Carbide for the asbestos-related liability and related insurance receivable described above were based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of disposing of each such claim, coverage issues among insurers, and the continuing solvency of various insurance companies, as well as the numerous uncertainties surrounding asbestos litigation in the United States, could cause the actual costs and insurance recoveries for Union Carbide to be higher or lower than those projected or those recorded.

Because of the uncertainties described above, Union Carbide’s management cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. Union Carbide’s management believes that it is reasonably possible that the cost of disposing of Union Carbide’s asbestos-related claims, including future defense costs, could have a material adverse impact on Union Carbide’s results of operations and cash flows for a particular period and on the consolidated financial position of Union Carbide.

It is the opinion of Dow’s management that it is reasonably possible that the cost of Union Carbide disposing of its asbestos-related claims, including future defense costs, could have a material adverse impact on the Company’s results of operations and cash flows for a particular period and on the consolidated financial position of the Company.

Synthetic Rubber Industry Matters

In 2003, the U.S., Canadian and European competition authorities initiated separate investigations into alleged anticompetitive behavior by certain participants in the synthetic rubber industry. Certain subsidiaries of the Company (but as to the investigation in Europe only) have responded to requests for documents and are otherwise cooperating in the investigations.

On June 10, 2005, the Company received a Statement of Objections from the European Commission (the “EC”) stating that it believed that the Company and certain subsidiaries of the Company (the “Dow Entities”), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the butadiene rubber and emulsion styrene butadiene rubber businesses. In connection therewith, on November 29, 2006, the EC issued its decision alleging infringement of Article 81 of the Treaty of Rome and imposed a fine of Euro 64.575 million (approximately $85 million at that time) on the Dow Entities; several other companies were also named and fined. As a result, the Company recognized a loss contingency of $85 million related to the fine in the fourth quarter of 2006. The Company appealed the EC’s decision and a hearing was held before the Court of First Instance on October 13, 2009. On July 13, 2011, the General Court issued a decision that partly affirmed the EC's decision with regard to the amount of the fine and the liability of the parent company, but rejected the EC's decision regarding the length of the conspiracy and determined that it was of a shorter duration. The Dow Entities are considering whether to file a further appeal. Subsequent to the imposition of the fine in 2006, the Company and/or certain subsidiaries of the Company became named parties in various related U.S., United Kingdom and Italian civil actions. The U.S. matter was settled in March 2010 through a confidential settlement agreement, with an immaterial impact on the Company’s consolidated financial statements. The United Kingdom and Italian civil actions are still pending.

Additionally, on March 10, 2007, the Company received a Statement of Objections from the EC stating that it believed that DuPont Dow Elastomers L.L.C. (“DDE”), a former 50:50 joint venture with E.I. du Pont de Nemours and Company (“DuPont”), together with other participants in the synthetic rubber industry, engaged in conduct in violation of European competition laws with respect to the polychloroprene business. This Statement of Objections specifically names the Company, in its capacity as a former joint venture owner of DDE. On December 5, 2007, the EC announced its decision to impose a fine on the Company, among others, in the amount of Euro 48.675 million (approximately $70 million). The Company previously transferred its joint venture ownership interest in DDE to DuPont in 2005, and DDE then changed its name to DuPont Performance Elastomers L.L.C. (“DPE”). In February 2008, DuPont, DPE and the Company each filed an appeal of the December 5, 2007 decision of the EC. Based on the Company’s allocation agreement with DuPont, the Company’s share of this fine, regardless of the outcome of the appeals, will not have a material adverse impact on the Company’s consolidated financial statements.

Rohm and Haas Pension Plan Matters

In December 2005, a federal judge in the U.S. District Court for the Southern District of Indiana (the “District Court”) issued a decision granting a class of participants in the Rohm and Haas Pension Plan (the “Rohm and Haas Plan”) who had retired from Rohm and Haas, now a wholly owned subsidiary of the Company, and who elected to receive a lump sum benefit from the Rohm and Haas Plan, the right to a cost-of-living adjustment (“COLA”) as part of their retirement benefit. In August 2007, the Seventh Circuit Court of Appeals affirmed the District Court’s decision, and in March 2008, the U.S. Supreme Court denied the Rohm and Haas Plan’s petition to review the Seventh Circuit’s decision. The case was returned to the District Court for further proceedings. In October 2008 and February 2009, the District Court issued rulings that have the effect of including in the class all Rohm and Haas retirees who received a lump sum distribution without a COLA from the Rohm and Haas Plan since January 1976. These rulings are subject to appeal, and the District Court has not yet determined the amount of the COLA benefits that may be due to the class participants. The Rohm and Haas Plan and the plaintiffs entered into a settlement agreement that, in addition to settling the litigation with respect to the Rohm and Haas retirees, provides for the amendment of the complaint and amendment of the Rohm and Haas Plan to include active employees in the settlement benefits. The District Court preliminarily approved the settlement on November 24, 2009 and, following a hearing on March 12, 2010, issued a final order approving the settlement on April 12, 2010. A group of objectors to the settlement filed an appeal from the final order. In November 2010, the District Court issued an order approving class counsel’s fee award petition in an amount consistent with the terms of the settlement. The same objectors also appealed this order. Both appeals are pending.

A pension liability associated with this matter of $185 million was recognized as part of the acquisition of Rohm and Haas on April 1, 2009. The liability, which was determined in accordance with the accounting guidance for contingencies, recognized the estimated impact of the above described judicial decisions on the long-term Rohm and Haas Plan obligations owed to the applicable Rohm and Haas retirees and active employees. The Company had a liability associated with this matter of $186 million at June 30, 2011 and $186 million at December 31, 2010.

Other Litigation Matters

In addition to breast implant, DBCP, environmental and synthetic rubber industry matters, the Company is party to a number of other claims and lawsuits arising out of the normal course of business with respect to commercial matters, including product liability, governmental regulation and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. Dow has an active risk management program consisting of numerous insurance policies secured from many carriers at various times. These policies provide coverage that will be utilized to minimize the impact, if any, of the contingencies described above.

Summary

Except for the possible effect of Union Carbide’s asbestos-related liability described above, it is the opinion of the Company’s management that the possibility is remote that the aggregate of all claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company.

Purchase Commitments

The Company has numerous agreements for the purchase of ethylene-related products globally. The purchase prices are determined primarily on a cost-plus basis. Total purchases under these agreements were $714 million in 2010, $784 million in 2009 and $1,502 million in 2008. The Company’s take-or-pay commitments associated with these agreements at December 31, 2010 are included in the table below. There have been no material changes to purchase commitments since December 31, 2010.

The Company also has various commitments for take-or-pay and throughput agreements. Such commitments are at prices not in excess of current market prices. The terms of all but two of these agreements extend from one to 25 years. One agreement has terms extending to 35 years and another has terms extending to 80 years. The determinable future commitments for these agreements are included for 10 years in the following table which presents the fixed and determinable portion of obligations under the Company’s purchase commitments at December 31, 2010:

Fixed and Determinable Portion of Take-or-Pay and Throughput Obligations at December 31, 2010 In millions
2011	$	3,603
2012	3,261
2013	2,647
2014	2,055
2015	1,341
2016 - 2020	8,203
Total	$	21,110

In addition to the take-or-pay obligations at December 31, 2010, the Company had outstanding commitments which ranged from one to ten years for materials, services and other items used in the normal course of business of approximately $180 million. Such commitments were at prices not in excess of current market prices.

Guarantees

The Company provides a variety of guarantees as described more fully in the following sections.

Guarantees

Guarantees arise during the ordinary course of business from relationships with customers and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to ten years, and trade financing transactions in Latin America, which typically expire within one year of their inception. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered unlikely.

Residual Value Guarantees

The Company provides guarantees related to leased assets specifying the residual value that will be available to the lessor at lease termination through sale of the assets to the lessee or third parties.

The following tables provide a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for each type of guarantee:

Guarantees at June 30, 2011 In millions	Final Expiration	Maximum Future Payments (1)		Recorded   Liability
Guarantees	2020	$	503	$	41
Residual value guarantees	2021	432		20
Total guarantees		$	935	$	61

(1) The Company was indemnified by a third party for $57 million if required to perform under a $113 million guarantee.

Guarantees at December 31, 2010 In millions	Final Expiration	Maximum Future Payments (1)		Recorded   Liability
Guarantees	2020	$	445	$	80
Residual value guarantees	2020	391		17
Total guarantees		$	836	$	97

(1) The Company was indemnified by a third party for $53 million if required to perform under a $106 million guarantee.

Asset Retirement Obligations

The Company has recognized asset retirement obligations for the following activities: demolition and remediation activities at manufacturing sites in the United States, Canada, Brazil, Chile, China and Europe; capping activities at landfill sites in the United States, Canada, Brazil and Europe; and asbestos encapsulation as a result of planned demolition and remediation activities at manufacturing and administrative sites in the United States, Canada, Brazil, Chile, China and Europe.

The aggregate carrying amount of asset retirement obligations recognized by the Company was $101 million at June 30, 2011 and $99 million at December 31, 2010. The discount rate used to calculate the Company’s asset retirement obligations was 1.78 percent at June 30, 2011 and 1.78 percent at December 31, 2010. These obligations are included in the consolidated balance sheets as “Other noncurrent obligations.”

The Company has not recognized conditional asset retirement obligations for which a fair value cannot be reasonably estimated in its consolidated financial statements. It is the opinion of the Company’s management that the possibility is remote that such conditional asset retirement obligations, when estimable, will have a material adverse impact on the Company’s consolidated financial statements based on current costs.

XML



FAIR VALUE MEASUREMENTS (Basis of Fair Value Measurements on a Recurring Basis) (Details) (Fair Value, Measurements, Recurring [Member], USD $) In Millions	Jun. 30, 2011		Dec. 31, 2010
US Treasury and Government [Member] | Quoted Prices in Active Markets for Identical Items (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	$ 0	[1],[2]	$ 0	[1],[2]
Corporate Debt Securities [Member] | Quoted Prices in Active Markets for Identical Items (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	0	[1]	0	[1]
Equity Securities [Member] | Quoted Prices in Active Markets for Identical Items (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	639	[1]	556	[1]
Quoted Prices in Active Markets for Identical Items (Level 1) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest in trade accounts receivable conduits	0	[3]	0	[3]
Foreign currency	0	[4]	0	[4]
Commodities	16	[4]	12	[4]
Assets, Fair Value Disclosure	655		568
Foreign currency	0	[4]	0	[4]
Commodities	5	[4]	7	[4]
Liabilities, Fair Value Disclosure	5		7
US Treasury and Government [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	600	[1],[2]	641	[1],[2]
Corporate Debt Securities [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	738	[1]	831	[1]
Equity Securities [Member] | Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	38	[1]	36	[1]
Significant Other Observable Inputs (Level 2) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest in trade accounts receivable conduits	0	[3]	0	[3]
Foreign currency	37	[4]	86	[4]
Commodities	22	[4]	18	[4]
Assets, Fair Value Disclosure	1,435		1,612
Foreign currency	47	[4]	84	[4]
Commodities	16	[4]	17	[4]
Liabilities, Fair Value Disclosure	63		101
US Treasury and Government [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	0	[1],[2]	0	[1],[2]
Corporate Debt Securities [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	0	[1]	0	[1]
Equity Securities [Member] | Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	0	[1]	0	[1]
Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest in trade accounts receivable conduits	1,389	[3]	1,267	[3]
Foreign currency	0	[4]	0	[4]
Commodities	0	[4]	0	[4]
Assets, Fair Value Disclosure	1,389		1,267
Foreign currency	0	[4]	0	[4]
Commodities	0	[4]	0	[4]
Liabilities, Fair Value Disclosure	0		0
US Treasury and Government [Member] | Netting and Collateral [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	0	[1],[2],[5]	0	[1],[2],[5]
Corporate Debt Securities [Member] | Netting and Collateral [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	0	[1],[5]	0	[1],[5]
Equity Securities [Member] | Netting and Collateral [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	0	[1],[5]	0	[1],[5]
Netting and Collateral [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest in trade accounts receivable conduits	0	[3],[5]	0	[3],[5]
Foreign currency	(15)	[4],[5]	(46)	[4],[5]
Commodities	(22)	[4],[5]	(16)	[4],[5]
Assets, Fair Value Disclosure	(37)	[5]	(62)	[5]
Foreign currency	(15)	[4],[5]	(46)	[4],[5]
Commodities	(17)	[4],[5]	(20)	[4],[5]
Liabilities, Fair Value Disclosure	(32)	[5]	(66)	[5]
US Treasury and Government [Member] | Total Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	600	[1],[2]	641	[1],[2]
Corporate Debt Securities [Member] | Total Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	738	[1]	831	[1]
Equity Securities [Member] | Total Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities, Fair Value Disclosure	677	[1]	592	[1]
Total Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest in trade accounts receivable conduits	1,389	[3]	1,267	[3]
Foreign currency	22	[4]	40	[4]
Commodities	16	[4]	14	[4]
Assets, Fair Value Disclosure	3,442		3,385
Foreign currency	32	[4]	38	[4]
Commodities	4	[4]	4	[4]
Liabilities, Fair Value Disclosure	$ 36		$ 42

[1] The Company’s investments in equity and debt securities are primarily classified as available-for-sale and are included in “Other investments” in the consolidated balance sheets.

[2] U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

[3] Included in “Accounts and notes receivable – Other” in the consolidated balance sheets. See Note K for additional information on transfers of financial assets.

[4] See Note H for the classification of derivatives in the consolidated balance sheets.

[5] Cash collateral is classified as “Accounts and notes receivable – Other” in the consolidated balance sheets. Amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

XML



OPERATING SEGMENTS AND GEOGRAPHIC AREAS (Schedule of Operating Segments) (Details) (USD $) In Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010
Segment Reporting Information [Line Items]
Sales to external customers	$ 16,046		$ 13,618		$ 30,779		$ 27,035
Earnings before interest, taxes, depreciation and amortization	2,332	[1]	1,881	[1]	4,274	[1]	3,662	[1]
Equity in earnings of nonconsolidated affiliates	291		244		589		548
Electronic And Specialty Materials [Member]
Segment Reporting Information [Line Items]
Sales to external customers	1,450		1,278		2,796		2,457
Earnings before interest, taxes, depreciation and amortization	429	[1]	426	[1]	773	[1]	786	[1]
Equity in earnings of nonconsolidated affiliates	97		112		188		225
Coatings And Infrastructure [Member]
Segment Reporting Information [Line Items]
Sales to external customers	1,587		1,437		2,985		2,722
Earnings before interest, taxes, depreciation and amortization	231	[1]	230	[1]	419	[1]	368	[1]
Equity in earnings of nonconsolidated affiliates	0		1		0		2
Health and Agricultural Sciences [Member]
Segment Reporting Information [Line Items]
Sales to external customers	1,500		1,276		3,106		2,645
Earnings before interest, taxes, depreciation and amortization	287	[1]	196	[1]	693	[1]	580	[1]
Equity in earnings of nonconsolidated affiliates	0		(1)		3		1
Performance Systems [Member]
Segment Reporting Information [Line Items]
Sales to external customers	1,901		1,808		3,568		3,483
Earnings before interest, taxes, depreciation and amortization	260	[1]	225	[1]	467	[1]	430	[1]
Equity in earnings of nonconsolidated affiliates	(6)		2		(10)		2
Performance Products [Member]
Segment Reporting Information [Line Items]
Sales to external customers	3,157		2,754		6,060		5,543
Earnings before interest, taxes, depreciation and amortization	387	[1]	330	[1]	843	[1]	618	[1]
Equity in earnings of nonconsolidated affiliates	3		2		(3)		9
Plastics [Member]
Segment Reporting Information [Line Items]
Sales to external customers	3,274		2,993		6,272		6,015
Earnings before interest, taxes, depreciation and amortization	751	[1]	696	[1]	1,560	[1]	1,414	[1]
Equity in earnings of nonconsolidated affiliates	65		59		133		124
Chemicals and Energy [Member]
Segment Reporting Information [Line Items]
Sales to external customers	1,044		847		2,014		1,686
Earnings before interest, taxes, depreciation and amortization	282	[1]	100	[1]	573	[1]	220	[1]
Equity in earnings of nonconsolidated affiliates	130		54		274		152
Hydrocarbons [Member]
Segment Reporting Information [Line Items]
Sales to external customers	2,044		1,151		3,796		2,316
Earnings before interest, taxes, depreciation and amortization	0	[1]	(1)	[1]	0	[1]	(1)	[1]
Equity in earnings of nonconsolidated affiliates	8		20		19		44
Corporate [Member]
Segment Reporting Information [Line Items]
Sales to external customers	89		74		182		168
Earnings before interest, taxes, depreciation and amortization	(295)	[1]	(321)	[1]	(1,054)	[1]	(753)	[1]
Equity in earnings of nonconsolidated affiliates	$ (6)		$ (5)		$ (15)		$ (11)

[1] The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. A reconciliation of EBITDA to “Income Before Income Taxes” is provided below.

XML



VARIABLE INTEREST ENTITIES (Nonconsolidated Variable Interest Entity) (Details) (USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010
Variable Interest Entity [Line Items]
Investment in nonconsolidated affiliates	$ 3,469	$ 3,453
Variable Interest Entity, Not Primary Beneficiary [Member] | Acrylic Acid Joint Venture [Member]
Variable Interest Entity [Line Items]
Investment in nonconsolidated affiliates	$ 147	$ 144

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Synthetic Rubber Industry Matters) (Narrative) (Details)	1 Months Ended		3 Months Ended	1 Months Ended
	Dec. 31, 2007 Fine Issued Polychloroprene Business [Member] USD ($)	Dec. 31, 2007 Fine Issued Polychloroprene Business [Member] EUR (€)	Dec. 31, 2006 Synthetic Rubber Industry Matters [Member] USD ($)	Nov. 30, 2006 Fine Issued for Butadiene Rubber and Emulsion Styrene Butadiene Rubber Business [Member] USD ($)	Nov. 30, 2006 Fine Issued for Butadiene Rubber and Emulsion Styrene Butadiene Rubber Business [Member] EUR (€)
Loss Contingencies [Line Items]
Fine issued in connection with alleged violation of competition laws	$ 70,000,000	€ 48,675,000		$ 85,000,000	€ 64,575,000
Loss contingency			$ 85,000,000

XML



RESTRUCTURING

6 Months Ended

Jun. 30, 2011

Restructuring and Related Activities [Abstract]

RESTRUCTURING

RESTRUCTURING

2009 Restructuring

On June 30, 2009, the Company’s Board of Directors approved a restructuring plan related to the Company’s acquisition of Rohm and Haas Company (“Rohm and Haas”) as well as actions to advance the Company’s strategy and to respond to continued weakness in the global economy. The restructuring plan included the elimination of approximately 2,500 positions primarily resulting from synergies to be achieved as a result of the acquisition of Rohm and Haas. In addition, the plan included the shutdown of a number of manufacturing facilities. These actions were substantially complete at March 31, 2011. As a result of the restructuring activities, the Company recorded pretax restructuring charges of $677 million in the second quarter of 2009, consisting of asset write-downs and write-offs of $454 million, costs associated with exit or disposal activities of $68 million and severance costs of $155 million.

The severance component of the 2009 restructuring charges of $155 million was for the separation of approximately 2,500 employees under the terms of the Company’s ongoing benefit arrangements, primarily over two years. At December 31, 2010, severance of $149 million had been paid and a currency adjusted liability of $6 million remained for approximately 189 employees. In the first quarter of 2011, the remaining severance of $6 million was paid, bringing the program to a close.

The following table summarizes the 2011 activities related to the Company’s restructuring reserve:

2011 Activities Related to 2009 Restructuring In millions	Costs associated with Exit or Disposal Activities		Severance Costs			Total
Reserve balance at December 31, 2010	$	68	$	6		$	74
Cash payments	—		(6		)	(6		)
Reserve balance at March 31, 2011	$	68	$	—		$	68

The shutdowns related to the 2009 restructuring plan were substantially completed in the first quarter of 2011, with remaining liabilities primarily related to environmental remediation to be paid over time.

2010 Adjustments to the 2009 Restructuring Plan

In the first quarter of 2010, the Company recorded an additional $8 million charge to adjust the impairment of long-lived assets and other assets related to the United States Federal Trade Commission (“FTC”) required divestitures completed in the first quarter of 2010, and an additional $8 million charge related to the shutdown of a small manufacturing facility under the 2009 restructuring plan. The impact of these charges is shown as “Restructuring charges” in the consolidated statements of income and was reflected in the following operating segments: Electronic and Specialty Materials ($8 million), Coatings and Infrastructure ($5 million) and Performance Products ($3 million).

In the second quarter of 2010, the Company recorded additional restructuring charges of $13 million which included the write-off of other assets of $5 million, additional costs associated with exit or disposal activities of $7 million and additional severance of $1 million related to the FTC required divestitures that were included in the 2009 restructuring plan. The impact of these charges is shown as “Restructuring charges” in the consolidated statements of income and was reflected in Performance Products ($12 million) and Corporate ($1 million).

Restructuring Reserve Assumed from Rohm and Haas

Included in liabilities assumed in the April 1, 2009 acquisition of Rohm and Haas was a reserve for severance and employee benefits for the separation of employees under the terms of Rohm and Haas’ ongoing benefit arrangement. The separations resulted from plant shutdowns, production schedule adjustments, productivity improvements and reductions in support services. A currency adjusted liability of $12 million remained at December 31, 2010; $5 million for employees who had left the Company and would continue to receive annuity payments in early 2011, and $7 million for approximately 44 employees. In the first quarter of 2011, the Company decreased the restructuring reserve $6 million to adjust the reserve to the expected future severance payments. The impact of this adjustment is shown as “Cost of sales” in the consolidated statements of income and was reflected in Corporate. Severance payments of $7 million were made in the six-month period ended June 30, 2011, bringing the program to a close.

Restructuring Reserve Assumed from Rohm and Haas In millions	Severance Costs
Reserve balance at December 31, 2010	$	12
Cash payments	(7		)
Adjustments to reserve	(6		)
Foreign currency impact	1
Reserve balance at June 30, 2011	$	—

XML



VARIABLE INTEREST ENTITIES

6 Months Ended

Jun. 30, 2011

VARIABLE INTEREST ENTITIES [Abstract]

Variable Interest Entities Disclosure [Text Block]

VARIABLE INTEREST ENTITIES

Consolidated Variable Interest Entities

The Company holds variable interests in six joint ventures for which the Company is the primary beneficiary.

Three of the joint ventures are development stage enterprises, which will produce certain chemicals and provide certain services in Asia Pacific. The Company’s variable interest in these joint ventures relates to arrangements between the joint ventures and the Company, involving the majority of the output on take-or-pay terms with pricing ensuring a guaranteed return to the joint ventures.

Another joint venture will construct, own and operate a membrane chlor-alkali facility to be located at the Company’s Freeport, Texas integrated manufacturing complex. The Company’s variable interests relate to equity options between the partners and a cost-plus off-take arrangement involving proportional purchase commitments on take-or-pay terms and ensuring a guaranteed return to the joint venture. The Company will provide the joint venture with operation and maintenance services, utilities and raw materials; market the joint venture’s co-products; and toll convert the other partner’s proportional purchase commitments into ethylene dichloride. The joint venture is expected to begin operations in mid-2013.

The fifth joint venture was acquired through the acquisition of Rohm and Haas on April 1, 2009. This joint venture manufactures products in Japan for the semiconductor industry. Each joint venture partner holds several equivalent variable interests, with the exception of a royalty agreement held exclusively between the joint venture and the Company. In addition, the entire output of the joint venture is sold to the Company for resale to third-party customers.

The sixth joint venture is an existing ethylene storage joint venture located in Alberta, Canada. Previously accounted for as an equity method investment, the Company became the primary beneficiary upon execution of new storage cavern agreements in the second quarter of 2011. The Company's variable interests relate to arrangements involving a majority of the joint venture's storage capacity on take-or-pay terms with pricing ensuring a guaranteed return to the joint venture; and favorably priced leases provided to the joint venture. The Company provides the joint venture with operation and maintenance services and utilities.

The Company also holds a variable interest in an owner trust, for which the Company is the primary beneficiary. The owner trust leases an ethylene facility in The Netherlands to the Company, whereby substantially all of the rights and obligations of ownership are transferred to the Company. The Company’s variable interest in the owner trust relates to a residual value guarantee provided to the owner trust. Upon expiration of the lease, which matures in 2014, the Company may purchase the facility for an amount based on a fair market value determination. At June 30, 2011, the Company had provided to the owner trust a residual value guarantee of $363 million, which represents the Company’s maximum exposure to loss under the lease.

As the primary beneficiary of these variable interest enetities ("VIEs"), the entities’ assets, liabilities and results of operations are included in the Company’s consolidated financial statements. The other equity holders’ interests are reflected in “Net income attributable to noncontrolling interests” in the consolidated statements of income and “Noncontrolling interests” in the consolidated balance sheets. The following table summarizes the carrying amounts of the entities’ assets and liabilities included in the Company’s consolidated balance sheets at June 30, 2011 and December 31, 2010:

Assets and Liabilities of Consolidated VIEs In millions	Jun 30, 2011		Dec 31, 2010
Cash and cash equivalents (1)	$	107	$	145
Other current assets	135		83
Property	1,747		1,388
Other noncurrent assets	135		122
Total assets (2)	$	2,124	$	1,738
Current liabilities (nonrecourse 2011: $237; 2010: $190)	$	323	$	837
Long-term debt (nonrecourse 2011: $930; 2010: $167)	1,276		513
Other noncurrent liabilities (nonrecourse 2011: $77; 2010: $64)	77		64
Total liabilities	$	1,676	$	1,414

(1) Includes $2 million at June 30, 2011 restricted for the construction of a specific manufacturing facility.

(2) All assets were restricted at June 30, 2011 and December 31, 2010.

The Company holds a variable interest in an entity created in June 2010 to monetize accounts receivable of select European entities. The Company is the primary beneficiary of this entity as a result of holding subordinated notes while maintaining servicing responsibilities for the accounts receivable. The carrying amounts of assets and liabilities included in the Company’s consolidated balance sheets pertaining to this entity, were current assets of $186 million (zero restricted) at June 30, 2011 ($158 million, zero restricted, at December 31, 2010) and current liabilities of $1 million ($1 million nonrecourse) at June 30, 2011 ($1 million, $1 million nonrecourse, at December 31, 2010).

Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at June 30, 2011 and December 31, 2010 are adjusted for intercompany eliminations, parental guarantees and residual value guarantees.

Nonconsolidated Variable Interest Entity

The Company holds a variable interest in a joint venture accounted for under the equity method of accounting, acquired through the acquisition of Rohm and Haas on April 1, 2009. The joint venture manufactures crude acrylic acid in the United States and Germany on behalf of the Company and the other joint venture partner. The variable interest relates to a cost-plus arrangement between the joint venture and each joint venture partner. The Company is not the primary beneficiary, as a majority of the joint venture’s output is sold to the other joint venture partner, and therefore the entity is not consolidated. At June 30, 2011, the Company’s investment in the joint venture was $147 million ($144 million at December 31, 2010), classified as “Investment in nonconsolidated affiliates” in the consolidated balance sheets, representing the Company’s maximum exposure to loss.

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Asset Retirement Obligations) (Narrative) (Details) (USD $) In Millions, unless otherwise specified	Jun. 30, 2011	Dec. 31, 2010
Commitments and Contingencies Disclosure [Abstract]
Asset retirement obligation	$ 101	$ 99
Asset retirement obligation discount rate	1.78%	1.78%

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Purchase Commitments) (Table and Narrative) (Details) (USD $) In Millions	12 Months Ended
	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008
Materials Services and Other Items [Member]
Unrecorded Unconditional Purchase Obligation [Line Items]
Other outstanding purchase commitments	$ 180
Ethylene related products [Member]
Unrecorded Unconditional Purchase Obligation [Line Items]
Purchase commitments Ethylene related products	714	784	1,502
Fixed and determinable portion of obligations under purchase commitments, 2011	3,603
Fixed and determinable portion of obligations under purchase commitments, 2012	3,261
Fixed and determinable portion of obligations under purchase commitments, 2013	2,647
Fixed and determinable portion of obligations under purchase commitments, 2014	2,055
Fixed and determinable portion of obligations under purchase commitments, 2015	1,341
Fixed and determinable portion of obligations under purchase commitments, 2016 through 2020	8,203
Fixed and determinable portion of obligations under purchase commitments, total	$ 21,110

XML



OPERATING SEGMENTS AND GEOGRAPHIC AREAS (Tables)

6 Months Ended

Jun. 30, 2011

Segment Reporting [Abstract]

Schedule of Operating Segments

Operating Segments	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Sales by operating segment
Electronic and Specialty Materials	$	1,450		$	1,278		$	2,796		$	2,457
Coatings and Infrastructure	1,587			1,437			2,985			2,722
Health and Agricultural Sciences	1,500			1,276			3,106			2,645
Performance Systems	1,901			1,808			3,568			3,483
Performance Products	3,157			2,754			6,060			5,543
Plastics	3,274			2,993			6,272			6,015
Chemicals and Energy	1,044			847			2,014			1,686
Hydrocarbons	2,044			1,151			3,796			2,316
Corporate	89			74			182			168
Total	$	16,046		$	13,618		$	30,779		$	27,035
EBITDA (1) by operating segment
Electronic and Specialty Materials	$	429		$	426		$	773		$	786
Coatings and Infrastructure	231			230			419			368
Health and Agricultural Sciences	287			196			693			580
Performance Systems	260			225			467			430
Performance Products	387			330			843			618
Plastics	751			696			1,560			1,414
Chemicals and Energy	282			100			573			220
Hydrocarbons	—			(1		)	—			(1		)
Corporate	(295		)	(321		)	(1,054		)	(753		)
Total	$	2,332		$	1,881		$	4,274		$	3,662
Equity in earnings (losses) of nonconsolidated affiliates by operating segment (included in EBITDA)
Electronic and Specialty Materials	$	97		$	112		$	188		$	225
Coatings and Infrastructure	—			1			—			2
Health and Agricultural Sciences	—			(1		)	3			1
Performance Systems	(6		)	2			(10		)	2
Performance Products	3			2			(3		)	9
Plastics	65			59			133			124
Chemicals and Energy	130			54			274			152
Hydrocarbons	8			20			19			44
Corporate	(6		)	(5		)	(15		)	(11		)
Total	$	291		$	244		$	589		$	548

(1) The Company uses EBITDA (which Dow defines as earnings (i.e., "Net Income") before interest, income taxes, depreciation and amortization) as its measure of profit/loss for segment reporting purposes. EBITDA by operating segment includes all operating items relating to the businesses, except depreciation and amortization; items that principally apply to the Company as a whole are assigned to Corporate. A reconciliation of EBITDA to “Income Before Income Taxes” is provided below.

Reconciliation of EBITDA to Income Before Income Taxes

Reconciliation of EBITDA to “Income Before Income Taxes”	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
EBITDA	$	2,332	$	1,881	$	4,274	$	3,662
- Depreciation and amortization	697		734		1,428		1,491
+ Interest income	10		10		17		17
- Interest expense and amortization of debt discount	328		367		705		743
Income Before Income Taxes	$	1,317	$	790	$	2,158	$	1,445

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

Geographic Areas	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Sales by geographic area
United States	$	5,238	$	4,484	$	10,020	$	8,845
Europe, Middle East and Africa	5,713		4,721		11,071		9,468
Rest of World	5,095		4,413		9,688		8,722
Total	$	16,046	$	13,618	$	30,779	$	27,035

XML



NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Schedule of Long-Term Debt) (Details) (USD $) In Millions, unless otherwise specified	6 Months Ended	12 Months Ended
	Jun. 30, 2011	Dec. 31, 2010
Debt Instrument [Line Items]
Unamortized debt discount	$ (412)	$ (458)
Long-term debt due within one year	(661)	(1,755)
Long-Term Debt	18,511	20,605
Maturities of Long-term Debt [Abstract]
Long-term Debt, Maturities, Repayments of Principal in Next Twelve Months	614
Long-term Debt, Maturities, Repayments of Principal in Year Two	2,818
Long-term Debt, Maturities, Repayments of Principal in Year Three	675
Long-term Debt, Maturities, Repayments of Principal in Year Four	2,347
Long-term Debt, Maturities, Repayments of Principal in Year Five	1,437
Long-term Debt, Maturities, Repayments of Principal after Year Five	904
Final Maturity 2011 [Member]
Debt Instrument [Line Items]
Long-Term Debt	253	1,057
Average interest rate in period	2.52%	5.30%
Final Maturity 2012 [Member]
Debt Instrument [Line Items]
Long-Term Debt	2,159	2,154
Average interest rate in period	5.35%	5.33%
Final maturity 2013 [Member]
Debt Instrument [Line Items]
Long-Term Debt	395	389
Average interest rate in period	6.11%	6.05%
Final Maturity 2014 [Member]
Debt Instrument [Line Items]
Long-Term Debt	2,103	2,096
Average interest rate in period	7.29%	7.27%
Final maturity 2015 [Member]
Debt Instrument [Line Items]
Long-Term Debt	1,257	1,250
Average interest rate in period	5.92%	5.90%
Final maturity 2016 [Member]
Debt Instrument [Line Items]
Long-Term Debt	757	757
Average interest rate in period	2.57%	2.57%
Final maturity 2017 and thereafter [Member]
Debt Instrument [Line Items]
Long-Term Debt	9,020	10,503
Average interest rate in period	7.02%	6.78%
U.S. Dollar loans, Various Rates and Maturities [Member]
Debt Instrument [Line Items]
Long-Term Debt	227	20
Average interest rate in period	2.64%	1.67%
Foreign Currency Loans, Various Rates and Maturities [Member]
Debt Instrument [Line Items]
Long-Term Debt	1,551	998
Average interest rate in period	3.36%	2.95%
Medium-term Notes, Varying Maturities Through 2022 [Member]
Debt Instrument [Line Items]
Long-Term Debt	972	2,005
Average interest rate in period	5.53%	5.96%
Euro Medium-term Notes, Final Maturity 2011 [Member]
Debt Instrument [Line Items]
Long-Term Debt	0	665
Average interest rate in period	0.00%	4.63%
Pollution Control/Industrial Revenue Bonds, Varying Maturities Through 2038 [Member]
Debt Instrument [Line Items]
Long-Term Debt	872	907
Average interest rate in period	5.70%	5.68%
Capital Lease Obligations [Member]
Debt Instrument [Line Items]
Long-Term Debt	$ 18	$ 17

XML



GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)

6 Months Ended

Jun. 30, 2011

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill By Operating Segment

Goodwill	Electronic and Specialty Materials		Coatings and Infra- structure		Health and Ag Sciences		Perf Systems		Perf Products		Plastics		Hydro- carbons		Total
In millions
Net goodwill at Dec. 31, 2010	$	5,747	$	4,191	$	1,546	$	859	$	526	$	35	$	63	$	12,967
Foreign currency impact	45		51		—		10		6		—		—		112
Net goodwill at June 30, 2011	$	5,792	$	4,242	$	1,546	$	869	$	532	$	35	$	63	$	13,079

Other Intangible Assets

Other Intangible Assets	At June 30, 2011							At December 31, 2010
In millions	Gross Carrying Amount		Accumulated Amortization			Net		Gross Carrying Amount		Accumulated Amortization			Net
Intangible assets with finite lives:
Licenses and intellectual property	$	1,715	$	(536	)	$	1,179	$	1,733	$	(466	)	$	1,267
Patents	123		(99		)	24		121		(95		)	26
Software	1,034		(557		)	477		965		(506		)	459
Trademarks	694		(199		)	495		693		(168		)	525
Customer related	3,750		(635		)	3,115		3,647		(492		)	3,155
Other	145		(101		)	44		122		(78		)	44
Total other intangible assets, finite lives	$	7,461	$	(2,127	)	$	5,334	$	7,281	$	(1,805	)	$	5,476
IPR&D (1), indefinite lives	55		—			55		54		—			54
Total other intangible assets	$	7,516	$	(2,127	)	$	5,389	$	7,335	$	(1,805	)	$	5,530

(1) Purchased in-process research and development (“IPR&D”).

Schedule of Amortization Expense of Intangible Assets

Amortization Expense	Three Months Ended				Six Months Ended
In millions	Jun 30, 2011		Jun 30, 2010		Jun 30, 2011		Jun 30, 2010
Other intangible assets, excluding software	$	125	$	125	$	248	$	253
Software, included in “Cost of sales”	$	22	$	22	$	45	$	43

Schedule of Expected Amortization Expense [Table Text Block]

Estimated Amortization Expense In millions
2011	$	620
2012	$	561
2013	$	537
2014	$	514
2015	$	496
2016	$	486

XML



Consolidated Statements of Cash Flows (USD $) In Millions	6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Operating Activities
Net Income	$ 1,798	$ 1,211
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,428	1,491
Provision (Credit) for deferred income tax	(99)	51
Earnings of nonconsolidated affiliates less than (in excess of) dividends received	50	(143)
Pension contributions	(282)	(133)
Net (gain) loss on sales of investments	(35)	(34)
Net (gain) loss on sales of property, businesses and consolidated companies	(6)	131
Other net (gain) loss	0	10
Net (gain) loss on sale of ownership interest in nonconsolidated affiliates	(61)	0
Restructuring charges	0	29
Loss on early extinguishment of debt	482	0
Excess tax benefits from share-based payment arrangements	(14)	(3)
Changes in assets and liabilities, net of effects of acquired and divested companies:
Accounts and notes receivable	(2,721)	(1,336)
Proceeds from interests in trade accounts receivable conduits	1,224	867
Inventories	(1,651)	(598)
Accounts payable	653	395
Other assets and liabilities	(146)	(655)
Cash provided by (used in) operating activities	620	1,283
Investing Activities
Capital expenditures	(969)	(691)
Construction of assets pending sale / leaseback	(113)	0
Proceeds from sale / leaseback of assets	80	0
Proceeds from sales of property, businesses and consolidated companies	85	1,651
Acquisitions of businesses	(6)	(5)
Purchases of previously leased assets	0	(45)
Investments in consolidated companies, net of cash acquired	(120)	(120)
Investments in nonconsolidated affiliates	(45)	(76)
Distributions from nonconsolidated affiliates	27	20
Proceeds from sale of ownership interests in nonconsolidated affiliates	81	0
Change in restricted cash	0	211
Purchases of investments	(427)	(593)
Proceeds from sales and maturities of investments	503	585
Cash provided by (used in) investing activities	(904)	937
Financing Activities
Changes in short-term notes payable	(557)	(298)
Proceeds from notes payable	0	84
Payments on notes payable	0	(668)
Proceeds from issuance of long-term debt	946	325
Payments on long-term debt	(4,738)	(1,092)
Purchases of treasury stock	(19)	(13)
Proceeds from issuance of common stock	171	79
Proceeds from sales of common stock	98	69
Excess tax benefits from share-based payment arrangements	14	3
Contribution from noncontrolling interests	20	0
Distributions to noncontrolling interests	(22)	(5)
Dividends paid to stockholders	(512)	(506)
Cash provided by (used in) financing activities	(4,599)	(2,022)
Effect of Exchange Rate Changes on Cash	64	(22)
Cash Assumed in Initial Consolidation of Variable Interest Entities	3	46
Summary
Increase (Decrease) in cash and cash equivalents	(4,816)	222
Cash and cash equivalents at beginning of year	7,039	2,846
Cash and cash equivalents at end of period	$ 2,223	$ 3,068

XML



PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

6 Months Ended

Jun. 30, 2011

Compensation and Retirement Disclosure [Abstract]

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS

Net Periodic Benefit Cost for All Significant Plans	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Defined Benefit Pension Plans:
Service cost	$	86		$	77		$	172		$	156
Interest cost	282			273			560			549
Expected return on plan assets	(326		)	(302		)	(649		)	(606		)
Amortization of prior service cost	7			7			14			14
Amortization of net loss	94			67			186			134
Curtailment cost	—			8			—			8
Net periodic benefit cost	$	143		$	130		$	283		$	255
Other Postretirement Benefits:
Service cost	$	3		$	4		$	6		$	8
Interest cost	25			28			50			56
Expected return on plan assets	(1		)	(3		)	(2		)	(6		)
Curtailment cost	—			3			—			3
Net periodic benefit cost	$	27		$	32		$	54		$	61

As a result of the divestiture of Styron on June 17, 2010, the Company recognized a curtailment loss of $11 million and improved the funded status (plan assets less benefit obligations) by $99 million due to settlements, remeasurements and curtailments (see Note D).

XML



INVENTORIES (Schedule of Inventories) (Details) (USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010
Inventory Disclosure [Abstract]
Finished goods	$ 5,034	$ 4,289
Work in process	2,021	1,498
Raw materials	924	644
Supplies	760	656
Total inventories	8,739	7,087
Inventory, LIFO Reserve	$ 1,396	$ 1,003

XML



EARNINGS PER SHARE CALCULATIONS

6 Months Ended

Jun. 30, 2011

Earnings Per Share [Abstract]

EARNINGS PER SHARE CALCULATIONS

EARNINGS PER SHARE CALCULATIONS

The following tables provide the earnings per share calculations for the three-month and six-month periods ended June 30, 2011:

Net Income	Three Months Ended			Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2011
Net income	$	1,077		$	1,798
Net income attributable to noncontrolling interests	(10		)	(21		)
Net income attributable to The Dow Chemical Company	$	1,067		$	1,777
Preferred stock dividends	(85		)	(170		)
Net income attributable to participating securities (1)	(12		)	(20		)
Net income attributable to common stockholders	$	970		$	1,587

Earnings Per Share Calculations - Basic	Three Months Ended			Six Months Ended
Dollars per share	Jun 30, 2011			Jun 30, 2011
Net income	$	0.94		$	1.57
Net income attributable to noncontrolling interests	(0.01		)	(0.02		)
Net income attributable to The Dow Chemical Company	$	0.93		$	1.55
Preferred stock dividends	(0.08		)	(0.15		)
Net income attributable to participating securities (1)	(0.01		)	(0.01		)
Net income attributable to common stockholders	$	0.84		$	1.39

Earnings Per Share Calculations - Diluted	Three Months Ended			Six Months Ended
Dollars per share	Jun 30, 2011			Jun 30, 2011
Net income	$	0.93		$	1.56
Net income attributable to noncontrolling interests	(0.01		)	(0.02		)
Net income attributable to The Dow Chemical Company	$	0.92		$	1.54
Preferred stock dividends (2)	(0.07		)	(0.15		)
Net income attributable to participating securities (1)	(0.01		)	(0.02		)
Net income attributable to common stockholders	$	0.84		$	1.37

Shares in millions
Weighted-average common shares - basic	1,149.6	1,144.6
Plus dilutive effect of stock options and awards	11.3	11.6
Weighted-average common shares - diluted	1,160.9	1,156.2
Stock options and deferred stock awards excluded from EPS calculations (3)	42.8	43.0
Conversion of preferred stock excluded from EPS calculations (4)	96.8	96.8

(1) Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

(2) Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

(3) These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

(4) Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

The following tables provide the earnings per share calculations for the three-month and six-month periods ended June 30, 2010:

Net Income	Three Months Ended				Six Months Ended
In millions		Jun 30, 2010			Jun 30, 2010
Net income		$	659		$	1,211
Net income attributable to noncontrolling interests		(8		)	(9		)
Net income attributable to The Dow Chemical Company		$	651		$	1,202
Preferred stock dividends		(85		)	(170		)
Net income available for common stockholders		$	566		$	1,032

Earnings Per Share Calculations - Basic	Three Months Ended				Six Months Ended
Dollars per share		Jun 30, 2010			Jun 30, 2010
Net income		$	0.59		$	1.08
Net income attributable to noncontrolling interests		(0.01		)	(0.01		)
Net income attributable to The Dow Chemical Company		$	0.58		$	1.07
Preferred stock dividends		(0.08		)	(0.15		)
Net income available for common stockholders		$	0.50		$	0.92

Earnings Per Share Calculations - Diluted	Three Months Ended				Six Months Ended
Dollars per share		Jun 30, 2010			Jun 30, 2010
Net income		$	0.58		$	1.07
Net income attributable to noncontrolling interests		(0.01		)	(0.01		)
Net income attributable to The Dow Chemical Company		$	0.57		$	1.06
Preferred stock dividends (1)		(0.07		)	(0.15		)
Net income available for common stockholders		$	0.50		$	0.91

Shares in millions
Weighted-average common shares - basic	1,125.4	1,121.4
Plus dilutive effect of stock options and awards	16.2	16.9
Weighted-average common shares - diluted	1,141.6	1,138.3
Stock options and deferred stock awards excluded from EPS calculations (2)	49.1	47.3
Conversion of preferred stock excluded from EPS calculations (3)	96.8	96.8

(1) Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

(2) These outstanding options to purchase shares of common stock and deferred stock awards were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

(3) Conversion of the Cumulative Convertible Perpetual Preferred Stock, Series A into shares of the Company’s common stock was excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive.

XML



NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Extinguishment of Debt) (Details) (USD $) In Millions	6 Months Ended		0 Months Ended		6 Months Ended		3 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Mar. 22, 2011 Tender Offer of Long Term Debt [Member]	Mar. 22, 2011 Redemption of Notes [Member]	Jun. 30, 2011 Corporate [Member] InterNotes [Member]	Jun. 30, 2011 InterNotes [Member]	Mar. 31, 2011 Corporate [Member]
Extinguishment of Debt [Line Items]
Redemption of debt			$ 1,500	$ 1,500		$ 1,208
Loss on early extinguishment of debt	$ 482	$ 0			$ 10		$ 472

XML



TRANSFERS OF FINANCIAL ASSETS (Certain Cash Flows Between the Company and the Third-party Holders of the Participating Interests) (Details) (Asia Pacific [Member], USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010	Dec. 31, 2010
Asia Pacific [Member]
Tranfers of Financial Assets [Line Items]
Derecognized from the consolidated balance sheet	$ 18		$ 18		$ 25
Outstanding in the consolidated balance sheet	291		291		281
Total accounts receivable in select Asia Pacific entities	309		309		306
Sale of participating interests	41	53	87	102
Collections reinvested in revolving receivables	$ 34	$ 76	$ 79	$ 96

XML



Consolidated Statements of Equity (Parenthetical) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Retained Earnings
Dividends declared on common stock (Per share)	$ 0.25	$ 0.15	$ 0.40	$ 0.30

XML



FINANCIAL INSTRUMENTS

6 Months Ended

Jun. 30, 2011

Financial Instruments [Abstact]

Financial Instruments Text Block

FINANCIAL INSTRUMENTS

Investments

The Company’s investments in marketable securities are primarily classified as available-for-sale.

Investing Results	Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010
Proceeds from sales of available-for-sale securities	$	460		$	535
Gross realized gains	$	26		$	27
Gross realized losses	$	(7	)	$	(50	)

The following table summarizes the contractual maturities of the Company’s investments in debt securities:

Contractual Maturities of Debt Securities at June 30, 2011
In millions	Amortized Cost		Fair Value
Within one year	$	23	$	23
One to five years	534		582
Six to ten years	467		498
After ten years	213		235
Total	$	1,237	$	1,338

At June 30, 2011, the Company had $330 million of held-to-maturity securities (primarily Treasury Bills) classified as cash equivalents, as these securities had original maturities of three months or less ($3.2 billion at December 31, 2010). The Company’s investments in held-to-maturity securities are held at amortized cost, which approximates fair value. At June 30, 2011, the Company had investments in money market funds of $122 million classified as cash equivalents ($35 million at December 31, 2010).

The net unrealized gain recognized during the six-month period ended June 30, 2011 on trading securities held at June 30, 2011 was $13 million ($16 million during the six-month period ended June 30, 2010).

The following table provides the fair value and gross unrealized losses of the Company’s investments that were deemed to be temporarily impaired at June 30, 2011 and December 31, 2010, aggregated by investment category:

Temporarily Impaired Securities Less than 12 Months(1)
	At June 30, 2011					At December 31, 2010
In millions	Fair Value		Unrealized Losses			Fair Value		Unrealized Losses
Debt securities:
Government debt (2,3)	$	—	$	—		$	62	$	(2	)
Corporate bonds	32		(1		)	43		(1		)
Total debt securities	$	32	$	(1	)	$	105	$	(3	)
Equity securities	96		(8		)	52		(3		)
Total temporarily impaired securities	$	128	$	(9	)	$	157	$	(6	)

(1) Unrealized losses of 12 months or more were less than $1 million.

(2) Unrealized losses of less than 12 months were less than $1 million at June 30, 2011.

(3) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

Portfolio managers regularly review the Company’s holdings to determine if any investments are other-than-temporarily impaired. The analysis includes reviewing the amount of a temporary impairment, as well as the length of time it has been impaired. In addition, specific guidelines for each instrument type are followed to determine if an other-than-temporary impairment has occurred.

For debt securities, the credit rating of the issuer, current credit rating trends, the trends of the issuer’s overall sector, the ability of the issuer to pay expected cash flows and the length of time the security has been in a loss position are considered in determining whether unrealized losses represent an other-than-temporary impairment. The Company did not have any credit-related losses on debt securities during the six-month periods ended June 30, 2011 or June 30, 2010.

For equity securities, the Company’s investments are primarily in Standard & Poor’s (“S&P”) 500 companies; however, the Company’s policies allow investments in companies outside of the S&P 500. The largest holdings are Exchange Traded Funds that represent the S&P 500 index or an S&P sector or subset. The Company considers the evidence to support the recovery of the cost basis of a security including volatility of the stock, the length of time the security has been in a loss position, value and growth expectations, and overall market and sector fundamentals, as well as technical analysis, in determining whether unrealized losses represent an other-than-temporary impairment. In the six-month period ended June 30, 2011, other-than-temporary impairment write-downs on investments still held by the Company were $3 million ($4 million in the six-month period ended June 30, 2010).

The aggregate cost of the Company’s cost method investments totaled $171 million at June 30, 2011 and $171 million at December 31, 2010. Due to the nature of these investments, the fair market value is not readily determinable. These investments are reviewed for impairment indicators. In the six-month period ended June 30, 2011, the Company's impairment analysis identified indicators that resulted in no reduction in the cost basis of these investments ($20 million reduction in the six-month period ended June 30, 2010).

The following table summarizes the fair value of financial instruments at June 30, 2011 and December 31, 2010:

Fair Value of Financial Instruments
	At June 30, 2011											At December 31, 2010
In millions	Cost			Gain		Loss			Fair Value			Cost			Gain		Loss			Fair Value
Marketable securities: (1)
Debt securities:
Government debt (2)	$	560		$	40	$	—		$	600		$	603		$	40	$	(2	)	$	641
Corporate bonds	677			62		(1		)	738			760			72		(1		)	831
Total debt securities	$	1,237		$	102	$	(1	)	$	1,338		$	1,363		$	112	$	(3	)	$	1,472
Equity securities	585			100		(8		)	677			501			94		(3		)	592
Total marketable securities	$	1,822		$	202	$	(9	)	$	2,015		$	1,864		$	206	$	(6	)	$	2,064
Long-term debt incl. debt due within one year (3)	$	(19,172	)	$	79	$	(2,419	)	$	(21,512	)	$	(22,360	)	$	175	$	(2,530	)	$	(24,715	)
Derivatives relating to:
Foreign currency	$	—		$	22	$	(32	)	$	(10	)	$	—		$	40	$	(38	)	$	2
Commodities	$	—		$	16	$	(4	)	$	12		$	—		$	14	$	(4	)	$	10

(1) Included in “Other investments” in the consolidated balance sheets.

(2) U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.

(3) Cost includes fair value adjustments of $22 million at June 30, 2011 and $23 million at December 31, 2010.

Risk Management

Dow’s business operations give rise to market risk exposure due to changes in interest rates, foreign currency exchange rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies, which enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as cash flow, fair value or net foreign investment hedges where appropriate. The guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value. A secondary objective is to add value by creating additional nonspecific exposures within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Company’s results.

The Company’s risk management program for interest rate, foreign currency and commodity risks is based on fundamental, mathematical and technical models that take into account the implicit cost of hedging. Risks created by derivative instruments and the mark-to-market valuations of positions are strictly monitored at all times, using value at risk and stress tests. Counterparty credit risk arising from these contracts is not significant because the Company minimizes counterparty concentration, deals primarily with major financial institutions of solid credit quality, and the majority of its hedging transactions mature in less than three months. In addition, the Company minimizes concentrations of credit risk through its global orientation by transacting with large, internationally diversified financial counterparties. It is the Company’s policy not to have credit-risk-related contingent features in its derivative instruments. The Company does not anticipate losses from credit risk, and the net cash requirements arising from counterparty risk associated with risk management activities are not expected to be material in 2011. No significant concentration of counterparty credit risk existed at June 30, 2011.

The Company reviews its overall financial strategies and the impacts from using derivatives in its risk management program with the Company’s Board of Directors and revises its strategies as market conditions dictate.

Interest Rate Risk Management

The Company enters into various interest rate contracts with the objective of lowering funding costs or altering interest rate exposures related to fixed and variable rate obligations. In these contracts, the Company agrees with other parties to exchange, at specified intervals, the difference between fixed and floating interest amounts calculated on an agreed-upon notional principal amount. At June 30, 2011, the Company had no open interest rate swaps.

Foreign Currency Risk Management

The Company’s global operations require active participation in foreign exchange markets. The Company enters into foreign exchange forward contracts and options, and cross-currency swaps to hedge various currency exposures or create desired exposures. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. The primary business objective of the activity is to optimize the U.S. dollar value of the Company’s assets, liabilities and future cash flows with respect to exchange rate fluctuations. Assets and liabilities denominated in the same foreign currency are netted, and only the net exposure is hedged. At June 30, 2011, the Company had forward contracts, options and cross-currency swaps to buy, sell or exchange foreign currencies. These contracts had various expiration dates, primarily in the third quarter of 2011.

Commodity Risk Management

The Company has exposure to the prices of commodities in its procurement of certain raw materials. The primary purpose of commodity hedging activities is to manage the price volatility associated with these forecasted inventory purchases. At June 30, 2011, the Company had futures contracts, options and swaps to buy, sell or exchange commodities. These agreements had various expiration dates through 2012.

Accounting for Derivative Instruments and Hedging Activities

Cash Flow Hedges

For derivatives that are designated and qualify as cash flow hedging instruments, the effective portion of the gain or loss on the derivative is recorded in “Accumulated other comprehensive income (loss)” (“AOCI”); it is reclassified to “Cost of sales” in the same period or periods that the hedged transaction affects income. The unrealized amounts in AOCI fluctuate based on changes in the fair value of open contracts at the end of each reporting period. The Company anticipates volatility in AOCI and net income from its cash flow hedges. The amount of volatility varies with the level of derivative activities and market conditions during any period. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current period income.

The net loss from previously terminated interest rate cash flow hedges included in AOCI at June 30, 2011 was $1 million after tax ($2 million after tax at December 31, 2010). The Company had no open interest rate derivatives designated as cash flow hedges at June 30, 2011 or December 31, 2010.

Current open foreign currency forward contracts hedge the currency risk of forecasted feedstock purchase transactions until September 2011. The effective portion of the mark-to-market effects of the foreign currency forward contracts is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying feedstock purchase affects income. The net loss from the foreign currency hedges included in AOCI at June 30, 2011 was $5 million after tax ($4 million after tax at December 31, 2010). At June 30, 2011, the Company had open forward contracts with various expiration dates to buy, sell or exchange foreign currencies with a notional U.S. dollar equivalent of $203 million ($827 million at December 31, 2010).

Commodity swaps, futures and option contracts with maturities of not more than 36 months are utilized and designated as cash flow hedges of forecasted commodity purchases. Current open contracts hedge forecasted transactions until December 2011. The effective portion of the mark-to-market effect of the cash flow hedge instrument is recorded in AOCI; it is reclassified to income in the same period or periods that the underlying commodity purchase affects income. The net gain from commodity hedges included in AOCI at June 30, 2011 was $6 million after tax ($3 million after tax at December 31, 2010). At June 30, 2011 and December 31, 2010, the Company had the following aggregate notionals of outstanding commodity forward contracts to hedge forecasted purchases:

Commodity	Jun 30, 2011	Dec 31, 2010	Notional Volume Unit
Crude Oil	0.5	0.1	million barrels
Ethane	0.6	1.6	million barrels
Natural Gas	1.0	2.7	million million British thermal units

Fair Value Hedges

For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current period income and reflected as “Interest expense and amortization of debt discount” in the consolidated statements of income. The short-cut method is used when the criteria are met. The Company had no open interest rate swaps designated as fair value hedges of underlying fixed rate debt obligations at June 30, 2011 or December 31, 2010.

Net Foreign Investment Hedges

For derivative instruments that are designated and qualify as net foreign investment hedges, the effective portion of the gain or loss on the derivative is included in “Cumulative Translation Adjustments” in AOCI. The results of hedges of the Company’s net investment in foreign operations included in “Cumulative Translation Adjustments” in AOCI was a net loss of $67 million after tax at June 30, 2011 (net gain of $70 million after tax at December 31, 2010). At June 30, 2011 and December 31, 2010, the Company had no open forward contracts or outstanding options to buy, sell or exchange foreign currencies that were designated as net foreign investment hedges. At June 30, 2011, the Company had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $614 million ($1,250 million at December 31, 2010).

Other Derivative Instruments

The Company utilizes futures, options and swap instruments that are effective as economic hedges of commodity price exposures, but do not meet the hedge accounting criteria in the accounting guidance for derivatives and hedging. At June 30, 2011 and December 31, 2010, the Company had the following aggregate notionals of outstanding commodity contracts:

Commodity	Jun 30, 2011	Dec 31, 2010	Notional Volume Unit
Crude Oil	0.3	—	million barrels
Ethane	3.0	3.8	million barrels
Naphtha	60.0	—	kilotons
Natural Gas	9.1	12.0	million million British thermal units

The Company also uses foreign exchange forward contracts, options, and cross-currency swaps that are not designated as hedging instruments primarily to manage foreign currency exposure. The Company had open foreign exchange contracts with various expiration dates to buy, sell or exchange foreign currencies with a notional U.S. dollar equivalent of $12,925 million at June 30, 2011 ($13,944 million at December 31, 2010).

The following table provides the fair value and gross balance sheet classification of derivative instruments at June 30, 2011 and December 31, 2010:

Fair Value of Derivative Instruments In millions	Balance Sheet Classification	Jun 30, 2011		Dec 31, 2010
Asset Derivatives
Derivatives designated as hedges:
Foreign currency	Accounts and notes receivable – Other	$	—	$	9
Commodities	Other current assets (1)	5		7
Total derivatives designated as hedges		$	5	$	16
Derivatives not designated as hedges:
Foreign currency	Accounts and notes receivable – Other	$	37	$	77
Commodities	Other current assets (1)	33		23
Total derivatives not designated as hedges		$	70	$	100
Total asset derivatives		$	75	$	116
Liability Derivatives
Derivatives designated as hedges:
Foreign currency	Accounts payable – Other	$	3	$	20
Commodities	Accounts payable – Other	1		8
Total derivatives designated as hedges		$	4	$	28
Derivatives not designated as hedges:
Foreign currency	Accounts payable – Other	$	44	$	64
Commodities	Accounts payable – Other	20		16
Total derivatives not designated as hedges		$	64	$	80
Total liability derivatives		$	68	$	108

(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheet at December 31, 2010.

Effect of Derivative Instruments for the three months ended June 30, 2011 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	—		Interest expense (5)	$	(1	)	$	—
Cash flow:
Commodities	5			Cost of sales	6			—
Foreign currency	(5		)	Cost of sales	(19		)	—
Total derivatives designated as hedges	$	—			$	(14	)	$	—
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	42
Commodities	—			Cost of sales	—			(14		)
Total derivatives not designated as hedges	$	—			$	—		$	28
Total derivatives	$	—			$	(14	)	$	28
Effect of Derivative Instruments for the three months ended June 30, 2010 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	(1	)	Interest expense (5)	$	—		$	(1	)
Cash flow:
Commodities	(14		)	Cost of sales	(2		)	—
Foreign currency	10			Cost of sales	3			—
Net foreign investment:
Foreign currency	(17		)	n/a	—			—
Total derivatives designated as hedges	$	(22	)		$	1		$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	14
Commodities	—			Cost of sales	—			(3		)
Total derivatives not designated as hedges	$	—			$	—		$	11
Total derivatives	$	(22	)		$	1		$	10

(1) Accumulated other comprehensive income (loss) (“AOCI”).

(2) Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain (Loss) – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity.

(3) Pretax amounts.

(4) Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness.

(5) Interest expense and amortization of debt discount.

(6) Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities.

Effect of Derivative Instruments for the six months ended June 30, 2011  In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	—		Interest expense (5)	$	(1	)	$	(1	)
Cash flow:
Commodities	10			Cost of sales	11			—
Foreign currency	(16		)	Cost of sales	(17		)	—
Total derivatives designated as hedges	$	(6	)		$	(7	)	$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	41
Commodities	—			Cost of sales	—			(13		)
Total derivatives not designated as hedges	$	—			$	—		$	28
Total derivatives	$	(6	)		$	(7	)	$	27
Effect of Derivative Instruments for the six months ended June 30, 2010 In millions	Change in Unrealized Gain (Loss) in AOCI (1,2)			Income Statement Classification	Gain (Loss) Reclassified from AOCI to Income (3)			Additional Gain (Loss) Recognized in Income (3,4)
Derivatives designated as hedges:
Fair value:
Interest rates	$	(1	)	Interest expense (5)	$	—		$	(1	)
Cash flow:
Commodities	(18		)	Cost of sales	(4		)	—
Foreign currency	20			Cost of sales	(3		)	—
Net foreign investment:
Foreign currency	(20		)	n/a	—			—
Total derivatives designated as hedges	$	(19	)		$	(7	)	$	(1	)
Derivatives not designated as hedges:
Foreign currency (6)	$	—		Sundry income (expense) – net	$	—		$	113
Commodities	—			Cost of sales	—			(4		)
Total derivatives not designated as hedges	$	—			$	—		$	109
Total derivatives	$	(19	)		$	(7	)	$	108

(1) Accumulated other comprehensive income (loss) (“AOCI”).

(2) Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain (Loss) – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statements of equity.

(3) Pretax amounts.

(4) Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge ineffectiveness.

(5) Interest expense and amortization of debt discount.

(6) Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and liabilities.

The net after-tax amounts to be reclassified from AOCI to income within the next 12 months are a $1 million loss for interest rate contracts, a $6 million gain for commodity contracts and a $5 million loss for foreign currency contracts.

XML



FINANCIAL INSTRUMENTS (Schedule of Effect of Derivative Instruments) (Details) (USD $) In Millions	3 Months Ended				6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	$ 0	[1],[2]	$ (22)	[1],[2]	$ (6)	[1],[2]	$ (19)	[1],[2]
Gain (Loss) Reclassified From AOCI to Income	(14)	[3]	1	[3]	(7)	[3]	(7)	[3]
Additional Gain (Loss) Recognized in Income	28	[3],[4]	10	[3],[4]	27	[3],[4]	108	[3],[4]
Foreign Currency Contract [Member] | Scenario, Forecast [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months	(5)				(5)
Commodity Contract [Member] | Scenario, Forecast [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Price Risk Cash Flow Hedge Unrealized Gain (Loss) to be Reclassified During Next 12 Months	6				6
Interest Rate Contract [Member] | Scenario, Forecast [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net	(1)				(1)
Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	(5)	[1],[2]	10	[1],[2]	(16)	[1],[2]	20	[1],[2]
Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Cost of Sales [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified From AOCI to Income	(19)	[3]	3	[3]	(17)	[3]	(3)	[3]
Additional Gain (Loss) Recognized in Income	0	[3],[4]	0	[3],[4]	0	[3],[4]	0	[3],[4]
Foreign Currency Contract [Member] | Designated as Hedging Instrument [Member] | Net Foreign Investment [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI			(17)	[1],[2]			(20)	[1],[2]
Gain (Loss) Reclassified From AOCI to Income			0	[3]			0	[3]
Additional Gain (Loss) Recognized in Income			0	[3],[4]			0	[3],[4]
Commodity Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	5	[1],[2]	(14)	[1],[2]	10	[1],[2]	(18)	[1],[2]
Commodity Contract [Member] | Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | Cost of Sales [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified From AOCI to Income	6	[3]	(2)	[3]	11	[3]	(4)	[3]
Additional Gain (Loss) Recognized in Income	0	[3],[4]	0	[3],[4]	0	[3],[4]	0	[3],[4]
Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value Hedging [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	0	[1],[2]	(1)	[1],[2]	0	[1],[2]	(1)	[1],[2]
Interest Rate Contract [Member] | Designated as Hedging Instrument [Member] | Fair Value Hedging [Member] | Interest Expense [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified From AOCI to Income	(1)	[3],[5]	0	[3],[5]	(1)	[3],[5]	0	[3],[5]
Additional Gain (Loss) Recognized in Income	0	[3],[4],[5]	(1)	[3],[4],[5]	(1)	[3],[4],[5]	(1)	[3],[4],[5]
Designated as Hedging Instrument [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	0	[1],[2]	(22)	[1],[2]	(6)	[1],[2]	(19)	[1],[2]
Gain (Loss) Reclassified From AOCI to Income	(14)	[3]	1	[3]	(7)	[3]	(7)	[3]
Additional Gain (Loss) Recognized in Income	0	[3],[4]	(1)	[3],[4]	(1)	[3],[4]	(1)	[3],[4]
Foreign Currency Contract [Member] | Nondesignated [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	0	[1],[2],[6]	0	[1],[2],[6]	0	[1],[2],[6]	0	[1],[2],[6]
Foreign Currency Contract [Member] | Nondesignated [Member] | Sundry income - net [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified From AOCI to Income	0	[3],[6]	0	[3],[6]	0	[3],[6]	0	[3],[6]
Additional Gain (Loss) Recognized in Income	42	[3],[4],[6]	14	[3],[4],[6]	41	[3],[4],[6]	113	[3],[4],[6]
Commodity Contract [Member] | Nondesignated [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	0	[1],[2]	0	[1],[2]	0	[1],[2]	0	[1],[2]
Commodity Contract [Member] | Nondesignated [Member] | Cost of Sales [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Gain (Loss) Reclassified From AOCI to Income	0	[3]	0	[3]	0	[3]	0	[3]
Additional Gain (Loss) Recognized in Income	(14)	[3],[4]	(3)	[3],[4]	(13)	[3],[4]	(4)	[3],[4]
Nondesignated [Member]
Derivative Instruments, Gain (Loss) [Line Items]
Change in Unrealized Gain/ (Loss) Recognized in AOCI	0	[1],[2]	0	[1],[2]	0	[1],[2]	0	[1],[2]
Gain (Loss) Reclassified From AOCI to Income	0	[3]	0	[3]	0	[3]	0	[3]
Additional Gain (Loss) Recognized in Income	$ 28	[3],[4]	$ 11	[3],[4]	$ 28	[3],[4]	$ 109	[3],[4]

[1] Accumulated other comprehensive income (los

[2] Net unrealized gains/losses from hedges related to interest rates and commodities are included in “Accumulated Derivative Gain (Loss) – Net hedging results” in the consolidated statements of equity; net unrealized gains/losses from hedges related to foreign currency (net of tax) are included in “Cumulative Translation Adjustments – Translation adjustments” in the consolidated statement

[3] Pre

[4] Amounts impacting income not related to AOCI reclassification; also includes immaterial amounts of hedge inef

[5] Interest expense and amortization of de

[6] Foreign currency derivatives not designated as hedges are offset by foreign exchange gains/losses resulting from the underlying exposures of foreign currency denominated assets and

XML



COMMITMENTS AND CONTINGENT LIABILITIES (Environmental Matters) (Narrative) (Details) (USD $) In Millions	Jun. 30, 2011	Dec. 31, 2010
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 675	$ 607
Accrual For Environmental Loss Contingencies Midland Offsite Matters [Member]
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	39	32
Accrual For Environmental Loss Contingencies Superfund Sites [Member]
Loss Contingencies [Line Items]
Accrual for environmental loss contingencies	$ 66	$ 59

XML



NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Schedule of Notes Payable) (Details) (USD $) In Millions, unless otherwise specified	Jun. 30, 2011	Dec. 31, 2010
Notes Payable Long Term Debt and Available Credit Facilities [Line Items]
Notes payable to banks	$ 692	$ 1,310
Notes payable to related companies	208	157
Notes payable trade	16	0
Notes payable	$ 916	$ 1,467
Period-end average interest rates	3.06%	2.64%

XML



NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES (Tables)

6 Months Ended

Jun. 30, 2011

Debt Disclosure [Abstract]

Schedule of Short-term Debt [Table Text Block]

Notes Payable In millions	Jun 30, 2011			Dec 31, 2010
Notes payable to banks	$	692		$	1,310
Notes payable to related companies	208			157
Notes payable trade	16			—
Total notes payable	$	916		$	1,467
Period-end average interest rates	3.06		%	2.64		%

Schedule of Long-term Debt Instruments [Table Text Block]

Long-Term Debt In millions	2011 Average Rate		Jun 30, 2011			2010 Average Rate		Dec 31, 2010
Promissory notes and debentures:
Final maturity 2011	2.52	%	$	253		5.30	%	$	1,057
Final maturity 2012	5.35	%	2,159			5.33	%	2,154
Final maturity 2013	6.11	%	395			6.05	%	389
Final maturity 2014	7.29	%	2,103			7.27	%	2,096
Final maturity 2015	5.92	%	1,257			5.90	%	1,250
Final maturity 2016	2.57	%	757			2.57	%	757
Final maturity 2017 and thereafter	7.02	%	9,020			6.78	%	10,503
Other facilities:
U.S. dollar loans, various rates and maturities	2.64	%	227			1.67	%	20
Foreign currency loans, various rates and maturities	3.36	%	1,551			2.95	%	998
Medium-term notes, varying maturities through 2022	5.53	%	972			5.96	%	2,005
Euro medium-term notes, final maturity 2011	—		—			4.63	%	665
Pollution control/industrial revenue bonds, varying maturities through 2038	5.70	%	872			5.68	%	907
Capital lease obligations	—		18			—		17
Unamortized debt discount	—		(412		)	—		(458		)
Long-term debt due within one year	—		(661		)	—		(1,755		)
Total long-term debt	—		$	18,511		—		$	20,605

Schedule of Maturities of Long-term Debt [Table Text Block]

Annual Installments on Long-Term Debt For Next Five Years at June 30, 2011 In millions
2011	$	614
2012	$	2,818
2013	$	675
2014	$	2,347
2015	$	1,437
2016	$	904

XML



NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

6 Months Ended

Jun. 30, 2011

Debt Disclosure [Abstract]

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES

Notes Payable In millions	Jun 30, 2011			Dec 31, 2010
Notes payable to banks	$	692		$	1,310
Notes payable to related companies	208			157
Notes payable trade	16			—
Total notes payable	$	916		$	1,467
Period-end average interest rates	3.06		%	2.64		%

Long-Term Debt In millions	2011 Average Rate		Jun 30, 2011			2010 Average Rate		Dec 31, 2010
Promissory notes and debentures:
Final maturity 2011	2.52	%	$	253		5.30	%	$	1,057
Final maturity 2012	5.35	%	2,159			5.33	%	2,154
Final maturity 2013	6.11	%	395			6.05	%	389
Final maturity 2014	7.29	%	2,103			7.27	%	2,096
Final maturity 2015	5.92	%	1,257			5.90	%	1,250
Final maturity 2016	2.57	%	757			2.57	%	757
Final maturity 2017 and thereafter	7.02	%	9,020			6.78	%	10,503
Other facilities:
U.S. dollar loans, various rates and maturities	2.64	%	227			1.67	%	20
Foreign currency loans, various rates and maturities	3.36	%	1,551			2.95	%	998
Medium-term notes, varying maturities through 2022	5.53	%	972			5.96	%	2,005
Euro medium-term notes, final maturity 2011	—		—			4.63	%	665
Pollution control/industrial revenue bonds, varying maturities through 2038	5.70	%	872			5.68	%	907
Capital lease obligations	—		18			—		17
Unamortized debt discount	—		(412		)	—		(458		)
Long-term debt due within one year	—		(661		)	—		(1,755		)
Total long-term debt	—		$	18,511		—		$	20,605

Annual Installments on Long-Term Debt For Next Five Years at June 30, 2011 In millions
2011	$	614
2012	$	2,818
2013	$	675
2014	$	2,347
2015	$	1,437
2016	$	904

On March 22, 2011, the Company concluded cash tender offers for $1.5 billion aggregate principal amount of certain notes issued by the Company. As a result of the tender offers, the Company redeemed $1.5 billion of the notes and recognized a $472 million pretax loss on early extinguishment of debt, included in “Sundry income (expense) – net” in the consolidated statements of income and reflected in Corporate.

In addition to the redemption of $800 million of notes that matured on February 1, 2011 and the redemption of Euro 500 million of notes that matured on May 27, 2011 ($707 million equivalent at March 31, 2011), the Company redeemed $1,208 million of InterNotes in the first six months of 2011 and recognized a $10 million pretax loss on early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and reflected in Corporate. The Company has also announced the planned redemption of $330 million of InterNotes in the third quarter of 2011, which is included in “Long-term debt due within one year.” In the second quarter of 2011, the Company issued $175 million of InterNotes.

The Company’s outstanding debt of $19.2 billion has been issued under indentures which contain, among other provisions, covenants with which the Company must comply while the underlying notes are outstanding. Such covenants include obligations to not allow liens on principal U.S. manufacturing facilities, enter into sale and lease-back transactions with respect to principal U.S. manufacturing facilities, or merge or consolidate with any other corporation, or sell or convey all or substantially all of the Company’s assets. The outstanding debt also contains customary default provisions. Failure of the Company to comply with any of these covenants could result in a default under the applicable indenture, which would allow the note holders to accelerate the due date of the outstanding principal and accrued interest on the subject notes.

The Company’s primary credit agreements contain covenant and default provisions in addition to the covenants set forth above with respect to the Company’s debt. Significant other covenants and default provisions related to these agreements include:

(a) the obligation to maintain the ratio of the Company’s consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Three Year Competitive Advance and Revolving Credit Facility Agreement dated June 4, 2010 exceeds $500 million,

(b) a default if the Company or an applicable subsidiary fails to make any payment on indebtedness of $50 million or more when due, or any other default under the applicable agreement permits the acceleration of $200 million or more of principal, or results in the acceleration of $100 million or more of principal, and

(c) a default if the Company or any applicable subsidiary fails to discharge or stay within 30 days after the entry of a final judgment of more than $200 million.

Failure of the Company to comply with any of the covenants or default provisions could result in a default under the applicable credit agreement which would allow the lenders to not fund future loan requests and to accelerate the due date of the outstanding principal and accrued interest on any outstanding loans.

At June 30, 2011, management believes the Company was in compliance with all of the covenants and default provisions referred to above.

XML



Consolidated Statements of Income (USD $) In Millions, except Per Share data	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Net Sales	$ 16,046	$ 13,618	$ 30,779	$ 27,035
Cost of sales	13,551	11,580	25,668	23,121
Research and development expenses	411	407	811	814
Selling, general and administrative expenses	695	648	1,395	1,310
Amortization of intangibles	125	125	248	253
Restructuring charges	0	13	0	29
Acquisition and integration related expenses	0	37	31	63
Equity in earnings of nonconsolidated affiliates	291	244	589	548
Sundry income (expense) - net	80	95	(369)	178
Interest income	10	10	17	17
Interest expense and amortization of debt discount	328	367	705	743
Income Before Income Taxes	1,317	790	2,158	1,445
Provision for income taxes	240	131	360	234
Net Income	1,077	659	1,798	1,211
Net income attributable to noncontrolling interests	10	8	21	9
Net Income attributable to The Dow Chemical Company	1,067	651	1,777	1,202
Preferred stock dividends	85	85	170	170
Net Income Available for The Dow Chemical Company Common Stockholders	982	566	1,607	1,032
Per Common Share Data:
Earnings per common share - basic	$ 0.84	$ 0.50	$ 1.39	$ 0.92
Earnings per common share - diluted	$ 0.84	$ 0.50	$ 1.37	$ 0.91
Common stock dividends declared per share of common stock	$ 0.25	$ 0.15	$ 0.40	$ 0.30
Weighted-average common shares outstanding - basic	1,149.6	1,125.4	1,144.6	1,121.4
Weighted-average common shares outstanding - diluted	1,160.9	1,141.6	1,156.2	1,138.3
Depreciation	526	571	1,085	1,162
Capital Expenditures	$ 564	$ 397	$ 969	$ 691

XML



PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Tables)

6 Months Ended

Jun. 30, 2011

Compensation and Retirement Disclosure [Abstract]

Schedule of Defined Benefit Plans Disclosures [Table Text Block]

Net Periodic Benefit Cost for All Significant Plans	Three Months Ended						Six Months Ended
In millions	Jun 30, 2011			Jun 30, 2010			Jun 30, 2011			Jun 30, 2010
Defined Benefit Pension Plans:
Service cost	$	86		$	77		$	172		$	156
Interest cost	282			273			560			549
Expected return on plan assets	(326		)	(302		)	(649		)	(606		)
Amortization of prior service cost	7			7			14			14
Amortization of net loss	94			67			186			134
Curtailment cost	—			8			—			8
Net periodic benefit cost	$	143		$	130		$	283		$	255
Other Postretirement Benefits:
Service cost	$	3		$	4		$	6		$	8
Interest cost	25			28			50			56
Expected return on plan assets	(1		)	(3		)	(2		)	(6		)
Curtailment cost	—			3			—			3
Net periodic benefit cost	$	27		$	32		$	54		$	61

XML



EARNINGS PER SHARE CALCULATIONS (Earnings Per Share Calculation - Diluted) (Details) (USD $)	3 Months Ended				6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010
Earnings Per Share [Abstract]
Net income	$ 0.93		$ 0.58		$ 1.56		$ 1.07
Net income attributable to noncontrolling interests	$ (0.01)		$ (0.01)		$ (0.02)		$ (0.01)
Net income attributable to The Dow Chemical Company	$ 0.92		$ 0.57		$ 1.54		$ 1.06
Preferred stock dividends (1)	$ (0.07)	[1]	$ (0.07)	[1]	$ (0.15)	[1]	$ (0.15)	[1]
Undistributed Earnings Allocated to Participating Securities Per Diluted Share	$ (0.01)	[2]			$ (0.02)	[2]
Net income available for common stockholders	$ 0.84		$ 0.50		$ 1.37		$ 0.91

[1] Preferred stock dividends were not added back in the calculation of diluted earnings per share because the effect of adding them back would have been antidilutive.

[2] Accounting Standards Codification Topic 260, "Earnings per Share," requires enterprises with participating securities to use the two-class method to calculate earnings per share and to report the most dilutive earnings per share amount. Deferred stock awards are considered participating securities due to Dow's practice of paying dividend equivalents on unvested shares. The impact on earnings per share in 2010 using the two-class method was immaterial.

XML



PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS (Net Periodic Benefit Cost and Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive Income for All Significant Plans) (Details) (USD $) In Millions	1 Months Ended		3 Months Ended		6 Months Ended		3 Months Ended		6 Months Ended
	Jun. 30, 2010 Styron [Member]	Jun. 17, 2010 Styron [Member]	Jun. 30, 2011 Defined Benefit Pension Plans [Member]	Jun. 30, 2010 Defined Benefit Pension Plans [Member]	Jun. 30, 2011 Defined Benefit Pension Plans [Member]	Jun. 30, 2010 Defined Benefit Pension Plans [Member]	Jun. 30, 2011 Other Postretirement Benefits [Member]	Jun. 30, 2010 Other Postretirement Benefits [Member]	Jun. 30, 2011 Other Postretirement Benefits [Member]	Jun. 30, 2010 Other Postretirement Benefits [Member]
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Service cost			$ 86	$ 77	$ 172	$ 156	$ 3	$ 4	$ 6	$ 8
Interest cost			282	273	560	549	25	28	50	56
Expected return on plan assets			(326)	(302)	(649)	(606)	(1)	(3)	(2)	(6)
Amortization of prior service cost (credit)			7	7	14	14
Amortization of net loss			94	67	186	134
Curtailment Cost	11		0	8	0	8	0	3	0	3
Net periodic benefit cost			143	130	283	255	27	32	54	61
Defined Benefit Plan, Effect of Settlements and Curtailments on Accumulated Benefit Obligation		$ 99

XML



GOODWILL AND OTHER INTANGIBLE ASSETS (Schedule of Future Amortization Expense of Intangible Assets) (Details) (USD $) In Millions	6 Months Ended
	Jun. 30, 2011
Goodwill and Intangible Assets Disclosure [Abstract]
Estimated Amortization Expense, 2011	$ 620
Estimated Amortization Expense, 2012	561
Estimated Amortization Expense, 2013	537
Estimated Amortization Expense, 2014	514
Estimated Amortization Expense, 2015	496
Estimated Amortization Expense, 2016	$ 486

XML



FAIR VALUE MEASUREMENTS (Additional Information) (Details) (USD $) In Millions, unless otherwise specified	6 Months Ended			6 Months Ended	12 Months Ended	3 Months Ended				6 Months Ended				3 Months Ended				6 Months Ended				3 Months Ended				6 Months Ended
	Jun. 30, 2010	Jun. 30, 2011	Dec. 31, 2010	Jun. 30, 2011 North America [Member]	Dec. 31, 2010 North America [Member]	Jun. 30, 2011 North America [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2010 North America [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2011 North America [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2010 North America [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2011 Europe [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2010 Europe [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2011 Europe [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2010 Europe [Member] Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2011 Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2010 Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2011 Significant Unobservable Inputs (Level 3) [Member]		Jun. 30, 2010 Significant Unobservable Inputs (Level 3) [Member]
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at beginning of period, fair value measurements using Level 3 inputs																						$ 1,343	[1]	$ 1,224	[1]	$ 1,267	[1]	$ 0	[1]
Gain (Loss) included in earnings, fair value measurements using Level 3 inputs																						3	[1],[2]	9	[1],[2]	(5)	[1],[2]	9	[1],[2]
Purchases, fair value measurements using Level 3 inputs						161	[1]	181	[1]	1,098	[1]	1,933	[1]	116	[1]	144	[1]	253	[1]	144	[1]
Settlements, fair value measurements using Level 3 inputs						(98)	[1]	(352)	[1]	(1,000)	[1]	(880)	[1]	(136)	[1]	0	[1]	(224)	[1]	0	[1]
Balance at end of period, fair value measurements using Level 3 inputs																						1,389	[1]	1,206	[1]	1,389	[1]	1,206	[1]
Derivative, Collateral, Obligation to Return Cash		6	4
Derivative, Fair Value, Amount Offset Against Collateral, Net		5	4
Unrealized gains (losses) related to derivatives under a master netting arrangement		$ 11
Anticipated credit losses in the portfolio of receivables sold that have not yet been collected	0.00%			1.38%	1.42%

[1] Included in “Accounts and notes receivable – Other” in the consolidated balance sheets.

[2] Included in “Selling, general and administrative expenses” in the consolidated statements of income.

XML



TRANSFERS OF FINANCIAL ASSETS (Certain Cash Flows Between the Company and the European Conduits) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended				6 Months Ended
	Jun. 30, 2011		Jun. 30, 2010		Jun. 30, 2011		Jun. 30, 2010		Dec. 31, 2010
Tranfers of Financial Assets [Line Items]
Anticipated credit losses in the portfolio of receivables sold that have not yet been collected							0.00%
Interests in conduits					$ 1,224		$ 867
Europe [Member]
Tranfers of Financial Assets [Line Items]
Carrying value of interests held	185				185				157
Europe [Member] | Trade Accounts Receivable [Member]
Tranfers of Financial Assets [Line Items]
Loss from sale of transferred financial assets	(2)				2
Sale of receivables	2		512		3		512
Collections reinvested in revolving receivables	2,197		167		4,059		167
Interests in conduits	136	[1]	0	[1]	224	[1]	0	[1]
Trade accounts receivable outstanding and derecognized from the consolidated balance sheet	479				479				405
Delinquencies on sold receivables that were outstanding at the end of the period	$ 21				$ 21				$ 42

[1] Presented in "Operating Activities" in the consolidated statements of cash flows.

XML



NONCONSOLIDATED AFFILIATES (Details) (Dow Corning Corporation [Member], USD $) In Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2011	Jun. 30, 2010	Jun. 30, 2011	Jun. 30, 2010
Dow Corning Corporation [Member]
Equity Method Investment, Financial Statement, Reported Amounts [Abstract]
Sales (at 100 percent)	$ 1,668	$ 1,545	$ 3,247	$ 2,898
Gross profit (at 100 percent)	533	554	1,072	1,060
Net income attributable to Dow Corning Corporation (at 100 percent)	$ 191	$ 221	$ 370	$ 439

XML



GOODWILL AND OTHER INTANGIBLE ASSETS (Goodwill By Operating Segment) (Details) (USD $) In Millions	6 Months Ended
	Jun. 30, 2011
Goodwill [Roll Forward]
Net goodwill, beginning balance	$ 12,967
Foreign currency impact	112
Net goodwill, ending balance	13,079
Electronic And Specialty Materials [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	5,747
Foreign currency impact	45
Net goodwill, ending balance	5,792
Coatings And Infrastructure [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	4,191
Foreign currency impact	51
Net goodwill, ending balance	4,242
Health and Agricultural Sciences [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	1,546
Foreign currency impact	0
Net goodwill, ending balance	1,546
Performance Systems [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	859
Foreign currency impact	10
Net goodwill, ending balance	869
Performance Products [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	526
Foreign currency impact	6
Net goodwill, ending balance	532
Plastics [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	35
Foreign currency impact	0
Net goodwill, ending balance	35
Hydrocarbons [Member]
Goodwill [Roll Forward]
Net goodwill, beginning balance	63
Foreign currency impact	0
Net goodwill, ending balance	$ 63

XML



FINANCIAL INSTRUMENTS (Schedule of Fair Values of Derivative Instruments) (Details) (USD $) In Millions	Jun. 30, 2011		Dec. 31, 2010
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	$ 75		$ 116
Derivative liability, fair value	68		108
Foreign Currency Contract [Member] | Accounts and Notes Receivable - Other [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	0		9
Foreign Currency Contract [Member] | Accounts and Notes Receivable - Other [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	37		77
Commodity Contract [Member] | Other Current Assets [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	5	[1]	7	[1]
Commodity Contract [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	33	[1]	23	[1]
Foreign Currency Contract [Member] | Accounts Payable - Other [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	3		20
Foreign Currency Contract [Member] | Accounts Payable - Other [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	44		64
Commodity Contract [Member] | Accounts Payable - Other [Member] | Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	1		8
Commodity Contract [Member] | Accounts Payable - Other [Member] | Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	20		16
Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	5		16
Derivative liability, fair value	4		28
Not Designated as Hedging Instrument [Member]
Derivatives, Fair Value [Line Items]
Derivative asset, fair value	70		100
Derivative liability, fair value	$ 64		$ 80

[1] Fair Value of Derivative InstrumentsIn millionsBalance Sheet Classification Jun 30, 2011 Dec 31, 2010Asset Derivatives     Derivatives designated as hedges:     Foreign currencyAccounts and notes receivable – Other $— $9CommoditiesOther current assets (1) 5 7Total derivatives designated as hedges  $5 $16Derivatives not designated as hedges:     Foreign currencyAccounts and notes receivable – Other $37 $77CommoditiesOther current assets (1) 33 23Total derivatives not designated as hedges  $70 $100Total asset derivatives  $75 $116Liability Derivatives     Derivatives designated as hedges:     Foreign currencyAccounts payable – Other $3 $20CommoditiesAccounts payable – Other 1 8Total derivatives designated as hedges  $4 $28Derivatives not designated as hedges:     Foreign currencyAccounts payable – Other $44 $64CommoditiesAccounts payable – Other 20 16Total derivatives not designated as hedges  $64 $80Total liability derivatives  $68 $108(1) Included in “Accounts and notes receivable – Other” in the consolidated balance sheet at December 31, 2010

XML



STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2011

Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]

Schedule of Unrecognized Compensation Cost, Nonvested Awards [Table Text Block]

Total Unrecognized Compensation Cost at June 30, 2011
In millions	Unrecognized Compensation Cost		Weighted-average Recognition Period (Years)
ESPP purchase rights	$	25	0.38
Unvested stock options	$	89	0.78
Deferred stock awards	$	138	0.83
Performance deferred stock awards	$	45	0.46